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Summary 
One major function of glial cells is to support neurons and create an environment that allows 
fast signal propagation. However, when neurons are ensheathed, they also get isolated from 
the extracellular environment and can no longer take up factors required for growth and 
function. Hence, glial cells have to regulate the neurons’ metabolic and trophic support. To 
identify candidate genes that are necessary for this support, we initiated a RNA interference 
screen in Drosophila peripheral nerves. 
In a screen for highly conserved molecules, we could successfully detect genes that are both 
required in glial cells and important for neuronal architecture and function. We found that 
pan-glial inhibition of p24-1 resulted in axonal loss, changed nerve architecture, 
transportation failure of axonal vesicles, migration defects of photoreceptor cells and 
swellings of neuronal mitochondria. p24 proteins act in the secretory pathway to shuttle 
cargo molecules through the biosynthetic pathway. A second p24 family member, opossum, 
reproduced the p24-1 phenotype revealing that they act in concert. Thus, we tried to identify 
the p24-1 cargo in a secondary RNAi screen. The iron binding protein Ferritin1 heavy chain 
was identified which displayed the same peripheral nerve phenotype as p24-1 knockdown. By 
in vivo and in vitro studies, we could show that Fer1HCH is released from glia cells and taken 
up by neurons. The inhibition of glial iron release caused accumulations of toxic ferrous iron 
resulting in ferroptosis. The application of inhibitors, which chelate iron or inhibit ferroptosis, 
reduced glial and axonal phenotypes. However, the transport defect of axonal vesicles was 
not recovered. As iron is essential for mitochondrial function, we assumed that iron import is 
required in neurons for energy production. Thus, we aimed to measure the effect of iron 
deprivation on neurons. Therefore, two binary expression systems were combined allowing 
for manipulations on glial cells and contemporaneous isolation of translating ribosomes from 
neurons. We found that several iron responsive transcripts are down-regulated upon 
blockage of glial Fer1HCH secretion. Hence, we identified a route for iron import into the 
nervous system of Drosophila and could show that blockage of this transport caused glial 
ferroptosis.
1 
1 Introduction 
Higher organisms are equipped with a complex nervous system, which consists only of the 
two cell types neurons and glia. 
Neurons transduce information through electrical and chemical signals. They connect to each 
other and thereby form a network, which is capable to compute complex inputs and permits 
the organism to adapt by a changed behavior. 
The glia was long time considered to be the glue that keeps the brain together (Virchow, 
1871). In fact, these cells have vital roles in development, health and function of the nervous 
system. They insulate axons by forming a multi-layered membrane structure (Bhat et al., 
2001; Salzer et al., 2008; Snaidero et al., 2014) and protect them by maintaining a constant 
ionic milieu through control of the blood-brain barrier (Abbott et al., 2006; Stork et al., 2008). 
Glial cells direct the outgrowth of axons during development (Gilmour et al., 2002; Sepp et al., 
2001) and they control synapse formation and maturation (Allen and Barres, 2005). They 
carry out the metabolic support of the neuron by providing lactate (Saab et al., 2013; 
Tsacopoulos and Magistretti, 1996; Volkenhoff et al., 2015). They respond to neural stimuli 
with calcium waves (Schummers et al., 2008), are involved in synaptic transmission (Fields, 
2002) and even modify neuronal signals by releasing gliotransmitters (Volterra and Meldolesi, 
2005). 
All these assignments are based on multiple reciprocal interactions between neuronal and 
glial cells. Thus, they need to communicate, which is mediated either by release of molecules 
or by direct cell contacts. Studies, mostly analyzing developmental nervous system processes 
showed that glia and neuron depend on each other (Ghosh et al., 2011; Hidalgo et al., 2006, 
2011; Stratoulias and Heino, 2015). Later, during maturation a spatial tight interaction 
between the two cell types is set, which is difficult to investigate in vivo and thus poorly 
understood. To examine this interaction process Drosophila serves as an favored model 
 Introduction  2 
organism because of the lower glia/neuron ratio compared to vertebrates (Herculano-Houzel, 
2014). The advantage of the more simple structure paired with a high degree of conserved 
characteristics makes the Drosophila nervous system an ideal system to also gain relevant 
insights into glial functions in mammals (Stork et al., 2012). 
1.1 Morphological classes of glia cells 
To be able to fulfill complex functions glia cells needed to specialize. This is reflected in a 
variety of different morphologies. In the next section, I want to summarize different classes of 
glial cells in the vertebrate and invertebrate system. 
1.1.1 Origin and function of glia cells in the vertebrate system 
In the vertebrate nervous system, we mainly find four glial cell types: astrocytes, 
oligodendrocytes, Schwann cells and microglia. 
Astrocytes and oligodendrocytes are resident in the central nervous system (CNS). In the 
embryo, neuroepithelial progenitor cells (NPC) develop to radial glia which first give rise to 
neurons and then to astrocytes and oligodendrocyte precursor cells (OPC) (Rowitch and 
Kriegstein, 2010). Astrocytes represent the most frequent glial cell type in the CNS. These 
cells are of great importance because they have both regulatory roles and are necessary for 
the neuronal survival (Allen, 2014). In addition to many other tasks, astrocytes mediate 
metabolic support of CNS cells through coupling to the vascular system (Pellerin et al., 2007). 
They control the formation, function and turnover of synapses for instance by removal of 
neurotransmitter, by pruning synapses and by buffering potassium levels (Allen, 2014; Clarke 
and Barres, 2013). 
Oligodendrocytes form myelin around axons of the CNS, which consists of multi-layered 
wraps of compacted membrane (Simons and Nave, 2015). This serves as an electric insulator 
and allows saltatory nerve conduction between the nodes of Ranvier (Seidl, 2014). 
Myelination in the CNS begins within the first weeks after birth. Thereby OPCs undergo 
morphological changes and send processes to enwrap multiple axons simultaneously 
(Snaidero et al., 2014). Recent studies suggest that myelination is not terminated after 
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development but rather adapts to neuronal activity for example during the acquisition of new 
motor skills (Gibson et al., 2014; Mckenzie et al., 2014). 
Microglia, the third class of glial cell in the CNS, arise from mesodermal erythromyeloid stem 
cells which have a yolk sac origin (Aguzzi et al., 2013; Ginhoux et al., 2013). They are mainly 
described to be the tissue-resident immune cells of the brain and come into action when 
apoptotic cells and pathogens need to be removed (Casano and Peri, 2015). Recent work 
suggests that microglia are also involved in neurogenesis and wiring of the brain by secreting 
neurotrophic factors (Shigemoto-Mogami et al., 2014; Squarzoni et al., 2014) as well as by 
participating in synaptic refinement (Holtmaat and Svoboda, 2009). 
Schwann cells, the main glial type in the peripheral nervous system (PNS), arise from cells of 
the neural crest (Jacob, 2015). Comparable to CNS progenitor cells, neural crest cells give first 
rise to neurons and later to glia. They generate two populations: Schwann cell precursors and 
satellite glia. The latter stay associated with the cell neuronal body where they probably 
regulate the metabolic support (Huang et al., 2013). Schwann cell precursors migrate along 
the peripheral nerve and form myelin around thick caliber axons. As in the CNS this ensures 
rapid signal conduction but in comparison to oligodendrocytes, they only form one internode 
(Salzer, 2015). During nerve injury, Schwann cells can remove dead cells and mediate repair 
(BrosiusLutz and Barres, 2014; Jessen and Mirsky, 2016). 
1.1.2 Glial cell types in Drosophila 
In the Drosophila nervous system, we find three main classes of glial cells: surface-associated 
glia, cortex-associated glia and neuropil-associated glia.  
Surface-associated glia has epithelial character and can be further subdivided based on 
morphological features (Stork et al., 2012). Perineurial glia represents the outermost glial 
layer. Together with macrophages they are thought to build the neural lamella and serve as a 
first physical barrier to protect the nervous system (Carlson et al., 2000; Leiserson et al., 
2000), but they do not form stable cell contacts (Stork et al., 2008). They also were described 
to be responsible for the import of the sugar trehalose from the hemolymph (Volkenhoff et 
al., 2015). Subperineurial glia cells, the second class of surface glia, lie underneath perineurial 
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glia cells and enclose the nervous system. They form a thin monolayer with stable contacts 
between the cells. These contacts consist of pleated septate junction (pSJ), which prevent 
para-cellular diffusion and thereby seal the nervous system forming the blood brain barrier 
(BBB) (Auld et al., 1995; Baumgartner et al., 1996; Stork et al., 2008). 
The cortex-associated glia is restricted to the CNS, where it ensheathes neuroblasts as well as 
neuronal cell bodies, and makes contacts to the blood-brain barrier and the tracheal system 
(Pereanu et al., 2005). Cortex glial cells are most likely also responsible to for the metabolic 
support of neuronal cell bodies. 
The neuropil-associated glia can be separated in three sub-classes. Wrapping glia cells, 
primarily in the PNS, have a tight interaction with axons and enwrap single axons during larval 
stages (Stork et al., 2008). The ensheathing glia resides in the CNS, where it sends processes 
around the synaptic neuropil and subdivides brain regions (Awasaki et al., 2008; Hartenstein, 
2011). Astrocyte-like glia cells, in contrast to the ensheathing glia, infiltrate the neuropil. Cells 
of this type are closely associated to synapses (Freeman, 2015; Stork et al., 2012). Drosophila 
astrocytes ensure signal transduction at the synapse by regulating the neurotransmitter 
homeostasis and even modulate neuronal transmission (Freeman, 2015). 
Most of the above-described so-called lateral glia cells arise during embryonic stages 8-12 
from neural precursor cells termed neuroglioblast, which produce ganglion mother cells 
giving rise to neurons and glia. Another type of stem cells are glioblasts, which produce solely 
glial progeny (Altenhein et al., 2015). The switch between neuronal and glial cell fate is 
mediated by the transcription factor glial cells missing (gcm), which is expressed in all glial 
cells (except midline glia) (Jones et al., 1995). Known target genes of gcm are reverse polarity 
(repo), poinedP1 and tramtrack p69 (Jones, 2005). The best studied glial transcription factor is 
repo, which is expressed in the longitudinal glia pattern throughout the fly life (Campbell et 
al., 1994; Xiong et al., 1994). Repo has a dual role in glial differentiation: Tramtrack p69 
together with repo represses neuronal differentiation (Yuasa, 2003), while repo in 
combination with pointedP1 drives glial differentiation by activating downstream genes like 
loco defects (loco) and Dead ringer (Granderath et al., 2000; Klaes et al., 1994; Shandala et al., 
2003). 
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1.1.3 Layout of the larval nervous system of Drosophila 
The Drosophila embryonic as well as the larval nervous systems has been a favored model to 
study neural development and function over the last decades. The advantage of these models 
is particularly the easy accessibility and the translucent cuticle. Combined with versatile 
genetic tools, the system has been used by researchers to identify molecular programs and 
basic principles of neural development (Doherty et al., 2009; Gerber and Stocker, 2007; Lee 
and Luo, 1999; Lee et al., 1999; Silies et al., 2014; Stork et al., 2008). 
The larval behavior is quite simple. Locomotion includes bending, peristalsis, turning and 
feeding (Green et al., 1983). The sensory organs perceive thermal, chemical and light stimuli 
(Gomez-Marin and Louis, 2012). During larval stages new connections are made, neuronal 
cells form and the sensory organs develop (Hartenstein, 1993). 
The larva is structured in eleven segments. Beside the specialized head structure, there are 
three thoracic segments and eight abdominal segments (A1-A8) (Keshishian et al., 1996). In 
each abdominal segment, one can find ~60 body-wall muscles (30 per hemi-segment) which 
are innervated by the segmental nerves. The synaptic connections they make with muscles 
are termed neuro muscular junctions (NMJs). 
The larval nervous system can be divided in a central and peripheral part (Figure 1). The CNS 
consists of two brain lobes and the ventral nerve cord (VNC). Around 90% of all cells are of 
neuronal fate (Rodrigues et al., 2011). The cell bodies reside in the neuronal cell cortex. This 
structure can be distinguished from the neuropil, in which the axons and dendrites form 
connections (Freeman, 2015). The PNS comprises two segmental nerves per segment (one 
per hemi-segment) which results in a total number of 16 segmental nerves. The detailed 
structure of the peripheral nerves will be discussed in the following section. The length of a 
larva at the beginning of the first larval stage is ~0.5 mm and increases over the larval stages 
to a length of 7-8 mm. The longest peripheral nerve at the end of the third larval stage 
reaches 3 mm (Matzat et al., 2015). 
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Figure 1: Layout of the larval nervous system. Overview over the complete nervous system of a third instar 
larva. Glial layers can be labeled with different sub-type specific markers. (A) Schematic overview of the 
nervous system. Muscles are depicted in yellow, glia in green and neurons in red. The nervous system can 
be divided in a central (CNS) and a peripheral part (PNS). The abdominal nerves A1 – A8 connect muscles 
and sensory organs with the VNC. Note that glia membrane covers all nerves. (B) Confocal maximum 
intensity projection of the whole nervous system. Glia are labeled in green by repo CD8GFP expression, 
neurons with anti-HRP antibody and glial nuclei with anti-repo antibody stain. Scale bar 150 µm. (C) 
Orthogonal section through peripheral nerves reveals cell sub-types, which can be labeled with different 
markers (green). Axons are depicted in blue, glial nuclei in red. (a) Viking-GFP trap labels the neural 
lamella around the nerve. (b) Perineurial glia cells can labeled by GFP expression with the C527Gal4 line 
or with the Jupiter-GFP trap. (c) Subperineurial glia can be labeled by GFP expression with gliotactinGal4 
or with the 261-GFP trap. (d) Septate junctions appear as a thin line along the nerve. They can be labeled 
by a GFP-trap insertion in neurexinIV. (e) All glia can be labeled by GFP expression with repoGal4. (f) 
Wrapping glia can be labeled with the GFP-trap in the nervana2 gene or by GFP expression with 
nervana2Gal4. Scale bar 2 µm. (c) Reproduced from Stork et. al. 2008 with permission from Society of 
Neuroscience. 
 
 
1.1.4 Development of axonal ensheathment in the PNS 
The peripheral nerves of the Drosophila larva have a quite simple structure compared to the 
nerves of the CNS. The peripheral nerve consists of the segmental (or abdominal) nerve and a 
smaller transverse nerve. Each abdominal nerve comprises efferent motor axons and afferent 
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sensory axons. Approximately 36 motor neurons are born at the dorsal site of the VNC and 
project their axons to innervate the muscles in a highly stereotypic manner (Bate and Arias, 
1993; Keshishian et al., 1996; Kohsaka et al., 2012). Around 42 sensory neurons are located in 
the body wall, which project their axons to the ventral site of the VNC. Thus, the motor 
output and sensory input are clearly segregated (Landgraf et al., 2003; Mahr and Aberle, 
2006). Motor and sensory axons fasciculate and are ensheathed by glia. Seven glia cells are 
generated in the VNC migrating along the nerve and five glia cells are born in the periphery. 
At the end of embryogenesis, twelve glial cells reside in every nerve (von Hilchen et al., 2013). 
All glial layers can be distinguished by expression of different maker genes (compare Figure 1 
C) (Stork et al., 2008). The outermost layer, as in the CNS, is comprised of perineurial glia 
cells. These cells divide post-embryonically (Leiserson et al., 2000) enabling them to cover the 
whole nerve during the extensive larval growth phase (Figure 2). In contrast, the underlying 
subperineurial glia does not proliferate but accommodates nerve growth by extending the 
cell surface (Sepp et al., 2000). Subperineurial cells in the PNS form a thin epithelial-like 
monolayer around the axons. Thereby the cell enwraps the axons completely and forms an 
auto-cellular connection. In this ~4.7 µm long overlap the septate junctions are located 
(Matzat et al., 2015), which consist of components such as NeurexinIV, Gliotactin, Nervana2 
and Coiled and exhibit a ladder–like structure (Auld et al., 1995; Baumgartner et al., 1996; 
Genova and Fehon, 2003; Limmer et al., 2014). As mentioned before, these cell junctions seal 
the nerve and represent the hemolymph-nerve barrier. Only this protection against the high 
potassium concentration in the hemolymph allows a normal electrical conductance (Carlson 
et al., 2000; Stork et al., 2008). Septate junctions are set up at embryonic stage 17 and 
maintained during longitudinal and radial extension of the nerve (Limmer et al., 2014). 
Another task is fulfilled by the subperineurial glia. Inhibition of the kinase Fray or its 
downstream target sodium-potassium-chloride transporter NCC69 leads to nerve swellings 
and suggests that the glia functions in the control of the ionic balance within the nerve 
(Leiserson and Keshishian, 2011; Leiserson et al., 2000). The innermost glial layer is termed 
wrapping glia. Three to four wrapping glia cells reside in each nerve. They develop their 
characteristic morphology during larval stages by producing vast amounts of membrane 
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(Figure 2). At the end of the third larval stage, they terminate their differentiation and 
separate all peripheral axons (Stork et al., 2008). Gap junctions between glial cells are formed 
by Innexin proteins in early larval stages and interconnect the glial layers (Spéder and Brand, 
2014; Stebbings et al., 2002). 
 
 
 
Figure 2: Development of larval peripheral nerves. Schematic overview over the development of a peripheral 
nerve. Cross section view. In first instar larvae three glial cell type are present in the PNS: perineurial glia, 
which is surrounded by neural lamella, subperineurial glia, and wrapping glia (green). Note that wrapping 
glia produces large membrane amounts to separate all axons until the end of the third instar stage. 
Subperineurial glia constitutes an impermeable barrier by forming auto-cellular septate junctions already 
during embryonic stages. SPG grow in size to cover the radial nerve growth and maintain BBB integrity. 
Perineurial glia divide to cover nerve growth. 
 
 
1.1.5 Comparing axonal ensheathment between Vertebrates and Invertebrates 
Vertebrate peripheral axons are tightly associated with Schwann cells (Taveggia, 2016). As 
described before, they form myelin around the axon allowing saltatory nerve conduction. 
However, only thick caliber axons are myelinated (Gillespie and Stein, 1983). The myelin 
thickness is regulated by the release of the axonal factor Neuregulin-1 (Nrg1). While 
overexpression of Nrg1 leads to hyper-myelination, reduced NRG1 expression causes hypo-
myelination (Michailov et al., 2004). Nrg1 binding to the glially expressed EGF receptor 
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complex ErbB2/ErbB3 activates signaling cascades (PI3 Kinase/AKT-1 and MAPK/ERK) driving 
myelination (Taveggia, 2016). Thinner axons stay unmyelinated and lay in pockets of Remak 
fibers (Nave and Trapp, 2008). These Remak fibers arise from Schwann cell precursors and 
resemble quite strongly Drosophila wrapping glia cells  (Rodrigues et al., 2011). Comparing 
the vertebrate and invertebrate ensheathing process, not only the appearance of the cells but 
also the molecular mechanisms seems to be similar. In the Drosophila compound eye for 
instance, proliferation and migration but also differentiation of retinal glia cells is regulated by 
the fibroblast growth factor (FGF) receptor Heartless (Silies et al., 2014). The wrapping 
process around photoreceptor axons is triggered by the neuronally derived FGF8-like ligand 
Thisbe which activate Heartless (Franzdóttir et al., 2009). In Drosophila segmental nerves 
differentiation of the wrapping process is regulated by the activation of the epidermal growth 
factor receptor (EGFR). Binding of the neuregulin-like protein Vein regulates extension of glial 
membrane around peripheral axons. However, this seems to be an autocrine mechanism 
since Vein is derived from wrapping glia cells themselves (Matzat et al., 2015). Although 
Drosophila does not form myelin, the wrapping process in both vertebrates and invertebrates 
is controlled by the activation of receptor tyrosine kinases (Rodrigues et al., 2011). 
1.2 Modes of neuron-glia interactions 
Development and function of the nervous system are not only based on performance but 
rather on the interactions between neurons, glia and the environment. Many examples can 
be found in higher organism: intercellular signaling is needed for the neural specification and 
differentiation (Urbán and Guillemot, 2014); shaping of the dendritic tree is influenced by the 
target field (Jan and Jan, 2010); the establishment of synapses requires a close interplay 
between pre- and post-synapse (Margeta and Shen, 2010); axon pathfinding relies on neuron-
glia interactions (Chotard and Salecker, 2004). Interestingly, the relation of neurons and glia 
seems to get more sophisticated the more complex the nervous system is developed. In 
Drosophila only 10% of the cells within the nervous system are of glial fate, whereas in 
mammals the ratio is ~50 % (Herculano-Houzel, 2014). The fact that the neuron-glia unit is 
relatively simple combined with the advantages of Drosophila as a genetically powerful model 
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system, makes Drosophila nerves an ideal system to study cell interaction and communication 
within the nervous system (Edenfeld et al., 2005). 
1.2.1 Signaling between neurons and glia 
Much of our knowledge about signaling mechanisms between neuron and glia derives from 
studying the embryonic nervous system development. In the embryonic brain, glia guide the 
fasciculation of pioneer axons and ablating peripheral glia cells causes defasciculation and 
projection failure of sensory neurons (Klämbt and Goodman, 1991; Sepp et al., 2001; Tessier-
Lavigne and Goodman, 1996). One example for direct cell contact has been described 
between commissural axons and midline glia, where the Immunoglobulin superfamily (IgSF) 
members Wrapper and NeurexinIV mediate adhesion. Wrapper, which is attached to 
differentiating midline glia cells via a glycosylphosphatidylinositol (GPI) anchor, can bind to 
NeurexinIV presented on the axonal surface. Wrapper mutants fail to ensheath the 
commissural axons and the positioning of glial cells is disturbed (Noordermeer et al., 1998; 
Stork et al., 2009). A second IgSF member has been described to be important for early glial 
migration of PNS glia along axons of motor neurons. Fasciclin2 (Fas2) is expressed by motor 
neurons and glia cells to mediate cell adhesion in a homophilic manner. The local 
down-regulation of the axonal Fas2 by the Fizzy-related/Cdh1 complex then initiates 
migration of the glia. Hence, axonal signals control the onset of glial migration (Silies and 
Klämbt, 2010). Third, the IgSF member Neuroglian (Nrg) is required for a homophilic cell 
interaction. Neuronal and glial cells each express a distinct isoform, which contains different 
intracellular domains allowing linkage to the cytoskeleton via Ankyrin (Hortsch et al., 1990, 
2009). Beside axon sprouting and dendrite branching, Nrg is also involved in septate junction 
formation and synaptic stability (Enneking et al., 2013; Genova and Fehon, 2003). 
1.2.2 Secreted molecules in the nervous system 
Many of the molecules regulating neuron-glia communication are secreted factors. The 
already mentioned EGF receptor, for instance, is not only important for wrapping glia 
differentiation (Franzdóttir et al., 2009; Matzat et al., 2015) but also for the cell number 
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control in the Drosophila embryo (Silies and Klämbt, 2011). The axonally derived factors Spitz 
and Vein activate the EGF receptor of midline and longitudinal glia respectively, to prevent 
cell death (Bergmann et al., 2002; Hidalgo et al., 2001). Glia can also regulate neuronal 
proliferation by reacting on fat body derived signal triggering a release of insulin-like peptides. 
Neuroblasts perceive this insulin signals and exit quiescence (Chell and Brand, 2010). 
During embryonic development of the ventral nerve cord axons grow in a highly stereotypic 
manner. The pattern they create during this process is guided by repulsive and attractive 
signals (Jacobs, 2000). Netrin, for example, is secreted by the midline glia and attracts motor 
axons, which express the receptor Frazzled (Kolodziej et al., 1996). Slit is a repulsive cue and 
retracts axons expressing the receptor Roundabout (Robo) (Kidd et al., 1999; Seeger et al., 
1993). Migrating peripheral glia express the Netrin receptor Uncoordinated5 (Unc5) which 
acts repulsive when detecting the Netrin signal from the ventral midline. Interestingly, in the 
CNS neuronally derived Netrin directs longitudinal glioblasts towards the midline (von Hilchen 
et al., 2010). 
Another migratory cue, which can be found in the vertebrate and invertebrate system, is 
regulated via the platelet derived growth factor (PDGF) receptor. Activation of its Drosophila 
homolog PVR through neuronally secreted PVF ligands can trigger migration of midline glia 
cells in the embryo and in glia of the optic stalk in the Drosophila larva (Kim et al., 2014; 
Learte et al., 2008). Likewise in vertebrates, binding of PDGFα to the PDGF receptor activates 
proliferation of OPCs (Zuchero and Barres, 2013). 
Another example for glia-axon interaction involves the transforming growth factor (TGF) 
signaling. During metamorphosis, γ neurons of the mushroom body have to be remodeled. 
Therefore, a pruning process is started, which is controlled by the hormone ecdysone (Lee et 
al., 2000). Cortical and astrocyte-like glia regulate this step by secreting the TGFβ ligand 
myoglianin, which activates the receptor Baboon causing intrinsic TGFβ signaling in 
mushroom body neurons. The effect of this signaling is the up-regulation of the ecdysone 
receptor in neurons (Awasaki et al., 2011). Signaling between neurons and glia is also 
described during NMJ formation and function (Ou et al., 2014). Peripheral glia secrete the 
TGFβ ligand Maverick, which binds to the post-synapse and in turn activates glass bottom 
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boat (gbb) transcription inducing synapse growth (Ball et al., 2010; Fuentes-Medel et al., 
2012). Another TGF ligand, which acts at the NMJ, is the TNFα ligand Eiger. Upon glial 
secretion, Eiger binds to the neuronally presented TNFα receptor Wengen, which activates 
caspases and causes axonal and synaptic degeneration (Keller et al., 2011). Another 
interesting study showed the involvement of the morphogen wingless (Wg) at the NMJ. Glial 
cells secrete Wg, which induces glutamate receptor clustering at the post-synaptic site. This 
mechanism enables glia cells to regulate synaptic functionality (Kerr et al., 2014). 
1.2.3 Metabolic support in the nervous system of Vertebrates and Invertebrates 
A tight neuron-glia interaction is required to respond to the metabolic needs of the nervous 
system. In both, flies and humans, the nervous system is shielded from the blood and nutrient 
circulation. Hence, all metabolites required for the nervous system have to be shuttled over 
the blood-brain barrier. In the PNS of Drosophila and mice, we find especially long nerve 
tracts. Still, the metabolic needs of these nerves need to be satisfied. Constant energy supply 
is needed for the axonal transport, to maintain the ion gradient but also to synthesize and 
send synaptic and structural proteins along these nerves (Nave, 2010). Energy in form of ATP 
could be generated in the cell body, however it is likely that only local energy supply can 
ensure the integrity of the axonal function (Morrison et al., 2013). 
In vertebrates, access to nutrients for neurons is restricted in two ways: first by the blood-
brain barrier, which is set up by impermeable tight junctions of the endothelial cells in brain 
capillaries (Reese and Karnovsky, 2005) and second by the myelin membrane covering large 
parts of the axons. Astrocytes form connections between neuronal cell bodies and blood 
capillaries to ensure the metabolic import of nutrients (Abbott et al., 2006; Bélanger et al., 
2011; Kasischke et al., 2004). Glucose is transferred to oligodendrocytes via gap junctions to 
be used for glycolysis. Lactate can then diffuse through cytoplasmic channels and be released 
by the monocarboxylate transporter 1 (MCT1) (Saab et al., 2013). Subsequently, axons take 
up the lactate with help of MCT2 and use it for their mitochondrial energy production (Suzuki 
et al., 2011). 
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In Drosophila, the blood-brain barrier is established by surface glia cells. Hence, import of 
nutrients has to be accomplished by transport through these cells. It has been shown that the 
sugar trehalose is taken up from the hemolymph and processed by perineurial glia cells to 
alanine and lactate. Possibly, products can be shuttled over gap junctions to other glia cells in 
order to be released to neurons. Inhibition of glycolytic genes in glia cause neuronal death. 
Neurons take up lactate, which is further used for ATP production over the TCA cycle 
(Volkenhoff et al., 2015). Expression of glycolytic genes in neurons seems dispensable for 
energy supply, but required for longevity (Miller et al., 2012). 
1.3 Iron homeostasis 
Iron is an essential metabolite ensuring survival of almost all eukaryotic and prokaryotic 
organisms. As part of heme, iron-sulfur clusters (ISC) and as a cofactor iron is involved in vital 
processes like DNA synthesis, oxygen transport, metabolic energy production and cellular 
respiration (Gozzelino and Arosio, 2016). Although iron has various functions, its ability to 
exchange electrons with many substrates can also be toxic for cells (Harrison and Arosio, 
1996). In the presence of hydrogen peroxide, free iron can cause the production of reactive 
oxygen species (ROS) such as hydroxyl radicals via the Fenton reaction (Dixon and Stockwell, 
2014). This leads to oxidative stress, lipid peroxidation and DNA damage, which will comprise 
cell viability. To prevent these toxic effects, organisms developed a fine-tuned regulatory 
mechanisms, which allow binding, uptake, storage, mobilization and recycling of iron (Arosio 
et al., 2009; Connor et al., 1990; Rouault, 2006). 
1.3.1 Distribution and storage of iron 
In vertebrates, systemic iron supply is regulated over the iron level of the blood plasma. The 
glycoprotein Transferrin (Tf) can bind two molecules of ferric iron and circulates in the plasma 
in order to deliver iron to cells. The transferrin receptor is expressed in target cells, which can 
take up iron bound transferrin via clathrin-dependent endocytosis (Harding et al., 1983). Body 
iron is released from duodenal enterocytes and macrophages. Thereby, in humans the 
majority of iron (20-25 mg per day) is coming from recycled senescent cells (erythrocytes) 
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and only 1-2 mg iron per day has to be taken up by nutrition (Hentze et al., 2010). Gut cells 
absorb dietary iron with help of the divalent metal transporter (DMT1) (Gunshin et al., 1997). 
The hormone hepcidin, released by hepatocytes, plays a crucial role in the systemic iron 
supply. It binds to the iron exporter ferroportin of iron releasing cells, triggers its 
internalization and leads to a reduction of iron efflux (Nemeth et al., 2004). Upon cellular 
internalization of Tf-Fe2 via the transferrin receptor, early endosomes are acidified which 
causes a conformational change and release of iron (Dautry-Varsat et al., 1983). Iron is then 
reduced to Fe2+ by metalloreductases (Ohgami et al., 2006) and shuttled via DMT1 into the 
cytosol, whereas Tf is recycled back to the cell surface. The cytoplasmic so-called labile iron 
pool (LIP) can be used directly for iron based reactions or stored within the Ferritin complex 
(Arosio et al., 2009). The complex is built of 24 subunits of Ferritin 1 heavy chains (FTH1) and 
Ferritin light chains (FTL) and generates a nano cavity, which can accommodate up to 4500 
iron atoms (Tandara and Salamunic, 2012). Ferritin has been described to protect cells from 
iron toxicity and oxidative stress. FTH1 harbors a ferroxidase domain, which can induce the 
oxidation of ferrous (Fe2+) to ferric (Fe3+) iron and the deposition into the complex core. This 
stored iron is kept in a redox inactive form that is unaffected by Fenton chemistry (Arosio et 
al., 2009). Although Ferritin is mainly localized in the cytosol, it is probably also secreted 
(Meyron-Holtz et al., 2011). Two surface receptors for Ferritin have been identified: Scara-5 
and Tim-2. Scara-5 is involved in kidney organogenesis and preferentially binds Ferritin light 
chain circulating in the blood serum. Subsequently, iron-loaded Ferritin can be taken up by 
cells via receptor-mediated endocytosis. In contrast, T cell immunoglobulin-domain and 
muncin-domain 2 receptor (Tim-2) mainly binds H Ferritin, which causes its internalization 
into endosomes (Chen et al., 2005). It is expressed on B-cells, kidney cells and 
oligodendrocytes (Han et al., 2011; Todorich et al., 2008). Beside transferrin iron transport, 
the mechanism of Ferritin uptake represents an alternative way to deliver iron to cells (Wang 
et al., 2010). 
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1.3.2 Regulation of iron consumption 
The best-described functions of iron are the participation in the prosthetic group heme and in 
iron-sulfur clusters (ISC). Though in higher organisms they are also synthesized in the 
cytoplasm (Lill and Mühlenhoff, 2006), the majority of iron is consumed by the heme and ISC 
machinery inside of mitochondria (Rouault, 2015). Proteins, which use heme as a prosthetic 
group, are for instance hemoglobin, myoglobin, cytoglobin, cytochrome c-oxidase, NO-
synthase, lactoperoxidase and catalase. NADH-dehydrogenase, succinate dehydrogenase, 
aconitase are examples for enzymes with ISC (Tandara and Salamunic, 2012). The import of 
iron into mitochondria is accomplished by transporters termed mitoferrins (Paradkar et al., 
2009). 
Inside the cell, the expression of iron-binding proteins is regulated on a post-translational 
level over the IRE/IRP system (iron response element / iron response protein). Ferritins and 
other transcripts of the iron metabolism contain an iron responsive element in their 5’ 
untranslated region (UTR) or, like Ferroportin in the 3’ UTR (Figure 3). Under iron deprivation, 
the iron responsive proteins IRP1 and IRP2 bind with high affinity to the 5’ located IRE 
blocking ribosome binding and translation. In case the IRP binds to a 3’ IRE site, the transcript 
will be stabilized (Rouault, 2006; Tandara and Salamunic, 2012). High cellular iron levels cause 
a conformational change of the IRP, which can no longer bind to the IRE. Now translation can 
proceed for transcripts with 5’ IRE and degradation is triggered of the transcript with 3’IRE 
(Subbarao et al., 2006). With this iron-sensing system, the cell can quickly react to iron excess 
by translating iron storage molecules. Vice versa during iron deprivation, the translation of 
iron internalization proteins like TfR ensures the cellular demands (Gozzelino and Arosio, 
2016). 
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Figure 3: Regulation of iron storage and export with the IRE/IRP system. Iron-
responsive protein amounts are regulated on a translational level. Iron regulatory 
proteins (IRPs) bind to 3’ or 5’ untranslated regions in the mRNA. (a) In iron 
deficiency, IRPs bind to the 3’ UTR of TfR, which protects mRNA from 
degradation. Binding of IRP to the 5’ UTR of Ferritin however inhibits translation 
by block of ribosome binding. (b) If iron is present in cells, IRPs cannot bind to 
IREs and TfR mRNA allowing the degradation, whereas Ferritin mRNA can be 
translated. Adapted from Iron brain ageing and neurodegenerative disorders. 
Reproduced from Zecca et. al. 2004 with permission from Nature Publishing 
Group. 
 
1.3.3 Iron metabolism in the brain 
Iron is required for many brain functions such as myelin synthesis, neurotransmitter 
production, synaptic plasticity and neural mitochondrial respiration and metabolism (Moos, 
2002). Disturbed iron homeostasis is linked to neural dysfunction (Salvador, 2010): iron 
deficiency during development causes impaired cognitive abilities whereas iron overload 
leads to neuronal death (Ghosh et al., 2015). The challenge for the body is to provide the 
brain with iron, which is per se disconnected from the systemic circulation because of the 
blood-brain-barrier. To bypass this barrier, cells of the brain exhibit all components of the iron 
transport and storage system but the expression varies between the cell types. Iron enters 
the brain over the transferrin receptor expressed on endothelial cells of the BBB (Figure 4) 
and is released into the interstitial fluid (ISF) by ferroportin (McCarthy and Kosman, 2013; 
Moos, 2002). Astrocytes, which are over their end-feet in contact to the endothelium, can 
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shuttle iron and express the ferroxidase ceruloplasmin. This enzyme, as well as the 
oligodendroglial ferroxidase hephaestin oxidizes iron to Fe3+, which facilitates ferroportin 
mediated iron export (Patel et al., 2002). In the CNS transferrin is mainly synthesized by 
oligodendrocytes (Bloch et al., 1985). After iron entered the brain, it can bind to Apo-
transferrin and circulate in the ISF. Ultimately, holo-transferrin can be internalized from cells 
that express the TfR. Neurons stain strongly for TfR whereas microglia are characterized by a 
strong Ferritin staining (Rouault, 2013). 
 
 
 
Figure 4: Iron metabolism in the mammalian CNS. Iron can cross the BBB by uptake 
of circulating holo-transferrin from the blood with help of the Transferrin receptor. 
The iron exporter Ferroportin helps to release iron to the interstitial fluid. The 
astrocytic ferroxidase Ceruloplasmin oxidizes Fe2+ to Fe3+, which can bind to apo-
transferrin secreted from oligodendrocytes. Probably, neurons and glia acquire the 
majority of iron from iron-loaded transferrin in the interstitial fluid. Reproduced 
from Rouault et. al. 2013 with permission from Nature Publishing Group. 
 
1.3.4 Iron homeostasis in Drosophila 
Much less is known about the iron metabolism in Drosophila melanogaster. Although there 
are conserved iron regulatory proteins in flies and mammals, other molecules either do not 
have a functional homolog or are not described yet. As in vertebrates, iron is required for the 
functionality of proteins in form of a cofactor, bound to heme or as part of ISC (Tang and 
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Zhou, 2013a). In Drosophila, dietary iron is absorbed by the cells of the midgut, which express 
the DMT1 homolog Malvolio (Rodrigues et al., 1995). However, no molecule with a similar 
function as ferroportin, which is able to release iron has been identified yet (Tang and Zhou, 
2013b). Two multi copper oxidases (MCO) have been described to have a potential regulatory 
oxidase function similar to hephastin in vertebrates. MCO3 contains a putative iron-binding 
site and gene mutation leads to iron accumulation in the gut (Bettedi et al., 2011). For MCO1 
it is known that it has multi copper ferroxidase activity but the exact function remains unclear 
(Lang et al., 2012). Insect and mammalian Ferritins have a conserved structure of 12 heavy 
and 12 light chains but the intercellular localization differs (Pham and Winzerling, 2010). 
While vertebrate Ferritin is mainly found in the cytosol, in many invertebrate species Ferritin 
localizes to the biosynthetic vesicular pathway (Nichol et al., 2002). In fact, insect Ferritin is 
secreted and present in the hemolymph. In Drosophila, we also find a set of transferrin genes 
(Yoshiga et al., 1999). Transferrin 1 (Tsf1) is the counterpart of the mammalian iron 
transporter and is secreted into the hemolymph as well (Yoshiga et al., 1999). There is 
evidence that it is involved in the immune response but so far the exact function of Tf1 
concerning the distribution of iron remains elusive (Levy et al., 2004). Although Tsf1 and 
Ferritin are secreted so far no iron receptor like TfR or Ferritin receptor could be identified 
(Mandilaras et al., 2013). The iron loading of Ferritin is dependent on the delivery of cytosolic 
iron into the endoplasmic reticulum, which is most likely fulfilled by the zinc regulated iron 
transporter 13 (Zip13, also known as Zip99C). Zip13 mutants fail to transport iron to ER-Golgi 
compartment. Supposedly Zip13 can act as an iron exporter (Xiao et al., 2014). 
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1.4 Aim of this work 
The aim of this work is to identify molecules, which are involved in neuron-glia interaction 
and communication. We set out to search for glial proteins, which can influence the neuronal 
integrity. To find new glial molecules, which are needed for the neuronal function we selected 
the Drosophila peripheral nerve as a model. The superiority of this model is its simplicity 
combined with the genetic tools available. Only three glial sub-types are present in the 
peripheral nerves and the axo-glial structure has a highly stereotypical pattern. We conducted 
a cell type specific RNA interference screen of conserved molecules, which might have glial 
function in vertebrates and invertebrates. RNA interference was induced in all glial cells using 
a pan-glial activator line. Neuronal and glial membranes were labeled with specific markers. 
As readout for the screen, we used confocal microscopy to detect changes of the axo-glial 
unit in the peripheral nervous system. 
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2 Material and Methods 
 
The listed chemicals used to prepare buffers, media and solutions were purchased in pro 
analysis or cell culture grade quality from the following companies: 
AppliChem Merck Stratec 
Carl Roth New England Biolabs Sigma Aldrich 
Life Technologies Promega Thermo Fisher Scientific 
Machery Nagel 
Serva 
 
Roche 
5Prime 
Vector Laboratories 
PeqLab 
 
The solutions were prepared with ultrapure water and autoclaved or sterile filtered before 
use. 
 
 
2.1 Buffer, Media and Solutions 
 
4% PFA  heat 300 ml ddH2O to 60°C, dissolve 20 g PFA, add 1N NaOH 
until solution is transparent; add 50 ml 10x PBS, adjust pH to 
7.2, add ddH2O to final volume of 500 ml; aliquot and store at -
20°C until use. 
 
5% Milk    5% non-fat milk powder in PBS-Tween 
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10% APS    10% ammonium persulfate in ddH2O, store at -20°C 
 
10% GS 10% goat serum in PBT 
 
10% SDS  10% sodium dodecyl sulfate in ddH2O 
 
50% Chlorix 50% Chlorix cleaning agent in ddH2O 
 
70% Ethanol 70% Ethanol in ddH2O 
 
Apple juice agar dissolve 18 g agar in 500 ml ddH2O, autoclave, store until use. 
Add 150 ml ddH2O, heat in microwave; add 3 ml glacial acetic 
acid 
 
DNA loading buffer 10x  4 M urea 
    50% sucrose 
    50 mM EDTA 
    Spatula tip of bromphenol blue and xylene cyanol 
 
Lämmli buffer (4x)  0.25M Tris/HCl pH6.8 
    8% SDS 
    40% Glycerol 
    0.02% bromphenol blue 
200 mM DTT or 0.8% β mercaptoethanol 
 
LB agar plates    18 g agar per 1 L LB medium 
 
LB medium    10 g tryptone 
    5 g yeast extract 
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    10 g NaCl 
    Fill up to 1 L with ddH2O, adjust pH to 7 and autoclave 
 
Mowiol dissolve 12 g Mowiol in 30 g Glycerol; add 30 ml ddH2O and mix 
for 5 min; add 60 ml Tris-HCl pH8.5, centrifuge at 5.000/ 5 min; 
store at -20°C 
 
PBS 130 mM NaCl 
 7 mM Na2HPO4 
 3 mM KH2PO4 
 2.7 mM KCl 
 Adjust to pH 7.4 
 
PBT PBS and 0.3% Triton X-100 
 
PBS-T PBS and 0.05% Tween 20 
 
Protein lysis buffer 5 x IP buffer (Life Technologies) 
 150 mM NaCl 
 2 mM MgCL2 
 1 mM DTT 
 1x cOmplete Protease Inhibitor (Roche) 
 
Polysome extraction buffer 20mM Hepes, pH7.5  
 150 mM KCl 
 5mM MgCl2 
 1% Triton X-100 
 0.5 mM DTT 
 100 µg/ml Cycloheximide 
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 100 U/ml RNAse OUT 
 1x cOmplete Protease Inhibitor (Roche) 
Polysome wash buffer 150 mM NaCl 
 0.05% Triton X-100 
 50 mM Tris 
 5 mM MgCl2 
 40 U/ml RNAse OUT 
 
Running buffer (SDS-Page) 25 mM Tris base 
(10x) 192 mM glycine 
 0.1% SDS 
 
Resolving gel buffer 375 mM Tris HCl, pH 8.8 
 
Stacking gel buffer 125 mM Tris HCl, pH 6.8 
 
TAE buffer (10x) 400 mM Tris-acetate 
 10 mM EDTA 
 
Western blot transfer buffer 20mM Tris base 
 153 mM glycine 
 20% Methanol 
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2.2 Fly Genetics 
2.2.1 Maintenance and Crossing of Flies 
Fly lines were kept in plastic vials with Standard Drosophila food and maintained on 18°C, 
21°C or 25°C. For crossings, virgin female and 2-5 days old male flies were used. 
2.2.2 Germline transformation 
ϕC31 mediated germline transformation is a method to create a transgenic fly line. 
Therefore, a plasmid containing the gene of interest and a visible marker is injected into an 
early embryo that can integrate into the germline. The integration event is mediated by the 
ϕC31 integrase. The integration site is predefined by using intergenic landing sites that carry 
an attP attachment element, which can recombine with the attB site of the plasmid (Bischof, 
2006). 
To use the ϕC31 mediated germline transformation plasmid DNA was prepared with the 
Machery-Nagel Endotoxin-free Midi Kit. The landing site was selected upon expression 
strength. The microinjection procedure was performed by BestGene Inc. After receiving the 
F2 generation of transformants, the flies were crossed to balancer lines and a stable 
transgenic fly line was established. 
2.2.3 Generation of recombinant fly lines 
For some experiments, it was necessary to create recombinant fly lines. First, flies were bred 
which were heterozygous for the two genes of interest (gene A and B). Female offspring was 
then crossed to a balancer line. Single offspring of the second crossing was again crossed to 
balancer animals and tested for recombination by PCR or marker gene expression. 
2.2.4 Inhibitor Test of Ferroptosis inhibiting drugs 
Ferroptosis is a form of iron dependent cell death, which can be inhibited by applying iron 
chelators or the compound Ferrostatin-1. To test whether the genotypes of interest display 
ferroptosis dependent cell death, larvae were treated with a series of iron chelators and 
inhibitors: Deferoxamine salt (DFO, 50 μM), Cyxlopirox olamine (CPX, 4 mM), 
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Bathophenanthroline disulfonic acid (BPS, 50 μM) as well as with Ferrostatin-1 (Fer-1, 150 
μM) and ferric ammonium citrate (FAC, 25mM). To treat animals, crossings of Gal4 driver and 
UAS-RNAi line were set up and embryos were collected for 1h on agar plates containing 
standard fly food mixed with inhibitor solutions at 25°C. After hatching, the larvae were 
counted and selected for the right genotype. Every two days the animals were transferred to 
new plates containing the food inhibitor mixture. At the indicated time points, several animals 
were dissected and stained for axon defects with the HRP and Bruchpilot antibody. 
2.2.5 Isolation of primary cells from Drosophila Embryos 
To prepare a mixed culture of primary Drosophila cells, crossings of around 100 virgins of the 
Gal4 driver line repoCD8/GFP with 30 males of the UAS effector line UAS-Ferritin1HCH-HA or 
wildtype males for control was set up in a large embryo collection cages on agar plates 
containing fresh backer’s yeast. The flies were allowed to lay eggs for 4-6 hours at 25°C. Then 
the apple juice agar plate was changed and the collected embryos were kept at 4°C until 
further processing. The embryos were washed off the agar plate with tap water and help of a 
sieve. Now, the embryos were placed in 50% Chlorix solution for 3 minutes to remove the 
chorion. After rinsing with excess tap water the embryos were carefully transferred to a 
dounce homogenizer and homogenized with 7-8 strokes in 1ml Schneider’s medium. The cell 
suspension was transferred to a sterile 1.5 ml reaction tube and centrifuged at 500 g for 5 
minutes at room temperature. The pellet was resuspended in 1ml Schneider’s medium 
containing 1 mg/ml elastase and incubated for 30 minutes at room temperature. Now the 
cell-elastase mix was transferred to a 15 ml Falcon tube containing 4 ml Schneider’s medium 
with 10% fetal bovine serum (FBS) to inactivate the enzyme. The solution was filtered through 
a 50 μm syringe filter and centrifuged at 400 g for 5 minutes. The cells were carefully 
resuspended in 1 ml Schneider’s medium with 10 % FBS and 0.01% Penicillin/Streptomycin 
(Gibco) and seeded in different densities. 
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2.2.6 List of fly lines 
2.2.6.1 Wild-type and balancer stocks 
Table 1: Drosophila wild-type and balancer stocks used in this study. 
fly sock comment source / reference 
OregonR Wild-type Lindsyley and Zimm, 1992 
w1118 white-, wild-type Lindsyley and Zimm, 1992 
w1118;;TM3,e,Sb/TM6b,e balancer III.chromosome Bloomington Stock Center 
w1118;Tft/CyO balancer II.chromosome Bloomington Stock Center 
w1118;Tft/CyO;TM2,e/TM6b,e Balancer II+III.chromosome Klämbt, unpublished 
 
2.2.6.2 Exon traps and other transposon insertions 
Table 2: Drosophila mutants and transposon insertions used in this study. 
fly sock comment source / reference 
Ferritin1HCH451 Lethal P-element insertion in fer1hch Bloomington Stock Center 
NeurexinIV]454[ GFP-trap in neurexinIV (Edenfeld et al., 2006) 
Nrv2]GFP[ GFP-trap in nervana2 Bloomington Stock Center 
261]GFP[ GFP-trap expressed in subperineurial glia C. Klämbt, unpublished 
Jupiter]GFP[ GFP-trap insertion in jupiter Bloomington Stock Center 
p24-1EY12314 Viable P-element insertion in p24-1 Bloomington Stock Center 
P24-1KG09084 Viable P-element insertion in p24-1 Bloomington Stock Center 
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2.2.6.3 Gal4 activator lines 
Table 3: Drosophila Gal4 activator lines used in this study. 
fly sock comment source / reference 
Act5CGal4 Gal4 actin 5 C promoter fusion Bloomington Stock Center 
N-sybGal4 (#51635) Neuronal synaptobrevin Gal4 Bloomington Stock Center 
elavC155 Gal4 Gal4 neuronal expression Bloomington Stock Center 
Nrv2Gal4 Gal4 expression in wrapping glia Bloomington Stock Center 
GliGal4 
Gal4 expression in subperineurial 
glia 
(Sepp and Auld, 1999) 
c527Gal4 Gal4 expression in perineurial glia (Hummel et al., 2002) 
RepoGal4 Gal4 expression in glia Bloomington Stock Center 
Repo4.3 Gal4 Gal4 expression in glia (Lee and Jones, 2005) 
LppGal4 Gal4 expression in fat body (Brankatschk and Eaton, 2010) 
 
2.2.6.4 UAS effector lines 
Table 4: Drosophila UAS effector lines used in this study. 
fly sock comment source / reference 
UAS-CD8GFP Membrane GFP expression 
Bloomington Stock 
Center 
UAS-Ferritin1HCH-HA Ferritin1HCH-HA expression This work 
UAS-p24-1[D.viri]-3xHA p24-1 from D. virilis expression This work 
UAS-24-1[stringDNA] Synthetic p24-1 expression This work 
UAS-24-1[stringDNA]-GFP Synthetic p24-1-GFP expression This work 
UAS-Rpl10ab-HA Rpl10ab-HA expression (Bischof et al., 2013) 
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2.2.6.5 Recombinants 
Table 5: Drosophila recombinants generated in this study. 
fly sock comment source  
repoGal4, CD8mCherry, 
ppkGFP 
repoGal4 and ppkGFP on third chromosome This work 
repoGal4, n-sybQF.2 
repoGal4 and nsybQF.2 on third 
chromosome 
This work 
 
2.2.6.6 Q-System stocks 
Table 6: Drosophila Q system lines used in this study. 
fly sock comment source / reference 
QF.2-Act5C  Actin 5 C promoter fusion Bloomington Stock Center 
QF.2-N-syb QF.2 expression in neurons Bloomington stock center 
QUAS-GFP-Rpl10ab 
Expression of GFP-Rpl10ab with Q 
system 
This work 
QUAS-HA-Rpl10ab 
Expression of HA-Rpl10ab with Q 
system 
This work 
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2.3 Immunohistochemistry 
2.3.1 Fixation and antibody staining of Drosophila primary cells 
The fixation protocol was performed at room temperature. Cells were grown in 24-well or 48-
well plates. First, the cell culture medium was removed and 4% PFA was added for 15 minutes 
at room temperature. Then the PFA was removed and the fixed cells were washed three 
times for 5 minutes each with PBS. The permeabilization as performed by adding PBS with 
0.1% Triton X-100 for two minutes followed by three washes with PBS. Now, the cells were 
blocked with 3% BSA in PBS for 30 minutes. The primary antibody was diluted in 3% BSA/PBS 
and the cells were either incubated for four hours at room temperature or overnight on 4°C. 
Afterwards, the coverslips were washed four times for 5 minutes with PBS. Now the 
secondary antibody was diluted 3% BSA and incubated on the cells for 2 h at room 
temperature. Upon three washes with PBS (5 min each), coverslips were briefly washed in 
ddH2O and mounted on objective slides with a drop of Mowiol. 
2.3.2 Dissection, fixation and antibody staining of larval nervous system 
To analyze the larval nervous system as a whole filet preparation of the 3rd instar larvae was 
performed. The larvae of the right genotype were collected in PBS on a silica gel preparation 
plate. One larva was transferred to a drop of ice cold PBS and pinned on the plate, dorsal site 
up, with minutiae needles on the most anterior and posterior ends. Several washes with cold 
PBS helped to anesthetize the animal. Now a small cut at the dorsal posterior end and a long 
cut at the midline until the mouth hawks opened the animal. After removal of trachea and gut 
tissue with help of fine forceps, the preparation could be opened and fixed on 4 outer sides 
with needles. After 30 minutes of dissection, the filet preparations should be fixed. 
For fixation, Bouin’s solution (3 min fixation) or 4 % PFA was used (20 min fixation) was used 
depending on the antibody. Fixation was followed by three short washes and transfer of the 
filet preparations into a 1.5 ml reaction tube. Additional three 15 min washes with PBT were 
performed. Tissue was blocked at least 1 h with 10% goat serum at room temperature or at 
4°C over night. Primary antibody was diluted in 10% goat serum and incubated with the 
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preparations at 4°C for 16 h. Antibody was removed and two short and three long washing 
steps (15 min each) was performed. Secondary antibody was again diluted in 10% goat serum 
and incubated with the preparations for 4 h at room temperature under agitation. Again, 
stained tissue was washed adequately. All liquid was removed and replaced by 2 drops of 
Vecta Shield mounting medium (Vector Laboratories). Tissue was stored several days until it 
was mounted. 
The preparations were mounted on an objective slide in a drop of Vecta Shield. As a small 
spacer for the cover slip a bit of modeling clay was used. The cover slip was attached with 4 
drops of transparent nail polish. 
2.3.3 Staining of iron in the larval tissue 
Iron can be found in two oxidation states, ferrous (Fe2+) and ferric (Fe3+) iron. To stain ferric 
iron the Perl’s stain was applied; to stain ferrous iron the Turnbull’s blue stain was used. 
Third instar larvae were collected and dissected as described in 2.3.2. The tissue was fixed for 
20 minutes in 4% Paraformaldehyde (PFA). The samples were washed three times with PBS. 
Before iron staining, the samples were incubated for 15 minutes in 2% H2O2 in Methanol. 
Then they rinsed well several times with distilled water. Now the staining working solutions 
could be prepared. For Perl’s stain one part of 10% potassium ferrocyanide solution was 
mixed with one part of 10% hydrochloric acid. For Turnbull’s blue stain one part of 2% 
ferricyanide solution was mixed with one part of 2% hydrochloric acid. The samples were 
immersed for 1 hour in the corresponding working solution. After removing the staining 
solution, the samples were washed 6 times with distilled water. To enhance the blue iron 
stain, a 3.3’-diaminobenzidine (DAB) enhancement was carried out with the ImmPACT DAB 
Peroxidase Substrate Kit (Cat.No. SK-4105, Vector Laboratories). The samples were covered 
with DAB working solution according to manufacturer’s instructions. Afterwards the samples 
were washed for 5 minutes in distilled water. Before mounting on an objective slide, the 
samples were dehydrated with an ethanol series and cleared with 2 washes of xylene. Finally, 
the preparations were embedded in DePeX (Serva). 
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2.3.4 List of antibodies used for immunohistochemistry 
2.3.4.1 Primary antibodies 
Table 7: Primary antibodies used in this study. 
Antibody origin Dilution source / reference 
α-Repo (8D12) mouse IgG 1 : 200 Developmental Studies Hybridoma Bank 
α-GFP rabbit IgG 1 : 1000 Life Technologies 
α-GFP mouse IgG 1 : 1000 Life Technologies 
α-HA (F7) Mouse IgG 1 : 100 Santa Cruz 
α-HA Rabbit IgG 1 : 250 abcam 
α-Bruchpilot mouse IgG 1 : 300 Developmental Studies Hybridoma Bank 
α-Elav rat IgG 1 : 50 Developmental Studies Hybridoma Bank 
α-Futsch mouse IgG 1 : 200 Developmental Studies Hybridoma Bank 
α-24B10 mouse IgG 1 : 100 Developmental Studies Hybridoma Bank 
α-E06 mouse IgM 1 : 500 Avanti 
α-ATP5α mouse IgG 1 : 1000 abcam 
α-HRP-Cy3 rabbit 1 : 200 Jackson ImmunoResearch 
α-HRP-Alexa647 goat 1 : 200 Jackson ImmunoResearch 
 
2.3.4.2 Secondary Antibodies and dyes 
Table 8: Secondary antibodies used in this study. 
Antibody Conjugation origin Dilution source / reference 
α-Mouse IgG Alexa 488, 555, 647 goat 1:1000 Life Technologies 
α-Rabbit IgG Alexa 488, 555, 647 goat 1:1000 Life Technologies 
α-Rat IgG Alexa 488, 555, 647 goat 1:1000 Life Technologies 
α-Mouse IgM Alexa 488, 555, 647 goat 1:1000 Life Technologies 
ToPro3 - - 1:10000 Life Technologies 
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2.4 Molecular biology 
2.4.1 Bacteria strains 
Table 9: Bacterial strains used for cloning in this study. 
Strain source 
E. coli DH5α Max Efficiency competent cells Thermo Fisher Scientific 
E. coli OneShot Top10 chemically competent cells Thermo Fisher Scientific 
E. coli OneShot ccdB Survival 2T1 chemically competent cells Thermo Fisher Scientific 
 
 
2.4.2 Plasmids 
Table 10: DNA plasmids used in this study. 
Plasmid Description Reference 
pUAST 
P-element mediated germline 
transformation 
(Brand and Perrimon, 1993) 
pUASTattB ϕC31 mediated germline transformation (Bischof et al., 2007) 
pUASTattB-RfA 
ϕC31 vector combined with Gateway 
system 
(Stephan, 2008) 
pUASTattB-RfA-GFP 
ϕC31 vector combined with Gateway 
system and c-terminal eGFP tag 
(Stephan, 2008) 
pUASTattB-RfA-3xHA 
ϕC31 vector combined with Gateway 
system and c-terminal 3 x HA tag 
(Stephan, 2008) 
pUASTattB-Myc-RfA 
ϕC31 vector combined with Gateway 
system and n-terminal Myc tag 
(Stephan, 2008) 
pQUAST Q system germline transformation vector (Potter et al., 2010) 
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pUAST-GFP-Rpl10ab 
Transformation vector to express n-
terminal GFP tagged Rpl10ab 
(Thomas et al., 2012) 
pUAST-HA-Rpl10ab 
Transformation vector to express n-
terminal HA tagged Rpl10ab 
(Thomas et al., 2012) 
pENTR/D-TOPO Cloning vector, Gateway system Life Technologies Inc. 
 
2.4.3 Transformation of DNA 
Transformation of plasmid DNA into chemically competent DH5α, TOP10 or ccdB Survival 2T1 
E. coli cells was performed according to manufacturer’s instructions. Upon heat-shock, 250 µl 
warm SOC medium was added and cells were incubated at 37°C for 1 hour under agitation. 
Finally, cells were spread on LB agar plates containing 100 µg/ml ampicillin or 50 µg/ml 
kanamycin according to the antibiotic resistance of the plasmid DNA and incubated for 16-18 
h at 37°C. 
2.4.4 DNA restriction 
For DNA restriction, usually 1µg DNA was used. Restriction was performed as recommended 
by manufacturer’s instructions (NEB). DNA and restriction enzyme mix was incubated for 2-3 
hours at 37°C. 
2.4.5 Mini plasmid purification 
Single bacteria clones were inoculated in 4 ml LB medium containing the corresponding 
antibiotic and incubated for 16-18 h at 37°C under constant shaking. Medium was centrifuged 
at 10000g for 5 minutes. The isolation of plasmid DNA was performed with NucleoSpin 
Plasmid purification kit (Machery-Nagel) following manufacturer’s instructions. DNA was 
eluted with 50 µl warm, sterile ddH2O. 
 
Material and Methods  34 
2.4.6 Midi plasmid purification 
50 ml LB medium was inoculated with bacterial mini cultures of single clones and incubated 
under constant shaking overnight at 37°C. Cultures were centrifuged at 4000 g for 15 min at 
4°C. Plasmid extraction was performed using NucleoBond Xtra Midi EF Kit (Machery-Nagel) 
followed by manufacturer’s instructions. DNA was eluted using 250 µl warm, sterile ddH2O. 
Concentration was determined with a NanoDrop2000c measuring the 260 nm absorbance of 
1 µl DNA solution. 
2.4.7 Isolation of genomic DNA from tissue 
Isolation of genomic DNA from single flies was performed using the Invisorb Mini Tissue Kit 
(Invitek) according to manufacturer’s instructions. Fly tissue was lysed overnight at 52°C and 
isolated DNA was reconstituted in 15 µl H2O and stored at -20°C. 
2.4.8 Polymerase Chain Reaction 
Specific DNA sequences for cloning or genotyping were amplified by polymerase chain 
reaction (PCR). For cloning purposes, the Phusion High-Fidelity DNA polymerase Kit (NEB) was 
used. For conventional genotyping, the GoTag Flexi DNA polymerase Kit (Promega) was used. 
The PCR mix contained 1 x Polymerase buffer, 1.25 mM MgCl2, 0.2 mM dNTPs, 0.5 mM of 
each primer, 1-5 µl of template DNA and 1.25 U of DNA polymerase. The mixture was filled up 
to 20 µl with ddH2O and incubated in a Thermocycler with an adapted temperature profile as 
indicated in Table 11. 
Table 11: Exemplary temperature profile for GoTaq and Phusion based PCR. 
Temperature profile GoTag PCR  Temperature profile Phusion PCR 
95°C 3 min.   95°C 30 sec.  
95°C 30 sec.   95°C 10 sec.  
64°C 30 sec. 39 cycles  68°C 15 sec. 35 cycles 
72°C 1 min.   72°C 15 sec.  
72°C 8 min.   72°C 8 min.  
4°C ∞   4°C ∞  
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2.4.9 Agarose gel electrophoresis 
To visualize PCR products or restriction enzyme digested products, DNA was separated by 
agarose gel electrophoresis and stained with the fluorescent DNA binding dye SybrSafe (Life 
Technologies). 1% agarose was mixed with 1 x TAE buffer and heated for 3 minutes in a 
microwave. SybrSafe (1 to 10 diluted) was added and the gel was cast in a gel chamber. 10-30 
µl of DNA mixed with 10 x DNA loading dye was loaded in gel pockets and gel was run at 120V 
for 30-60 minutes. Finally, DNA was visualized with an INTAS UV system and the INTAS 
capture software. 
2.4.10 Molecular Cloning 
For cloning of most DNA plasmids, Life Technology’s Gateway system was used. First, pENTR 
clones were generated using the pENTR/D-TOPO cloning Kit according to manufacturer’s 
instructions. Plasmids were amplified by transformation in chemically competent E. coli 
Top10 cells. Screening for correct clones was performed by restriction enzyme digestion of 
plasmid mini preparations (MiniSpin Kit, Machery-Nagel) and sequencing followed by large 
scale DNA isolations via Midi preparations (Nucleobond Midi Kit EF, Machery-Nagel). To 
generate expression plasmids the Gateway LR clonase enzyme kit was used according to 
manufacturer’s instructions. 100 ng pENTR containing the gene of interest was incubated wit 
150 ng of expression vector containing the Gateway cassette (RfA). Correct clones were 
negatively selected in the presence of ccdB gene and by antibiotics resistance. 
For integration of short sequences into a DNA plasmid site directed mutagenesis PCR was 
used (Liu and Naismith, 2008). PCR was performed as described with Pfu DNA polymerase 
(Promega). Integration was verified by sequencing. 
2.4.11 Sequencing and primer design 
Primers were designed with the DNAStar8 software SeqBuilder. Primer synthesis as well as 
sequencing was performed by the AGCTLab (core facility, MPI for experimental medicine). 
Sequences were evaluated with DNAStar8 software SeqMan. 
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2.5 Biochemical methods 
2.5.1 Protein extraction from Drosophila larvae 
Third instar larvae of the correct genotype were collected and washed in PBS. If brain extracts 
were needed, larvae were dissected in ice cold PBS. Brains were collected on ice in a fresh 
1.5 ml reaction tube with protein lysis buffer. Depending on the downstream application 
either 2-3 μl of lysis buffer was used per brain. If whole larval extracts were needed, the 
larvae were transferred directly to a pre chilled dounce homogenizer. 10-15 μl of lysis buffer 
was used per larva. The tissue or the larvae were homogenized on ice with a pestle, passed 
through a 27 gauge needle and if needed, sonicated for 1 minute (Branson type sonicator) 
with 30% power. The crude lysate was cleared by centrifugation at 10000 g, 4°C for 20 
minutes. The liquid phase (between the pellet and the lipid phase) was transferred to a fresh 
reaction tube 
2.5.2 SDS polyacrylamide gel electrophoresis 
Proteins of tissue lysates were separated by size on a sodium dodecyl polyacrylamide gel 
electrophoresis (SDS page) (Laemmli, 1970). To cast the polyacrylamide gels the Bio-Rad mini 
gel system was used. The composition of a 10 % mini gel is indicated in Table 12 . Prior to 
loading equal amounts of protein lysate on the gel, 4x Laemmli buffer was added to the 
protein lysate and samples were heated for 10 min at 70°C. For non-reducing gel 
electrophoresis no reducing agent (DTT or β mercaptoethanol) was added to the sample 
buffer. Empty gel pockets were loaded with Laemmli buffer only and one pocket was loaded 
with 5 µl of pre-stained protein ladder (Thermo Fisher Scientific). Electrophoresis was 
performed at 100 V in running buffer. 
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Table 12: Recipe for polyacrylamide mini gels. 
Stacking Gel  Resolving Gel 10%  
H2O 1.21 ml H2O 1.66 ml 
30% Acrylamide solution 0.27 ml 30% Acrylamide solution 2.04 ml 
Stacking buffer 0.5 ml Resolving buffer 1.3 ml 
10% SDS solution 20 µl 10% SDS solution 50 µl 
10% APS solution 20 µl 10% APS solution 50 µl 
TEMED 3 µl TEMED 2 µl 
 
2.5.3 Western blot and protein detection 
Upon separation of proteins Western blot was performed (Burnette, 1981). The mini gel (only 
the resolving gel part) was incubated for 5 minutes in transfer buffer. Then, the gel together 
with Whatman filter papers and nitrocellulose membrane was assembled in a blotting 
cassette (Bio-Rad). Blotting was performed at 4°C with a cooling pack at 30 V for 16 h. After 
transfer, the nitrocellulose membrane was transferred to a 50 ml tube and blocked with 5% 
milk in PBS-T for 60 min under agitation. Then, the first antibody was added and the 
membrane was incubated on 4°C overnight. After washing with PBS-T, the second HRP-
coupled antibody was added and incubated for 60 min at room temperature followed by 30 
min washing with PBS-T. Proteins were detected by adding Pierce ECL Western Blotting 
substrate. The light emission was detected with X-ray films. 
 
2.5.4 Cell type specific affinity isolation of translating Ribosomes (TRAP) 
For this method flies were bred expressing the ribosomal Protein RPL10 tagged with the HA 
protein label. The UAS- or QUAS-HA-Rpl10ab construct was either expressed in glial cells (with 
repoGal4) or in neurons (with n-syb QF.2). Around 200 3rd instar larvae of the corresponding 
genotype were collected and washed in PBS. All the following steps were performed on ice. 
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3 ml of polysome extraction buffer per genotype was prepared freshly by adding 0.5 mM DTT, 
100 μg/ml cycloheximide, 1x Complete Protease Inhibitor and 100 U/ml RNAse OUT. For 
dissection, 10 ml polysome extraction buffer was prepared without RNAse OUT. Larval 
nervous systems were dissected and collected in 500 µl cold extraction buffer. 
Homogenization was conducted with a pre-cooled pestle and by passing the lysate through 
needles (20 gauge, 23 gauge, 27 gauge). Lysates were incubated for 30 min on ice and finally 
centrifuged at 10000 g for 30 min at 4°C. In the meantime, magnetic α-HA beads (F-7, Santa 
Cruz) were washed two times with 900 µl extraction buffer by collecting the beads for 1 min 
on a magnet. The liquid phase was transferred to a fresh 1.5 ml reaction tube and incubated 
with the magnetic beads overnight at 4°C under agitation. 
4 ml of wash buffer was prepared. The supernatant was removed from the beads and three 
washes with gentle resuspending followed. Beads were transferred to a fresh RNAse free 1.5 
ml reaction tube and resuspended in 400 µl wash buffer. 5 µl 10% RNAse-free SDS solution 
and 5 µl of Proteinase K (RNAse-free, PeqLab) were added followed by an incubation at 55°C 
for 30 min. For RNA extraction, 400 µl Phenol/Chloroform/Isoamylalcohol (acidic, C. Roth) 
was added and vortexed for 30 sec. Mixture was transferred to Phase Lock Gel tube (5Prime), 
mixed by handshaking for 5 min and centrifuged at 14000 g for 5 min at RT. The upper phase 
was transferred to a fresh Phase Lock Gel tube, 400 µl Phenol/Chloroform/Isoamylalcohol was 
added and extraction was repeated. The upper phase was transferred to a fresh 1.5 ml 
reaction tube. RNA was precipitated by adding 0.1 x volumes of 8M LiCl, 0.007 x volumes of 
Glycoblue (15mg/ml) and 3 x volumes of 100% ice cold Ethanol. Mix was inverted and 
incubate for 8-15 hours on -20°C. The sample was centrifuged at 16000 g for 45 min at 4°C. 
The pellet was washed carefully with 500 µl 70% Ethanol and 5 min centrifugation at 4°C. 
After removal of the Ethanol the pellet was dried for 30 to 45 min at 4°C, resuspended in 20 
µl RNAse-free water and stored at -80°C.  
 
 
39  Material and Methods 
 
2.5.5 DNAse treatment of RNA 
Before starting, the complete work place as well as pipettes and devices were cleaned with 
RNAseZAP or with an Ethanol/ 2% SDS mixture to avoid RNAse contamination. 
RNA was thawed slowly on ice and filled up to 50 µl volume by adding 5 µl 10 x DNAse 
reaction buffer, 1 µl DNAse I (10 U/µl, Roche), 0.5 µl RNAse OUT and RNAse-free ddH2O. The 
mix was incubated at 37°C for 20 min. Then, 150 µl ddH2O and 200 µl P/C/I was added. After 
mixing for 30 sec on a vortex, the liquid was transferred to a Phase Lock Gel tube and mixed 
by hand shaking for 5 min. Upon centrifugation at 14000 g for 5 min at RT, the upper phase 
was transferred to a fresh 1.5 ml reaction tube. 200 µl P/C/I was added and mixed on a vortex 
followed by centrifugation. The upper phase was transferred to a fresh reaction tube. RNA 
was precipitated by adding 0.1 x volumes of 3 M NaAcetate, pH4.8, 0.007 x volumes of 
GlycoBlue (15 mg/ml) and 1 x volume of isopropanol on -20°C for at least 1 h. The mixture 
was centrifuged at 16000 g for 30 min at 4°C. The supernatant was removed carefully and the 
pellet was washed with 1 ml 75% Ethanol and 5 min centrifugation at 4°C. After removing the 
supernatant, the pellet was dried for 30 to 45 min and resuspended in 20 µl RNAse-free 
ddH2O. The concentration was determined using a NanoDrop. RNA was stored at -80°C. 
 
2.6 Image acquisition, processing and equipment 
2.6.1 Equipment used for image acquisition 
Table 13: List of microscopes used in this study. 
Equipment Company 
LSM 510 Confocal Microscope Carl Zeiss 
Stereo Discovery V8 Microscope Carl Zeiss 
Axiovert 100 M Fluorescent Microscope Carl Zeiss 
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2.6.2 Software 
Table 14: List of software and online resources used in this study. 
Name of the 
Software 
Application Source 
Adobe Illustrator 
CS4 
Image processing www.adobe.com/products/illustrator.html 
Adobe 
Photoshop CS4 
Image Processing www.adobe.com/products/photoshop.html 
DNASTAR 
Lasergene 8 
DNA analysis and editing www.dnastar.com/t-dnastar-lasergene.aspx 
Zen Software Image acquisition 
www.zeiss.com/microscopy/en_de/products/.../zen-
lite.htm 
Mendeley Bibliography manager https://www.mendeley.com/ 
Graphpad Prism Statistical analysis www.graphpad.com/scientific-software/prism/ 
Bitplane Imaris 
Image processing and 
analysis 
www.bitplane.com/ 
Flybase 
Genomic annotations in 
D.m. 
http://flybase.org/ 
Bloomington Fly line distributor http://flystocks.bio.indiana.edu/ 
VDRC RNAi lines distributor http://stockcenter.vdrc.at/ 
DPiM Protein interaction map https://interfly.med.harvard.edu 
Uniprot Protein database www.uniprot.org/ 
Signal P 4.1 Protein prediction tool www.cbs.dtu.dk/services/SignalP/ 
Panther Gene list analysis http://pantherdb.org/ 
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2.6.3 Statistical analysis 
The statistical analysis was performed with the Graphpad prism software. To compare two 
groups a Student’s t-test was used. For the comparison of tree or more groups the one-way 
ANOVA was performed. The post-hoc Bonferroni test was applied for a pairwise comparison. 
A p value of smaller than 0.05 was considered statistically significant for all tests. Results were 
expressed as standard error of the mean (SEM). 
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3 Results 
3.1 Screening of conserved glial proteins 
To study neuron-glia interactions, we used the Drosophila peripheral nerves as a model 
system. The fly’s peripheral nerves have a simple structure, are easy to access and versatile 
genetic tools make them suitable for a screening approach. To identify glial genes, which are 
important for neurons, we designed a screen in which we inhibited a set of genes in the glia 
and searched for neuropathies. The technique of RNA interference combined with the 
UAS/Gal4 expression system allows tissue specific gene silencing.  
3.1.1 Selecting candidates that are necessary in vertebrates and invertebrates 
We were interested to identify candidates, which are conserved between vertebrates and 
invertebrates. As a basis for the selection of candidates, a proteome analysis of axo-glial 
fractions from human and mouse central nervous system has been used (Manrique-Hoyos, 
2012). With the help of the NCBI search tool HomoloGene 
(www.ncbi.nlm.nih.gov/homologene), we selected those proteins, which had a homolog, or a 
similar protein in Drosophila. The UAS-RNAi fly lines for the selected 141 candidates were 
provided by VDRC (Table 18). As a glia specific driver line repo4.3;repoGal4,CD8GFP was used 
also expressing a membrane bound GFP. Most analyses in this study were performed with the 
repoGal4 line harboring two Gal4 insertions (also referred to as repoGal4,CD8GFP). 
 
3.1.2 Screening concept and results 
For the screening procedure, crossings of repoGal4,CD8GFP virgins and UAS-RNAi males were 
incubated at 25°C (Figure 5 A). The nervous system of third instar larvae was dissected and 
immunohistochemically stained for glial (anti-repo, anti-GFP) and neuronal markers (anti-HRP, 
43  Results 
 
anti-Futsch). A confocal analysis revealed that 40.14% of all candidates (56 lines) showed 
changes of the peripheral nerves after glia specific knockdown (Figure 5 B). The alterations 
included defasciculated and destabilized axons, axonal swellings, glial swellings, glial wrapping 
failure and faint glial signal. 
To categorize the positive candidates, we used the Panther gene list analysis tool (Mi et al., 
2013). The majority of the identified gene functions included binding (24%), catalytic activity 
(24%) and transporter activity (14%) (Figure 5 C).  
 
 
 
Figure 5: Scheme and results of glial specific RNAi screen. (A) The screening procedure is depicted. Drosophila 
RNAi of the selected candidates was expressed with the glial-specific repoGal4 driver line. Third instar larval PNS 
were scored after confocal analysis for PNS changes. (B) Results from screening. 141 RNAi lines were analyzed. 
56 lines showed defects in the nervous system upon glial inhibition. (C) Panther gene list analysis. Positive 
candidates were grouped by gene function. 
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3.2 p24-1 is crucial for the axon-glial architecture 
3.2.1 p24-1 expression is essential for glial cells 
Regarding the screening outcome, the candidate p24-1 displayed the strongest effect on 
peripheral nerves upon knockdown in the glia. Therefore, we subjected p24-1 to a more 
elaborate investigation. 
Inhibition of p24-1 in glial cells with VDRC line p24-1GD 12196 resulted in lethality of the animals 
during late larval stages. Observations of the animals’ behavior indicated no effect in first and 
second instar larval stage. Third instar larvae, in contrast, developed crawling problems. The 
motor defects became more prominent in older animals. In comparison to wild-type larvae, 
p24-1 RNAi expressing larvae were not able to crawl up the walls of housing vials (during 
wandering larval stage). In addition, the larvae could not enter pupal stage and remained up 
to several days in third instar stage until they died. 
The confocal analysis of third instar larval nervous system upon glial p24-1 inhibition showed 
severe malformations of the peripheral nerves (Figure 6 B). The glia membrane was visualized 
by antibody staining of the membrane bound GFP. Neurons were stained with the pan-
neuronal marker anti-HRP as well as with a sensory neuron specific antibody against Futsch. 
The confocal pictures revealed that glia and axons generated swellings along the nerve, which 
never occurred in wild-type control nerves. The glia cell seemed disassembled in swelling 
regions. In some parts of the nerve, the glial GFP signal appeared faint, whereas in other parts 
it appeared similar to wild-type nerves. 
 
3.2.2 p24-1 inhibition has an strong effect on axons 
Glial p24-1 RNAi expression however had a much more remarkable effect on the axon 
morphology. The axons formed protrusions, which were in parts not ensheathed by glia 
membrane (Figure 6 B, C). Before and after this local out-foldings, the axons appeared normal 
which was in contrast to wild-type axons that were completely covered by glia membrane 
(Figure 6 A). To be able to distinguish between axonal membrane and cytoskeleton we used a 
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neuronal membrane marker (HRP) and an antibody against the microtubule associated 
protein Futsch. With both markers, we were able to detect the characteristic bulging 
phenotype. This antibody combination also allowed us to distinguish between motor and 
sensory axons since Futsch is only expressed in sensory neurons (Hummel et al., 2000). The 
pictures showed that not only Futsch-positive but also all other HRP labeled axons undergo 
morphological alterations, meaning that sensory and motor axons are affected (Figure 6 C). 
 
 
 
Figure 6: Glial inhibition of p24-1 gene function shows out-foldings in PNS. (A) Along peripheral nerves glial 
damage (green) and axonal out-foldings were observed upon expression of p24-1 RNAi in the glia. (B) 
repo4.3;repoGal4>CD8GFP/+ was used as control. (C) Futsch labeled sensory neurons and other HRP marked 
neurons are affected by the out-foldings. Glia membrane is not ensheathing the out-folded areas. Scale bar 10 
µm. 
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3.2.3 Weak glial defects after p24-1 inhibition in glial sub-classes 
To dertermine in which glial cell type p24-1 function was required, we induced RNA 
interference in the three glial subtypes seperately. Glial membrane was labeled by expression 
of a membrane bound CD8GFP. Neurons were visualilzed with the HRP antibody. Inhibition of 
p24-1 in the wrapping glia with nervana2Gal4 did not cause lethality in third instar larvae, but 
the evaluation of the confocal images revealed strong wrapping defects (Figure 7 A). 
Membranes of wrapping glia cells were not evenly distributed along the nerve or were even 
missing (compared to control Figure 8 B). In some nerves, deposits of CD8GFP labeled 
membrane could be found, which indicates rather a degenerating than a developmental 
defect. An axonal phenotype was not detectable after p24-1 inhibition in the wrapping glia. 
Inhibition in the subperineurial glia with gliotactinGal4 (Figure 7 B) and in the perineurial glia 
with C527Gal4 (Figure 7 C) neither displayed the out-folding phenotype nor lethality. The only 
defect observed was a faint GFP signal after p24-1 inhibition in subperineurial glia (Figure 7 B) 
indicating mild defects. To conclude the analysis of the glial sub-classes, p24-1 seems to have 
a function in wrapping and subperineurial glia. 
Because of the strong axonal phenotype after inhibition with repoGal4, we wondered if p24-1 
function is also required in neuronal cells. Therefore we expressed p24-1 RNAi with the 
neuron specific Gal4 driver n-syb (neuronal synaptobrevin). As shown in Figure 7 D, there was 
no defect visible after neuronal inhibition. Hence, p24-1 seems to have no or minor functions 
in neurons during larval stages. 
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Figure 7: p24-1 inhibition in glial subclasses and neurons. Glia membrane 
was labeled with anti-GFP (green), glial nuclei with anti-Repo (blue) and 
neurons with anti-HRP (red). (A) p24-1 RNAi was expressed in wrapping 
glia with nervana2 Gal4. Wrapping defects were observed. (B) Expression 
in subperineurial glia with gliotactin Gal4, (C) in perineurial glia with C527 
Gal4 and (D) in neurons with n-syb Gal4. No neuronal out-foldings were 
detected. Scale bar 10 µm. 
 
 
3.2.4 p24-1 is required in wrapping and subperineurial glia 
Because the axonal out-folding phenotype was not detectable after p24-1 inhibition in the 
different glial sub-classes, we repeated the analysis of the sub-classes by using GFP exon trap 
lines, which allow Gal4 independent labeling of glia sub-types. The wrapping glia was marked 
with a GFP insertion into the nervana2 gene (BL #6828). The subperineurial glia was labeled 
by a GFP insertion in a not-yet defined gene (Piggy Bac #261, C. Klämbt unpublished). Septate 
junctions were labeled by a GFP insertion (#454) into the neurexinIV gene (Edenfeld et al., 
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2006) and perineurial glia by a GFP insertion into the jupiter gene (Bl #6836). The marker lines 
were combined with the pan-glial driver line repoGal4.  
When examining the wrapping glia, we could detect strong wrapping defects (Figure 8 A) 
compared to control nerves (Figure 8 B). In some parts the wrapping glia cells were present 
but did not enwrap the axons, in other areas the cell looked fragmented. In the protrusion, 
the wrapping glia appeared disassembled. These observations are in accordance to the 
phenotype generated by p24-1 RNAi expression with nervana2 Gal4 (Figure 7 A). 
The subperineurial glia seemed to be present surrounding the nerve (Figure 8 C) as in control 
images (Figure 8 D), but the GFP signal in the PNS was faint, which indicated a defect in this 
cell type. As described in 1.1.3, the most important feature of the subperineurial glia is 
formation and maintenance of the BBB, which is based on auto-cellular septate junctions. To 
investigate the integrity of the BBB, we used the neurexinIV#454 GFP trap line as a marker for 
septate junctions. In control animals, the NeurexinIV signal formed one straight line along the 
nerve and a ring-like structure at the sites where two subperineurial cells met (Figure 8 F). 
Inhibition in the glia led to a disturbed NeurexinIV pattern. In nerves not displaying out-
foldings the signal was diffuse, whereas in nerves with axonal out-foldings the signal was 
interrupted (Figure 8 E). 
Perineurial glia cells surrounded the nerve as in control animals (Figure 8 G, H). In some cases, 
they covered the out-folded areas but in others not (Figure 8 G). To summarize the analysis of 
the glial sub-types, we found that the wrapping glia and the subperineurial glia were affected 
upon pan-glial p24-1 inhibition. 
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Figure 8: Gal4 independent analysis of glial sub-classes after p24-1 inhibition in glial cells. GFP marks 
glial structure (green), HRP stains neurons (red). (A, B) wrapping glia was labeled with the nrv2GFP 
trap. (C, D) subperineurial glia was labeled with the #261-GFP trap. E, F septate junctions were 
labeled with the nrx IV 454 GFP trap. (G, H) perineurial glia was labeled with the Jupiter GFP trap. 
Genotypes of GFP-trap;repoGal4/p24-1 RNAi (A, C, E, G) was compared to GFP-trap;repoGal4/+ (B, D, 
F, H). Scale bar 10 µm. 
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3.2.5 Ultrastructure reveals massive glial defects and axonal loss 
Transmission electron microscopy (TEM) was used to analyze the details of the cellular 
structure of glial cells upon p24-1 inhibition. In control nerves of third instar larvae, we could 
clearly distinguish between perineurial, subperineurial and wrapping glia cells. Wrapping glia 
was separating all the axons at the end of the larval stage (Figure 9 C). Upon p24-1 RNAi 
expression with repoGal4, the glia seemed disorganized (Figure 9 A, B). In non-protrusion 
areas perineurial glia and subperineurial was present and surrounded the axons. However, 
there was no separation of axons by wrapping glia (Figure 9 B). We also found vesicular 
structures and signs of degradation. The neural lamella was thinner compared to wild-type 
nerves. In the out-folded areas, the structure seemed severely destructed. Discrimination 
between the glial sub-types was not possible (Figure 9 B). Quantifications of the axon number 
revealed 76 axons (SEM ± 0.8) wild-type segmental nerves A4-A6. After inhibition of p24-1 in 
glial cells we found significantly less axons per nerve (mean = 55.3 SEM ± 1.66, Figure 9 C). 
The TEM data show that upon p24-1 inhibition, degradation occurred in peripheral nerves 
causing disassembly of glial cells and loss of axons. 
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Figure 9: Ultrastructural analysis of the p24-1 phenotype in the PNS. TEM 
micrograph of third instar larval peripheral nerves, cross sections. (A, B) 
Nerve sections upon p24-1 inhibition in glia, genotype repoGal4/p24-1 
RNAi, display massive disassembly in non-protrusion (A) as well as in 
protrusion areas (B). (C) Control nerve, genotype repoGal4/+. All glial sub-
types can be identified. (D) Quantification of axon number reveals axonal 
loss upon p24-1 inhibition. Scale bar 2 µm. 
 
 
3.2.6 No apoptosis detectable upon p24-1 inhibition 
Regarding the massive glial and axonal defects observed in the ultrastructural analysis, we 
expected glial and neuronal cell death. To monitor cell death, the terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) assay was performed, which can detect 
fragmented DNA resulting from apoptotic nuclei. For the assay, glial membrane was labeled 
by expression of membrane bound mCD8Cherry red-fluorescent protein (red). TUNEL positive 
cells were detected by green fluorescence and all nuclei were labeled with the DNA 
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intercalating dye ToPro3. Glial inhibition of p24-1 did not result in TUNEL positive cells (Figure 
10 A). In control nerves there was, as well no TUNEL staining detectable (Figure 10 B). DNase 
treated tissue served as positive control in which TUNEL staining was observed in all nuclei of 
the PNS and CNS (Figure 10 C). 
 
 
Figure 10: Tunel assay is negative upon p24-1 inhibition. Tunel assay in third 
instar PNS. Glia membrane was labeled by mCD8Cherry expression (red), 
TUNEL positive cells (green) and all nuclei with ToPro dye (blue). (A) Inhibition 
of p24-1 in glial cells did not show TUNEL positive cells. (B) Control nerves 
were negative for TUNEL stain. (C) DNase treated control nerves with nerves 
were positive for TUNEL stain. Scale bar 10 µm. 
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3.3 Non-cell autonomous effects of p24-1 inhibition 
3.3.1 Single axon labeling illustrates local instabilities 
Regarding the initial experiments, we deduced that p24-1 RNAi expression in glial cells had a 
strong non-cell autonomous effect on axons. To clarify what happens to the neuron, we made 
use of the fly line pickpocket-GFP expressing a GFP fusion protein of the sodium channel 
pickpocket (ppk), which labels two to four axons per nerve. This fly line was combined with 
the pan-glial driver line repoGal4 and a membrane bound CD8mCherry insertion (red). In 
control nerves, the axons were aligned straightly throughout the nerve (Figure 11 C). In 
contrast, inhibition of p24-1 in the glia displayed local axonal instabilities. Before and after the 
out-folding the axons run straight, but in the area of the protrusion, it made a loopy structure 
(Figure 11 A). Exemplarily, the dimension of the out-folding was 23 µm in length and 20 µm in 
height. 
The single axon labeling revealed another characteristic. Upon inhibition of p24-1, we 
observed small swellings of the axon itself (Figure 11 B). The swellings were found all along 
the nerve, in the out-folded areas and in the straight parts. 
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Figure 11: Single axon labeling shows local instabilities.  Glia membrane was labeled by CD8mCherry 
expression (red) and axons by ppk-GFP expression (green). (A) Expression of ppk-GFP allowed single 
axon labeling of 2 to 4 axons per nerve. Upon pan-glial p24-1 inhibition, local axonal instabilities and 
axonal swellings were visible. (B) Imaris 3D reconstruction of ppkGFP expressing axons reveals out-
foldings of ~20 x 23 µm length. In addition, axonal swellings are visible. (C) Projections of control axons 
do not show swellings or alterations. Scale bar 10 µm. 
 
3.3.2 Axonal transport defects after p24-1 inhibition 
One feature of axonal integrity is fast axonal transport. Synaptic proteins synthesized in the 
cell body need to be transported along the axon to the synapse (anterograde transport), and 
other proteins need to be transferred back from the periphery to the cell body (retrograde 
transport). Because we observed swellings in the axon upon p24-1 inhibition in larval nerves, 
we wondered if axonal transportion is affected. For the analysis, we used an antibody against 
the synaptic protein Bruchpilot (Brp). Brp-positive vesicles are transported from the neuronal 
cell body in the CNS to the motor synapse. In third instar larval nerves of control animals, only 
few vesicles were visible (Figure 12 A). Upon pan-glial p24-1 inhibition, a high number of Brp-
positive vesicles were visible along the axon (Figure 12 B) revealing massive traffic jam. A high 
vesicle density was observed in the protrusion area, but also in straight part of the nerve. 
Thereby, some nerves seemed to be heavily affected while others showed a lower vesicle 
density. 
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Regarding the non-uniform distribution of axonal vesicles, we wondered if the transport 
defects were linked to the axonal out-folding phenotype. To answer this question, we had a 
look at second instar larvae, which did not display out-foldings yet. In control second instar 
larval nerves few Brp-positive vesicles were detected (Figure 12 C). In second instar larvae 
after glial p24-1 inhibition, we could detect a higher density of Brp vesicles than in control. 
To summarize the above findings, we found that p24-1 inhibition in glial cells generates 
transport defects of axonal vesicles from second instar stage on. 
 
 
Figure 12: Vesicular traffic jam in axons upon p24-1 inhibition 
Anterograde transport of Bruchpilot-positive vesicles (red). (A, C) In 
control peripheral nerves of third instar (A) and second instar (L2) larval 
nerves (C) few vesicles are visible. Genotype repoGal4CD8GFP/+. (B, D) 
Peripheral nerves after p24-1 inhibition in glial cells reveals axonal 
transport defects in third instar (B) and second instar stage (D). 
Genotype repoCD8GFP/p24-1 RNAi. Scale bar 10 µm. 
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3.3.3 p24-1 phenotype kinetics reveal progressive defects 
From previous experiments, in which we analyzed the axonal out-foldings (Figure 6 B) and 
transport defects of axonal vesicles (Figure 12 B), but also from behavioral observations of the 
animals, it became obvious that nervous system defects appeared late during larval stages. 
Therefore, we analyzed the kinetics of the p24-1 phenotype. First, the average number of 
protrusions per nerve was quantified (Figure 13 A). For that purpose, confocal 3D images of 
the whole nervous system were generated. We visualized neurons with the HRP antibody. In 
late second instar stage at 70 hours after egg lay (AEL) nearly no protrusions were detected 
(mean = 0.05). In mid third instar stage at 96 hours AEL, 1 to 3 nerves per filet preparation 
were affected (mean = 0.29). In wandering larval stage at 118h AEL on average nearly every 
nerve was affected (mean = 0.77). As upon p24-1 inhibition larvae did not enter pupal stage 
and remained in third instar stage, animals were also dissected at 140h AEL. In that prolonged 
third larval stage we detected the highest number of out-foldings per nerve (mean = 1.94). 
Next, the kinetics of the axonal transport was assessed (Figure 13 B). Brp-positive vesicles 
were stained and counted with help of the software Bitplane Imaris. Vesicle numbers were 
normalized to those of control animals of corresponding stage. Quantification of Brp-positive 
vesicles in second instar larvae (70 hours AEL) revealed a 1.39 fold increased vesicle number 
of p24-1 RNAi versus control. This result confirmed the observations of the vesicle transport 
defect in peripheral nerves we made in previous experiments (Figure 12 C, D). In mid third 
instar stage, we observed a 2.11 fold increase of vesicle number compared to control. At 
118h and 140h AEL, the increase was even higher compared to control with 3.45 fold and 
3.61 fold respectively (Figure 13 B). 
In conclusion, the out-folding phenotype and the transport defect after glial p24-1 inhibition 
display progressive kinetics. While the out-foldings became apparent in the mid to late third 
instar stages, the axonal transport defects were already detectable in second instar larvae. 
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Figure 13: Quantification of out-folding phenotype and transport defects. Larvae were dissected at different 
stages after p24-1 inhibition in glial cells: second instar stage (70h AEL), mid third instar stage (96h AEL), late 
third instar stage (118h AEL) and prolonged third instar stage (140h AEL). Genotype of dissected larvae was 
repo4.3Gal4;repoGal4,CD8GFP/p24-1 RNAi. Tissue was stained for GFP (glia), HRP (neurons) and Bruchpilot 
(axonal vesicles). Filet preparation was used to analyze the whole PNS, n=8. One-way Anova (p < 0.0001) was 
used to assess statistical significance. (A) Quantification of absolute number of axonal out-foldings per PNS 
indicates increase over time. (B) Relative vesicle number showed transport defects already at 70h AEL and a 
progressive phenotype. Brp-positive vesicles were counted in four 100 µm lone nerve tracts per animal. 
Numbers were normalized to average vesicle number in control animals of corresponding age. 
 
 
3.3.4 p24-1 inhibition affects mitochondria appearance 
Not only vesicles but also mitochondria are transported along axons. The energy consuming 
transport process is dependent on mitochondria function. As we could show that transport is 
affected upon p24-1 inhibition in the glia, we wondered if mitochondria are distributed 
normally. Therefore, p24-1 was inhibited with the pan-glial driver line repoGal4 and third 
instar larval peripheral nerves were dissected. Glia was labeled by CD8GFP expression (green), 
mitochondria were stained with the ATP5α antibody (red) and neurons with the HRP antibody 
(blue). In control nerves, mitochondria were evenly distributed over the nerve (Figure 14 B). 
In glial cells they were forming a mesh like structure whereas in axons they were more 
separated (Figure 14 B’). Upon p24-1 inhibition, the distribution of mitochondria changed 
(Figure 14 A, A’). There were parts with a high density of the organelles and others with none. 
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In total, we found less axonal mitochondria upon p24-1 inhibition (96 in p24-1 RNAi and 276 
in control axons). Because not only the number but also the size appeared to be changed, we 
measured the volume of the axonal mitochondria upon glial p24-1 inhibition. This was 
performed with Bitplane’s Imaris software and the mitochondria were analyzed in a nerve 
section of 75 µm. As indicated in Figure 14 C the mitochondrial volume compared to control 
was significantly increased (t-test, p < 0.0001). P24-1 axonal mitochondria volume showed a 
mean of 145.5 µm3, SEM ± 18.64 whereas control mitochondria volume was 59.48 µm3, SEM 
± 5.72. As there were overall fewer volumes detectable, we reasoned that also the number of 
axonal mitochondria was decreased after p24-1 knockdown. Also in glial cells, the number 
and size seemed decreased. 
In summary, we found that glial and axonal mitochondria size and shape were altered in 
peripheral nerves upon p24-1 inhibition. 
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Figure 14: Enlargement of axonal mitochondria upon glial p24-1 inhibition. To examine 
mitochondria distribution third instar larval peripheral nerves were dissected and 
stained with for the mitochondrial protein ATP5α (red). Glia membrane was labeled 
by CD8GFP expression (green) and neurons with the HRP antibody. (A) p24-1 
inhibition reveals a changed mitochondria size and distribution. (B) In control nerves 
(genotype repoCD8GFP/+) mitochondria are evenly distributed. (C) Quantification of 
mitochondria volume shows significant increase of p24-1 RNAi compared to control 
(p < 0.0001). Significance was determined by t-test. Scale bar 10 µm. 
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3.3.5 Target defects after glial p24-1 inhibition in photoreceptor cells 
Regarding the axonal out-folding phenotype, we decided to consider photoreceptor axons as 
another class of functional neurons of the peripheral nervous system. Photoreceptor cells 
(R-cells) grow during larval stages from the eye disc over the optic stalk into the optic lobes. 
Here they make connections in a distinct pattern. R1-R6 cells terminate in the lamina 
(asterisk) whereas R7 and R8 cells pass this layer and stop in the medulla (Figure 15 B). Glia 
membrane was visualized by CD8GFP expression. Neurons were labeled with the HRP 
antibody and R-cells specifically with the 24B10 antibody. 
Inhibition of p24-1 with the pan-glial driver line repoGal4 did not lead to characteristic axonal 
out-foldings in photoreceptor cells (Figure 15 A). The axons of R-cells showed normal 
appearance compared to control (compare Figure 15 A’ and B’) but path-finding seemed to 
be affected by the p24-1 RNAi expression, since most axons terminated in the lamina (Figure 
15 A’). Hence, we concluded that pathfinding of photoreceptor neurons is affected upon 
p24-1 inhibition. 
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Figure 15: Migration defects of photoreceptor axons. Glial membrane was 
stained with anti-GFP (green), photoreceptor cells with anti-24B10 (red) 
and neurons with anti-HRP (blue). (A) Migration of photoreceptor axons 
was disturbed after glial inhibition. All axons terminate in lamina. 
Genotype repoCD8GFP/p24-1 RNAi. (B) Photoreceptor axons grow 
through the optic stalk and terminate in lamina and medulla. Scale bar 
10 µm. 
 
 
3.3.6 No alterations of the neuro-muscular junction stability after p24-1 inhibition 
After observing the motor defects of the third instar larvae upon glial p24-1 inhibition, we 
wondered if not only the axons but also the neuro-muscular connections are malfunctioning. 
To examine the appearance of the NMJ, we stained the presynaptic localized protein 
Bruchpilot and the postsynaptic localized protein Disc large with specific antibodies. Glia 
membrane was visualized by CD8GFP expression. The presynaptic marker Bruchpilot 
appeared normally distributed after glial p24-1 inhibition (Figure 16 A) compared to control 
Results  62 
NMJ (Figure 16 B). Upon p24-1 inhibition, also the postsynaptic Protein Disc large was 
localized as in control NMJs (compare Figure 16 C and D). In control animals, the glia 
membrane was associated to the NMJ and extended fine processes to the synaptic terminals 
(Figure 16 B, D). However, in p24-1 RNAi animals the glia was retracted from NMJs (Figure 16 
A, C). 
To summarize this we found that the NMJ morphology appeared unaltered upon p24-1 
knockdown but glial processes were retracted from synaptic terminals. 
 
 
Figure 16: No neuro-muscular junction defects after p24-1 inhibition. 
Glia membrane was stained with anti-GFP (green), neurons with anti-
HRP (blue) and synaptic proteins with anti-Bruchpilot or anti-Disc large 
(red). (A) Glial p24-1 inhibition did not alter the presynaptic marker Brp. 
(B) Control NMJ displays wild-typical presynaptic appearance. (C) 
Normal postsynaptic marker expression after p24-1 inhibition, (D) 
compared to control NMJ. After p24-1 inhibition, glia membrane is 
retracted from NMJ (A, C). Scale bar 10 µm. 
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3.4 Specificity of the p24-1 RNAi phenotype 
3.4.1 p24-1 antibody confirmed absence of protein after p24-1 knockdown 
To validate the specificity of the p24-1 RNA interference phenotype we made use of a specific 
antibody against the p24-1 protein (Saleem et al., 2012). Glia was marked with anti-GFP 
(green), neuronal membrane with anti-HRP in blue and anti-p24-1 was depicted in red. In 
control animals p24-1 appeared to be present in all tissues visible like muscles, glia and 
trachea (Figure 17 B). After knockdown in glial cells the p24-1 signal was absent frrom glia 
(Figure 17 A) and the peripheral nerve didin’t show p24-1 protein expression whereas the 
signal was still detectable in trachea. 
Hence, knockdown with the p24-1GD12196 RNAi line inhibited the expression of the p24-1 
protein completely. 
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Figure 17: p24-1 Antibody showed p24-1 absence in glia upon p24-1 
knockdown Glia was labeled by CD8GFP expression (green), anti-p24-1 
(red) and neurons with anti-HRP (blue). (A) Glial p24-1 inhibition caused 
absence of p24-1 signal in glia. (B) Control animals showed ubiquitous 
p24-1 expression. Scale bar 10 µm. 
 
3.4.2 Expression of Drosophila virilis p24-1 could not rescue the RNAi induced phenotype  
As the experimental setup is based on RNA interference, we sought to rule out off-target 
effects. To test the specificity of the RNAi construct used in above experiments, we designed 
an RNAi rescue approach. The two different approaches cross-species RNAi rescue (Kondo et 
al., 2009) or Drosophila RNAi Escape Strategy Construct (RESC) (Schulz et al., 2009) can be 
used. For cloning of the cross-species RNAi rescue construct, mRNA from wild-type Drosophila 
virilis was isolated. The p24-1 gene was amplified by PCR from synthesized cDNA and cloned 
with the Gateway System into the UAS expression vector pUAST containing a HA tag (Figure 
18A). The DNA plasmid was further integrated into the D. melanogaster genome via ϕC31 
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integrase mediated site-directed mutagenesis in landing site 51C on the second chromosome 
(2R). For the generation of the RESC construct first the target sequence of the p24-1GD12196 
RNAi construct was identified in the p24-1 gene. This target sequence was then modified in 
silico with silent mutations, making it unlikely for RNA interference to occur. The modified 
p24-1-string sequence was synthesized by GeneArt by Thermo Fisher Scientific Inc. and 
cloned into a UAS expression vector with or without GFP tag (Figure 18 A). The pUAST 
constructs were integrated into the fly genome at landing sites 51D (2nd chromosome, 2R) 
and 22A (2nd chromosome, 2L) respectively. 
Expression of the generated transgenic constructs in glial cells with repoGal4 (Figure 18 B) 
indicated that p24-1-D.Virilis-HA was localized in a similar pattern as the endogenous D. 
melanogaster p24-1 (Figure 17B). p24-1-string-GFP revealed a diffuse distribution upon 
anti-GFP staining (not shown) indicating the gene product was not functional and degraded. 
To test the rescue capacity of the p24-1 D. virilis transgenic constructs, it was simultaneously 
expressed with the p24-1GD12196 RNAi construct in glial cells. However, the constructs could 
not rescue the p24-1 induced neuronal phenotype or lethality, which might be due to 
degradation of the transcript, off-target effects or malfunctioning of the D. virilis p24-1 
protein. 
 
Figure 18: RNAi rescue experiment RNAi rescue constructs were cloned and transgenic fly strains 
generated. (A) Three different pUAST plasmid constructs were generated containing the p24-1 gene 
of D. virilis with HA tag and a D. melanogaster p24-1 gene with silent mutations in RNAi target 
region (p24-1 string) with or without GFP tag. (B) The p24-1-D.virilis-HA construct was expressed 
with repoGal4. Scale bar 10 µm. 
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3.4.3 Inhibition of other p24 family members reproduces p24-1 phenotype 
The p24 family in Drosophila consists of nine members (Saleem et al., 2012). For the eight p24 
genes (p24-1, p24-2, éclair, Chop24, CG9308, CG31787, opossum and baiser) RNAi lines were 
available. To investigate the relevance of the entire p24 family in glial function, we acquired 
UAS RNAi lines for those members (if available two different lines). 
Knockdown in glial cells with the pan-glial driver line repoGal4 showed that p24-1, Chop24 
and opossum are required in glial cells (Figure 19A). Inhibition of Chop24 (lines Chopp24GD7039 
and Chop24KK100274) caused lethality in pupal stages or early adulthood. Induction of the RNA 
interference with lines p24-1GD 12196, opmGD10168 and opmKK101312 led to lethality in third instar 
larval stage. Pan-glial knockdown of p24-1 RNAi with line KK100594 though, had no 
detectable effect. 
Next, we examined the appearance of the larval nervous system after inhibition of p24 family 
members. Chop24 did not display alterations of the larval nervous system after glial inhibition 
like the other viable p24 family members (p24-2, éclair, CG9308, CG31787 and baiser). For 
p24-1, only glial expression of line GD12196 but not of line KK100594 caused the 
characteristic axonal out-folding phenotype (Figure 6 B). Glial inhibition of opossum with both 
available lines (GD10168 and KK101312) displayed the axonal out-folding phenotype (Figure 
19B). 
The analysis of the p24 family revealed that p24-1 and opossum expression is necessary for 
glial cells as inhibition caused axonal protrusions and glial degradation in third instar larval 
PNS and resulted in lethality. 
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Figure 19: The p24 family member opossum reproduced the p24-1 phenotype. 
(A) UAS-RNAi lines were ordered for all p24 family members. Knockdown was 
performed with the pan-glial driver line repoGal4. V = viable, semi lethal = flies 
die as young adults or short after hatching, pupal lethal = animals died during 
pupal stages, L3 lethal = animals died during third instar larval stage. Chop24, 
p24-1 and opossum showed lethality after glial knockdown. (B) Glial inhibition 
of opossum (Line GD10168) displayed the axonal out-folding phenotype. Glia 
was visualized with CD8GFP (green), sensory axons with anti-Futsch (red) and 
all neurons with anti-HRP (blue). Scale bar 10 µm. 
 
 
3.5 Identification of p24-1 interaction partners 
p24 proteins are components of the secretory pathway and mainly described to transport 
cargo  
from the endoplasmic reticulum (ER) towards the Golgi apparatus (reviewed in Strating and 
Martens, 2009). The globular GOLD domain, a feature of p24 proteins, serves probably as a 
selective protein cargo selection motive (Anantharaman and Aravind, 2002). 
We hypothesized that p24-1 and opossum are responsible to secrete glial proteins. In 
Drosophila, it has been shown that different combinations of p24 proteins are needed for the 
secretion of the signaling molecule wingless. It was proposed that either éclair and Chop24 
(Port et al., 2011) or p24-1, Chop24 and opossum (Buechling et al., 2011) play a role in 
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secreting Wg by shuttling the molecule through the ER-Golgi interface. Because of these 
findings, we also tested if Wg signaling was involved in generating the characteristic axon-glial 
phenotype. Therefore, we acquired RNAi lines from VDRC for different members of the 
canonical Wg signaling pathway (winglessKK104579, FrizzledKK105493, armadilloKK107344, 
cateninKK107298 and dishevelledKK101525). RNA interference was induced with the pan-glial driver 
line repoGal4 but no defects in viability or alterations of the larval nervous system were 
detected (data not shown). Therefore, we intended to conduct a broader search for p24 
interaction partners. 
 
3.5.1 Genetic approach to identify p24-1 interaction partners 
To identify p24-1 interaction partners we executed a secondary screening. Since p24-1 and 
opossum are key players in the secretory pathway, we aimed for candidates, which are 
secreted. The screening strategy was to inhibit gene functions of a set of candidates via RNA 
interference in the nervous system. Because p24-1 and opossum inhibition was lethal in third 
instar larvae, we screened for lethality. 
As candidates, we selected all Drosophila genes, which were annotated as ‘secreted’ in the 
UniProt database (www.uniprot.org). Of those, we selected all candidates for which a UAS-
RNAi line from VDRC was available (220 candidates). Additionally, all members of the 
Immunoglobulin Superfamily were selected for the screen as these proteins are transported 
through the secretory pathway. Furthermore, several IgSF members are described to be 
involved in cell communication and adhesion, which we thought might be affected in the 
absence of p24-1. For the immunoglobulin superfamily, we found another 142 RNAi lines 
from VDRC. 
In total, we screened 362 RNAi lines for lethality with a combined neuronal (n-sybGal4) and 
glial (repoGal4) driver line (Table 19). 25% of all candidates (95 lines) displayed lethality upon 
nervous system specific inhibition (Figure 20 A). These positive candidates were re-screened 
with the single pan-neuronal (n-sybGal4) and pan-glial (repoGal4) driver line only. As 
depicted, 51% of the candidates showed lethality and were required in neurons (46 lines) and 
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21% in glia (19 lines) (Figure 20 B). 28% of all lines showed only lethality after pan-neural 
inhibition (25 lines). 
Because p24-1 inhibition resulted in lethality after glia specific knockdown, we first examined 
the candidates of the secondary screen, which also were lethal upon glial inhibition. For those 
19 lines, a detailed confocal analysis of the nervous system was carried out. We found that 
the three candidates ferritin 1 heavy chain (fer1hch), yolk protein 2 (yp-2) and defective 
proboscis response 2 (dpr-2) produced the p24-1 nervous system phenotype upon glial 
inhibition. 
 
 
Figure 20: Secondary RNAi screening identifies candidates required for nervous system function. (A) Knockdown 
of 380 candidates (secreted proteins and Immunoglobulin superfamily members) with a combined n-sybGal4 
and repoGal4 driver line was performed. 95 lines showed lethality (25%). (B) Re-screening of the lethal 
candidates with single pan-glia (repoGal4) and pan-neuronal (n-sybGal4) driver lines was performed. 51% 
showed lethality after neuronal inhibition, 21% after glial inhibition and 28% showed lethality only with the 
combined neuronal and glial driver line 
 
 
3.6 Ferritin1 heavy chain is necessary for neural function 
The genetic approach showed that inhibition of Ferritin 1 heavy chain (Fer1HCH) displayed 
the same phenotype as p24-1 upon glial inhibition (Figure 21 A). A large study of protein 
complex networks in Drosophila Schneider cells tested interactions of 5000 individual epitope 
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tagged proteins by mass spectrometry. This biochemical approach revealed a direct 
interaction between p24-1 and Fer1HCH (Guruharsha et al., 2011). Therefore, we decided to 
continue with the analysis of Fer1HCH. 
 
3.6.1 Fer1HCH phenotype kinetics show progressive development 
Upon glial Fer1HCH inhibition, we could detect the same axonal out-foldings, which were 
observed upon glial p24-1 inhibition. Glia membrane was labeled by expression of a 
membrane bound CD8GFP in repo pattern (green), sensory neurons with the Futsch antibody 
(red) and all neurons with the HRP antibody (blue) (Figure 21 A). The glial membrane was 
altered in some regions along the peripheral nerves and occasionally absent at the sites of the 
axonal out-folding. The axonal protrusions were distributed over the whole PNS and could be 
found in proximal or distal regions (Figure 21 A). The animals developed severe motor defects 
in third instar stage and remained up to several days in the larval stage until they died. 
To characterize the Fer1HCH RNAi phenotype further, the kinetics of the phenotype were 
determined. Therefore a confocal analysis of the complete PNS was performed. Axons were 
labeled with the HRP antibody and axonal vesicles with the Bruchpilot antibody. The 
quantification of axonal protrusions showed a significant increase of protrusions per nerve 
over time (p < 0.0001) (Figure 21 B). At an age of 70 hours (in second larval stage), there were 
no protrusions detectable yet. The axonal alterations started to develop in mid third instar 
larval stage (96 hours) when on average 0.75 protrusion per nerve could be found. The 
protrusions became more frequent at 118 (mean = 2.01 protrusions/axon) and 140 hours 
(mean = 3.47 protrusions/axon) after egg lay. In addition, we detected transportation defects 
of axonal vesicles upon glial Fer1HCH inhibition. We stained Bruchpilot-positive vesicles upon 
Fer1HCH knockdown and quantified the vesicle number in axons of peripheral nerves. The 
counts were then normalized to numbers of Bruchpilot-positive vesicles of control animals of 
the corresponding age. We could detect a significant increase (p < 0.0001) of vesicles over 
time compared to control (Figure 21 C). At 70 hours after egg lay, the second instar larvae 
already showed a 1.51 fold increase of vesicles number compared to control. In subsequent 
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stages, the axonal vesicle transport defect became stronger and we could detect up to 3.58 
fold increase in vesicles during the prolonged third instar larval stage at 140 hours AEL. 
Taken together, the characterization of the Fer1HCH RNAi induced phenotype revealed a 
strong disturbance of the axo-glial architecture. The phenotype kinetics exhibits a progressive 
increase in the occurrence of axonal out-foldings as well an increase in the number of axonal 
vesicles in peripheral nerves. 
 
 
 
Figure 21: Inhibition of Ferritin 1 heavy chain shows alterations in axo-glial structure with progressive 
development. Glial inhibition of Fer1HCH revealed axonal failure. (A) Confocal analysis of third instar 
larval PNS shows axonal out-foldings. Glia was labeled by CD8GFP expression, sensory neurons were 
stained with anti-Futsch and all neurons with anti-HRP. (B) For quantification, larvae were dissected 
at different stages after p24-1 inhibition in glial cells: second instar stage (70h AEL), mid third instar 
stage (96h AEL), late third instar stage (118h AEL) and prolonged third instar stage (140h AEL). 
Genotype was repo4.3Gal4;repoGal4,CD8GFP/Fer1HCH RNAi. Tissue was stained for GFP (glia), HRP 
(neurons) and Bruchpilot (axonal vesicles) in filet preparation, n=8. One-way Anova was used to 
assess statistical significance. Quantification of absolute number of axonal out-foldings per PNS 
indicates increase over time. p < 0.0001. Quantification of relative vesicle number showed transport 
defects already at 70h AEL and a progressive phenotype. Brp-positive vesicles were counted in four 
100 µm lone nerve tracts per animal. Numbers were normalized to average vesicle number in control 
animals of corresponding age. Numbers are significantly different (p < 0.0001). 
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3.6.2 Glial inhibition of Fer1HCH indicates axonal transport defect and axonal swellings 
To find out in which neural cell type ferritin1hch expression is specifically required, an analysis 
with sub-class specific Gal4 driver lines was performed. To determine the effect on the axon 
morphology and function, we stained third instar larval peripheral nerves with the HRP 
antibody to check for axonal protrusions and with the Bruchpilot antibody to check for axonal 
transport failure (Figure 22). 
First, pan-neuronal inhibition of Fer1HCH was tested with n-sybGal4 (Figure 22 B). The 
animals had no behavioral impairments and no neuronal phenotype could be observed upon 
knockdown. Expression of Fer1HCH RNAi in wrapping glia cells led to a higher density of Brp-
positive vesicles in axons (Figure 22 C) but behavior of the larvae and morphology of the axon 
was not altered. However, we observed a wrapping defect comparable to p24-1 inhibition 
with nrv2Gal4 (not shown). A transport defect of axonal vesicles was also visible upon 
Fer1HCH RNAi expression in subperineurial glia cells with gliotactinGal4 (Figure 22 D). Ferritin 
inhibition in subperineurial glia was not followed by the characteristic axonal out-foldings, but 
axonal swellings appeared (triangle, Figure 22 E).These swellings occurred over long stretches 
of the axon. 
In summary, we found that Fer1HCH inhibition in wrapping glia, subperineurial glia and in all 
glia cells produced a traffic jam of axonal Bruchpilot-positive vesicles, whereas inhibition in 
neurons had no effect. Axonal out-foldings only occurred upon pan-glial knockdown. Axonal 
swellings were detected upon Fer1HCH inhibition in subperineurial glia. 
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Figure 22: Altered axonal transport upon Feritin1HCH inhibition in glial sub-classes. Fer1HCH RNAi was 
expressed in wrapping glia, subperineurial glia and neurons. Neurons were labeled with the HRP antibody 
(blue), axonal vesicles with the Bruchpilot antibody (red), CD8GFP is not shown. (A) Inhibition of Fer1HCH with 
the pan-glial driver repoGal4 led to axonal out-foldings and traffic jam of Brp-positive vesicles. (B) Knockdown 
of Fer1HCH with the pan-neuronal driver line n-sybGal4 had no effect on neurons or axonal transport. (C) 
Inhibition of Fer1HCH in wrapping glia cells with nervana2Gal4 showed transport defects of Brp-positive 
vesicles. (D) Inhibition in subperineurial glia wit gliotactinGal4 led to traffic jam of vesicles and (E) neurons 
showed axonal swellings. Scale bar 10 µm. 
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3.7 Ferritin1HCH is secreted by the glia and transferred to neurons 
3.7.1 Overexpression study reveals transfer of Ferritin from glia to neuron 
For a better characterization of Ferritin1HCH function in glial cells, a transgenic fly line was 
generated that allowed tissue specific overexpression of Fer1HCH. For this purpose, the 
Drosophila fer1hch gene was cloned into a UAS expression vector pUAST and integrated into 
the fly genome with the ϕC31 integrase mediated site-specific recombination system. Since 
no commercial antibody was available to detect Ferritin1HCH, we added a c-terminal HA tag. 
To determine the localization upon Fer1HCH overexpression in peripheral nerves, third instar 
larvae were dissected and stained with an HA antibody (green) to mark Fer1HCH. Neuronal 
membrane was labeled with the HRP antibody (magenta). Expression with the pan-glial driver 
line repoGal4 showed that Fer1HCH-HA was expressed (Figure 23 A). The HA signal was 
present all over the nerve and colocalized with the neuronal marker HRP (Figure 23 A’’). The 
average Pearson’s coefficient of P= 0.4414 (n = 3) confirmed the colocalization. 
 
3.7.2 p24-1 is required for Ferritin1HCH secretion 
To test, if p24-1 regulated the release of Fer1HCH to neurons, we generated flies that allow 
simultaneous expression of p24-1 RNAi and Fer1HCH-HA. Expression of both constructs with 
the pan-glial driver line repoGal4 let to the described axonal out-folding phenotype (Figure 23 
B’). HA signal could be detected in a dotted pattern but the HA signal was restricted to glial 
cells (Figure 22 B). No colocalization of HRP and HA was visible in out-folded areas and 
straight nerve tracts. The average Pearson’s coefficient was P= 0.092. 
In summary, we found that inhibition of glial p24-1 expression prevented glial release of 
Fer1HCH-HA and colocalization with neurons. 
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Figure 23: Transfer of Ferritin1HCH from glia to neuron can be blocked by p24-1 inhibition To 
evaluate the localization of Ferritin1HCH a tagged version of the protein was overexpressed with 
the pan-glial driver line repoGal4. HA protein was detected with the HA antibody (green), neurons 
were labeled with the HRP antibody (magenta). (A) Expression of Fer1HCH-HA in glial cells shows a 
spotted distribution and a colocalization of HA and HRP signal. Average Pearson’s coefficient P = 
0.4414 (n=3) indicated uptake of Ferritin1HCH-HA by neurons. (B) Simultaneous block of p24-1 in 
glial cells inhibits release of Fer1HCH-HA. No colocalization of HA and HRP antibody was detected. 
Scale bar 10 µm. 
 
3.7.3 Subperineurial and wrapping glia are responsible for Fer1HCH release to neurons 
To find out which glial sub-class was responsible for the release of Fer1HCH-HA, we expressed 
it in wrapping, subperineurial and perineurial glia with the driver lines nervana2Gal4, 
gliotactinGal4 and C527Gal4 respectively. As a control, Fer1HCH-HA was expressed outside 
the nervous system in fat body cells with LppGal4. The larval nerves were depicted by a 
confocal analysis for which neurons were marked with the HRP antibody (magenta) and 
Fer1HCH-HA with the HA antibody (green). 
Figure 24 A shows expression of Fer1HCH-HA in wrapping glia. The HA signal could be found 
in wrapping glial cells but was also slightly colocalizing with the neuronal HRP signal in some 
axons. The average Pearson’s coefficient was P= 0.24. Upon expression in subperineurial glia, 
the HA signal was colocalizing with the HRP signal (Figure 24 B) (average Pearson’s coefficient 
P= 0.43) indicating stronger colocalization compared to nervana2Gal4 expression. Upon 
expression in perineurial glia, there was no colocalization observed (Figure 24 C) indicated by 
the low Pearson’s coefficient (P = 0.07). The weak HA signal was restricted to glial cells. 
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Expression outside the nervous system with LppGal4 in the fat body led to a dotted HA signal 
of the Fer1HCH-HA outside the nervous system and eventually with glial cells (Figure 24 D). 
No colocalization between HRP and HA could be detected (P = -0.612). 
In conclusion, we observed a colocalization of Fer1HCH-HA with the neuronal marker HRP 
after expression in wrapping glia and subperineurial glia. No colocalization was measurable 
after expression in perineurial glia or fat body. 
 
Figure 24: Ferritin1HCH expression in wrapping and subperineurial glia 
shows colocalization with neurons. To evaluate the localization of 
Ferritin1HCH a tagged version of the protein was overexpressed with the 
glial sub-type specific driver lines. For control, the construct was 
expressed in the fat body with LppGal4. HA protein was detected with 
the HA antibody (green), neurons were labeled with the HRP antibody 
(magenta). (A) Expression of Fer1HCH-HA in wrapping glial cells with 
nervana2Gal4 showed colocalization of HA and HRP signal. (B) Expression 
of Fer1HCH-HA in subperineurial glial cells with gliotactinGal4 showed 
colocalization of HA and HRP signal. (C) Expression in perineurial glia with 
C527Gal4 showed a weak signal restricted to the glia. (D) Expression of 
Fer1HCH-HA in fat body cells showed a dotted distribution of HA signal 
and no colocalization was observed. Scale bar 10 µm. 
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3.7.4 Overexpression of Fer1HCH in cultured primary Drosophila cells confirmed transfer 
To study the transfer of glially expressed Fer1HCH-HA to neurons, we used cultures of 
neurons and glia cells. For that purpose, a method was established that allowed us to culture 
cells isolated from embryos for several days. To label the glia, cells were isolated from 
embryos expressing a membrane bound CD8GFP (green) under control of the pan-glial driver 
line repoGal4. Neuronal membrane as before was stained with the HRP antibody (blue). As 
depicted in Figure 25 A beside other cells, neurons and glia cells were isolated and 
differentiated in vitro. After five days in vitro (DIV), glial cells were mostly associated with 
neurons (Figure 25 A). To test transfer of Fer1HCH-HA cells were isolated from embryos 
expressing CD8GFP and Fer1HCH-HA under the control of repoGal4. Cells were cultured 
under same condition as control cells. At five DIV, cells were fixed and stained with the HA 
antibody (red) as well as for glial and neuronal markers (Figure 25). Fer1HCH-HA was detected 
in glial cells but also colocalizing with neurons (Figure 25 B, B’). In comparison, there was no 
HA signal detectable in control cells, which did not express Fer1HCH-HA (Figure 25 A’). 
In conclusion, the experiment could confirm the transfer of glially expressed Fer1HCH-HA 
protein to neurons in vitro. 
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Figure 25: Overexpression of Fer1HCH-HA in cultured primary cells shows colocalization 
with neuronal marker. Cells were isolated from embryos expressing only CD8GFP 
(control) or CD8GFP and Fer1HCH-HA in glial cells (green). Neurons were labeled with 
the HRP antibody (blue), HA protein tag with the HA antibody (red). After five DIV, cells 
were fixed. (A) Control cells did not stain for HA protein. (B). Expression of Fer1HCH-HA 
in glial cells showed localization of HA protein in glial cells as well as with neurons. 
Scale bar 10 µm. 
 
 
3.7.5 Ferritin1HCH-HA can integrate into the Ferritin complex 
After detecting the Fer1HCH-HA protein colocalizing with the neuronal marker, we wondered 
if the protein is functional. 
Frist, the integration into the ferritin complex was analyzed. Therefore, HA labeled Fer1HCH 
was expressed in glial cells and brain lysates were subjected to non-reducing SDS 
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polyacrylamide gel electrophoresis (SDS page) and visualized via western blot. For detection 
of the protein, the HA antibody was used. As shown in Figure 26 A, several bands were visible. 
Two strong signal bands appeared at ~33 kDa and 55 kDa. The 33 kDa band corresponded to 
the Fer1HCH-HA monomer. The size of 55 kDa indicated a dimer of Fer1HCH-HA and the 
endogenous expressed Ferritin2 light chain (Fer2LCH). That the dimer band showed stronger 
signal than the monomer band indicated a high degree of stability of the Fer1HCH-Fer2LCH 
interaction. We also saw several other bands of a higher molecular weight that most likely 
represent multimers of Fer1HCH-HA and Fer2LCH. It has been described that the ferritin 
complex consists of 12 Fer1HCH and 12 Fer2LCH subunits which can be detected at a band 
size of ~240 kDa (Kosmidis et al., 2011). Therefore, the band with the highest molecular 
weight (~270 kDa) in Figure 26 A corresponded to the whole ferritin complex. The ~ 30 kDa 
difference was due to the HA protein tag. 
In summary, we found that Fer1HCH-HA is integrated into the Ferritin complex. 
 
 
 
Figure 26: Fer1HCH-HA is not fully functional. To test the functionality of the Fer1HCH-HA, the construct was 
expressed in vivo. (A) Fer1HCH-HA was expressed in glial cells. Protein lysates were separated over non-reducing 
PAGE. Western blot analysis showed HA signal bands of different molecular weights which correspond to dimers 
and multimers of Fer1HCH-HA and Fer2LCH. Fer1HCH-HA is integrated into the Ferritin complex (~270 kDa). 
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3.8 Iron accumulation is toxic for glial cells 
3.8.1 Iron accumulates upon p24-1 inhibition 
As ferritin is described as an iron binding molecule (Granick, 1942) we asked, if the iron 
homeostasis was changed upon p24-1 inhibition. To answer this question, a staining 
procedure for Drosophila peripheral nerves was established allowing detection of ferrous iron 
(Fe2+) with the Turnbull’s blue staining method. The signal was subsequently enhanced with 
3,3’ diaminobenzidine (DAB). To test for iron accumulation, p24-1 gene function was inhibited 
in glial cells and third instar larval peripheral nerves were dissected. As control, the repoGal4 
driver line was crossed to wild-type. In control nerves there was only little signal visible 
(Figure 27 A). Upon expression of p24-1 RNAi in glial cells, we could detect a strong signal 
along the nerve (Figure 27 B, C). There were accumulations visible that appeared in the outer 
layers of the nerve. Although the glia and neurons could not be distinguished with this 
staining method, it is likely that those accumulations are restricted to glial cells. 
 
 
Figure 27: Glial p24-1 inhibition exhibited ferrous iron 
accumulation. To detect ferrous iron Turnbull’s blue stain wit 
DAB enhancement was applied in third instar peripheral nerves. 
(A) In control nerves (genotype repoGal4/+) only little signal was 
detected. (B, C) After p24-1 inhibition in glial cells, (genotype 
repoGal4/p24-1 RNAi) dark spots were detected mainly in the 
outer layers of the nerve indicating accumulation of ferrous iron. 
Scale bar 20 µm. 
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3.8.2 Phenotype strength can be modulated by ferroptosis inhibitors 
After detecting iron accumulation in the PNS, we wondered if this dysfunctional regulation 
could be modulated by applying drugs that can alter the toxic effect of iron. Ferroptosis has 
been described to be an iron-dependent form of cell death. The small compound named 
Ferrostatin-1 as well as different iron chelators were found to rescue from ferroptosis (Dixon 
et al., 2012). To test the involvement of ferroptosis, we applied the two iron chelators 50 µM 
bathophenanthroline sulfate (BPS) and 50 µM deferoxamine as well as 150 µM of the 
inhibitor Ferrostatin-1 to the animals. For control purposes, ddH2O was applied. To provide 
more iron 25 mM ferric ammonium citrate (FAC) was used. As readout for the phenotypic 
strength, the relative number of protrusions per nerve was quantified as well as the 
normalized number of Brp-positive vesicles. Standard food with inhibitor was supplied over 
the development, and then the animals were dissected at third instar stage and stained with 
the neuronal marker HRP and the axonal vesicle marker Bruchpilot. 
First, we performed pan-glial inhibition of p24-1 (Figure 28 A). Application of ddH2O and FAC 
showed a mean protrusion number of 1.08 and 0.72 respectively. When the chelators BPS 
and DFO were provided peripheral nerves showed a significant decrease in the number of 
out-foldings per nerve (BPS mean = 0.22 and DFO mean = 0.14). Also after treatment with 
ferrostatin-1 we observed a significant decrease of protrusions per nerve (mean = 0.31) 
compared to water control. One-way Anova revealed a significant difference of the values (p 
= 0.0003) and Bonferroni post-hoc test showed significance between the groups as indicated 
(* < 0.01, ** < 0.001, *** < 0.0001). Quantification of the vesicle number after glial p24-1 
inhibition showed no significant difference between the groups (p < 0.0001). 
The PNS of animals after pan-glial Fer1HCH inhibition and inhibitor application was 
considered (Figure 28 B). The quantifications of the axonal protrusions per nerve were 
significantly different (p < 0.0001). Applying ddH2O and FAC led to mean of 1.88 and 2.14 
protrusions per nerve respectively. The quantification of the protrusions upon BPS, DFO and 
Ferrostatin-1 application revealed a strong decrease in the occurrence of the phenotype (BPS 
mean = 0.136 DFO mean = 0.095, Ferrostatin-1 mean = 0.358). Bonferroni’s post-hoc test 
showed as well a significant difference between the groups as indicated (Figure 28 B). The 
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vesicle number again was not significantly different between the groups. The quantification of 
the vesicle number upon p24-1 (Figure 28 C) or Fer1HCH (Figure 28 D) inhibition revealed 
that there was no difference in strength of the axonal transport defects. 
In summary, the inhibitor test showed that the axonal out-folding phenotype, which occurred 
after p24-1 and fer1HCH knockdown in glial cells, could be alleviated by application of iron 
chelators and the drug ferrostatin-1. The axonal transport defect of Brp-positive was not 
changed upon application of inhibitors. 
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Figure 28: Inhibitors can modulate p24-1 phenotype penetrance. Iron chelators and the 
small compound Ferrostatin-1 were applied to Drosophila third instar larvae. Phenotype 
strength was quantified as number of protrusions found in nerves and as normalized 
number of Brp-positive vesicles in 4 x 100 µm nerve sections. Third instar larval tissue was 
stained for GFP (glia), HRP (neurons) and Bruchpilot (axonal vesicles). Filet preparation 
were used to analyze the whole PNS, n=6. One-way Anova and Bonferroni post-hoc test 
was used to assess statistical significance * < 0.001, ** < 0.0001, *** < 0.00001. (A) Animals 
after pan-glial inhibition of p24-1 were analyzed. Quantification of absolute number of 
axonal out-foldings per larval nerves counted indicates decrease of protrusions after 
application of BPS, Fer-1 and DFO compared to H2O and FAC. p = 0.0003. The normalized 
vesicle number was not significantly different between the groups. (B) Animals after pan-
glial inhibition of Fer1HCH were analyzed. Quantification of absolute number of axonal out-
foldings per larval nerves counted indicates significant decrease of protrusions after 
application of BPS, Ferrostatin-1 and DFO compared to ddH2O and FAC p < 0.0001. The 
normalized vesicle number was not significantly different between the groups. 
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3.8.3 Ferritin1HCH mutant reveals defects in the nervous system 
Next, we examined the appearance of peripheral nerves in Ferritin1HCH mutants. For p24-1, 
there was no lethal allele available. For Fer1HCH, the mutant allele fer1hch451 was 
homozygous lethal. It has been described that 43% of the embryos die during embryonic 
stages and a fraction of mutant animals showed nervous system defects (González-Morales et 
al., 2015).  
We analyzed the peripheral nerves of homozygote mutants, which survived until larval stages 
(~50%). First instar larvae were dissected and stained with the neuronal marker HRP. In few 
animals, we found defasciculated axons in peripheral nerves (Figure 29 A). However many 
animals did not display axonal changes. Ubiquitous expression of Fer1HCH-HA with act5cGal4 
in fer1hch-null mutant background rescued to some extent and animals survived until second 
instar stage. When we examined the nerves, we could not find axonal alterations (Figure 29 
B). Expression of Fer1HCH-HA in glial cells with the weaker repo4.3Gal4 driver could also not 
rescue from lethality or PNS alterations. To investigate the appearance of glial cells in mutant 
animals, a membrane bound CD8GFP (green) was expressed under the glial repo4.3Gal4 
driver in homozygous mutant background. In ~ 50% of the analyzed animals, we found an 
uneven distribution of the CD8GFP signal (Figure 29 C). Because CD8GFP is associated to glial 
membranes, we speculated about a perturbed synthesis of glial membrane or developmental 
defects. As wrapping glia is not yet differentiated in first instar larvae, it is likely that 
subperineurial glia is affected in fer1hch451 mutants. 
To conclude above findings, we found that homozygous ferritin1hch mutants displayed 
developmental defects in neuronal and glial cells. 
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Figure 29: fer1hch-null mutant shows alterations of glia and axons.  The homozygous lethal fer1hch451 allele 
was analyzed. Animals die between embryonic and first instar larval stage. Glia was labeled by repoGal4 > 
CD8GFP expression and neurons were labeled with the HRP antibody. (A) Few homozygous mutants display 
axonal defasciculation distributed over peripheral nerves. (B) Ubiquitous expression of Fer1HCH-HA with the 
actin5cGal4 driver repressed axonal alterations. (C) Labeling of glia membrane reveals glial alterations in 
fer1hch451 mutants. Scale bar 10 µm. 
 
 
 
3.9 Neuronal transcriptome changes after glial iron blockage 
3.9.1 Experimental design of the ribosome profiling experiment 
To evaluate the neuronal response upon p24-1 or Fer1HCH inhibition in the glia, we designed 
a ribosome profiling experiment, which allowed the purification of neuronal translating 
ribosomes and parallel knockdown in glial cells. 
We made use of the binary Q expression system (Potter et al., 2010). First, the ribosomal 
protein Rpl10ab was amplified from a pUAST-Rpl10ab vector (Thomas et al., 2012) and cloned 
into a pQUAST expression vector. Either a HA protein tag or a GFP was n-terminally attached. 
The pQUAST-Rpl10ab-HA/GFP vector was then integrated into the fly genome with help of 
the ϕC31 site-specific integration system in landing site 22A (2nd chromosome, 2L). Flies 
harboring the QUAS-Rpl10ab-HA construct were recombined with fly lines containing the 
UAS-p24-1 RNAi or the UAS-Fer1HCH RNAi constructs, respectively. As a pan-glial driver line 
repoGal4 was used to express p24-1 RNAi. To drive pan-neuronal expression of the QUAS-HA-
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Rpl10ab the fly line n-sybQF.2 was selected. The two drivers RepoGal4 and n-sybQF.2 were 
recombined in one fly line (Figure 30 A). A similar line was also generated harboring a 
pQUAST-GFP-Rpl10ab construct. 
To verify expression of the newly generated QUAS-Rpl10ab-HA construct in vivo, we first 
crossed n-sybQF.2 to QUAS-HA-Rpl10ab or QUAS-GFP-Rpl10ab flies. Staining with an HA 
antibody (green) confirmed expression in neuronal cells (Figure 30 B). Nuclei were labeled 
with ToPro dye (blue). The Rpl10ab-GFP line was neglected from further applications because 
expression in glial cells led to lethality of the animals in pupal stages. This indicated that the 
Rpl10ab-GFP version is not fully functional or even toxic for cells. 
Second, we verified expression of the Rpl10ab-HA by western blot. Therefore, lysates of 
repoGal4 > UAS-Rpl10-HA, n-sybQF.2 > QUAS-HA-Rpl10ab and combined animals repoGal4, n-
sybQF.2 >> UAS-p24-1 RNAi, QUAS-HA-Rpl10ab were separated on a SDS page. Western blot 
detection with the HA antibody reveled expression of HA-Rpl10ab in all three conditions 
(Figure 30 C). The ribosomal protein Rpl10ab was then immuno-purified over the HA protein 
tag and RNA was isolated from neuronal ribosomes as described in 2.5.4. After several 
purification steps the RNA was sequenced  
In summary, we created a system that allowed the manipulation of glial cells by the 
expression of the RNAi construct and the contemporaneous isolation of translating 
ribosomes. From immune-purified ribosomes, we could successfully isolate neuronal RNA. 
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Figure 30: Ribosome profiling experimental design. To determine the neuronal response upon 
glial p24-1 or Fer1HCH inhibition ribosome profiling was performed. (A) A transgenic fly line 
harboring a QUAS-Rpl10ab-HA construct was combined to a fly line with the p24-1 RNAi 
construct. The pan-glial repoGal4 driver line was recombined to a pan-neuronal n-sybQF.2 driver 
line. (B) Rpl10ab-HA was successfully expressed in third instar larval brain. HA was labeled with 
the HA antibody (green), Nuclei were stained with the ToPro dye. (C) Lysates of third instar larvae 
were prepared for repo > UAS-Rpl10ab-HA, n-sybQF.2 > QUAS-Rpl10ab-HA and the combined 
line repoGal4, n-sybQF.2 >> UAS-p24-1 RNAi, QUAS-Rpl10ab-HA. Separation with reducing SDS 
page and detection over western blot showed expression of RPL10ab-HA in all three conditions. 
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3.9.2 RNA sequencing results 
The sequencing procedure was performed with an Illumina next-generation sequencing setup 
(in collaboration with Moritz Rossner, LMU München).We sequenced the whole 
transcriptome isolated from neurons (with nsybQF.2) and glia (repoGal4) from third instar 
larvae. We could detect ~7200 transcripts of which 763 were significantly differently 
expressed (not shown). High expression levels of known neuronal transcripts such as futsch, 
bruchpilot and synapsin appeared in the probe isolated from n-sybQF.2 > HA-Rpl10ab 
expressing animals. This confirmed that with this method we were able to isolate cell type 
specific translating ribosomes. 
The comparison of neuronal transcripts isolated from animals, which expressed Fer1HCH 
RNAi to control revealed 592 differentially, expressed transcripts. The glial inhibition of 
Fer1HCH causes a down-regulation of iron-responsive transcripts in neurons. These 
transcripts harbor an iron-response element or need iron as cofactor for Fe-S clusters and 
heme binding. The results are listed in Table 15. 
 
Table 15: Iron-dependent transcripts are differentially expressed upon glial Fer1HCH inhibition. Neuronal RNA 
transcripts were sequenced. LSMean shows average number of reads per transcript of three technical samples. 
Control neuronal (n-syb) versus and neuronal transcripts with glial Fer1HCH RNAi (Fer1HCH) were compared 
(Fold change). Fold change > 1.8 was considered as significantly changed. 
Gene ID Gene symbol P-Value Fold change 
LSMean 
(nsyb) 
LSMean 
(Fer1HCH) 
FBgn0013972 Gycalpha99B 5,79E-02 1,05E+01 3,22E+01 3,08E+00 
FBgn0000108 Appl 7,09E-02 8,22E+00 1,03E+03 1,25E+02 
FBgn0031684 ND-13A 1,35E-01 5,35E+00 2,34E+01 4,37E+00 
FBgn0038295 Gyc88E 2,61E-01 3,78E+00 4,31E+00 1,14E+00 
FBgn0030733 UQCR-14 3,36E-01 2,62E+00 1,13E+01 4,32E+00 
FBgn0062442 Cisd2 3,88E-01 2,57E+00 6,86E+00 2,67E+00 
FBgn0036728 UQCR-Q 2,98E-01 2,51E+00 1,68E+01 6,68E+00 
FBgn0030718 ND-20 4,55E-01 2,12E+00 7,69E+00 3,62E+00 
FBgn0032597 CG17904 4,68E-01 2,03E+00 6,48E+00 3,19E+00 
FBgn0017567 ND-23 4,89E-01 1,97E+00 4,38E+00 2,22E+00 
FBgn0015222 Fer1HCH 4,42E-01 1,95E+00 1,19E+02 6,11E+01 
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4 Discussion 
The main task of glial cells is the axonal ensheathment. In vertebrates, this is accomplished by 
oligodendrocytes in the CNS and Schwann cells in the PNS, which form myelin around axons. 
In a similar manner, Drosophila glia cells ensheath peripheral axons to form the blood-brain 
barrier and to separate single axons. Due to the neuron-glia architecture, all signals, 
metabolites and other molecules have to be shuttled through the glial layers. Thus, a tight 
interaction between neuron and glia cells is indispensable. However, our knowledge about 
this interaction or communication process and the molecules involved remains limited. 
 
4.1 Molecules involved in neuron-glia interactions 
4.1.1 Identification of factors affecting neuronal integrity 
By conducting an RNAi screen of highly conserved molecules, we sought to uncover glial 
molecules, which have an impact on function or morphology of neurons. As a system to 
analyze neuron-glia interactions, we selected the Drosophila larval peripheral nerve because 
of certain advantageous attributes: first, it is easily accessible; second, the organization of the 
nerves is rather simple since only three glial cell types exist, for which genetic markers are 
available; third, RNAi efficiency is high during larval stages; fourth glial development is mostly 
terminated and glial function can be studied (in the sense that cell types are specified, 
migration is finished and most of the cells only grow in size). For the screening, we selected 
homologs from a proteome analysis of the axo-glial fraction from mouse and human tissue 
(Figure 5 A). This guaranteed the exclusive analysis of candidates having human and mouse 
homologs. 
Strikingly, around 40% of the tested candidates showed at least a mild disturbance in the 
larval segmental nerves (Figure 5 B). This number suggests that the screening setup was 
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sensitive enough to detect small failures but also indicates that glial cells are susceptible upon 
genetic manipulations. Confocal analysis allowed us to detect viable defects, since not 
necessarily all nervous system alterations are lethal. For instance, glial knockdown of the 
solute carrier NCC69 or the motor protein Khc generates severe defects, but animals are 
viable (Leiserson and Keshishian, 2011; Schmidt et al., 2012). In other, more global screening 
approaches looking for vital glia functions, the positive hit rate was between 11 and 13% 
(Ghosh et al., 2013; Schmidt et al., 2012). Hence, the high positive rate found in this study 
reveals that many protein functions are highly conserved between the initial vertebrate and 
the invertebrate candidates. 
4.1.2 Glial secretion is necessary for neuronal function 
The positive candidates could be clustered regarding their gene function (Figure 5 C). The 
majority of the candidates are involved in binding and catalytic processes. A smaller number 
of candidates had transport activity. When we had a closer look on the molecules, we found 
that several candidates, such as Atlastin, several Syntaxins, Gdi, p24-1 were involved in the 
secretory pathway. In a global RNAi screen it has been found that especially metabolic 
pathways were over represented within adult glia (Ghosh et al., 2013). Hence, it is likely that 
parts of the metabolic products are delivered to neuronal cells. This phenomenon has been 
described in vertebrates and invertebrates for carbohydrates which are transported over the 
glial barrier and provided to the neuron (Saab et al., 2013; Volkenhoff et al., 2015). 
We found that one candidate, p24-1, which is involved in the secretory pathway, showed the 
strongest effect on the nervous system upon knockdown with the pan-glial driver line 
repoGal4. Therefore, we decided to continue with the analysis of p24-1 in the context of 
neuron-glia interaction. 
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4.2 Glial p24-1 function is required for the architecture and function of the nervous 
system 
Pan-glial inhibition of p24-1 gene function had a massive impact on the nervous system 
(Figure 6). We observed a faint CD8GFP signal indicating disturbances of glia membranes. In 
some areas, we found thickenings of the peripheral nerve. In parts in which the glia 
membrane was disrupted, the neuronal alterations were evident. Out-foldings of the axons 
occurred randomly over the PNS and affected sensory as well as motor axons. Single axon 
labeling in sections, which were beginning to form out-foldings, revealed local instabilities of 
the axon although glial membranes still covered the nerve (Figure 11). The onset of those 
alterations was in the third instar stage. With increasing age, also the axonal out-foldings 
increased in size and occurrence (Figure 13 A). At the end of the larval stage, a considerable 
amount of axons degraded (Figure 9). Although the glia appeared destructed, we could not 
detect signs of apoptosis (Figure 10). The attempt to find out in which glial sub-type p24-1 
function was required surprisingly did not mirror the axonal phenotype (Figure 7) and had no 
effect on the larval nervous system at all upon inhibition in neuronal cells (Figure 7 D). 
Eventually, the Gal4 driver lines just expressed the UAS-RNAi in a too weak fashion or at a too 
late time point during embryonic and larval development. Labeling the glial sub-types Gal4 
independently by GFP exon trap lines revealed a more precise picture of the glial phenotype 
(Figure 8). Wrapping glia cells did not differentiate in order to separate axon and septate 
junctions in subperineurial glia were disrupted, meaning that BBB integrity was affected. 
Thus, p24-1 function is probably required in wrapping glia and subperineurial glia cells. 
4.2.1 Specificity of the p24-1 phenotype 
The experimental setup of the screen based on the RNA interference technique. This targeted 
gene silencing allowed for a fast and cell-type specific analysis of a big set of candidate genes. 
Nevertheless, the method also has its drawbacks since it can generate false-positive and 
false-negative results. The false-negative rate can be up to 34.7% of the genes but depends 
strongly on the Gal4 driver line used and the tissue assessed. The false-positive rate for the 
VDRC GD library was estimated to be below 2% (Dietzl et al., 2007). We discovered the p24-1 
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phenotype upon induction of RNA interference with the VDRC line p24-1GD12196. Line 
GD12196 had three off-targets but inhibition of those genes did not cause similar defects or 
lethality. To ensure the specificity of the RNAi induced phenotype, p-element insertions 
within the p24-1 locus were investigated, but none of them was a lethal allele showing 
nervous system defects. To further validate the specificity, tissue was stained with an specific 
antibody against p24-1 (Saleem et al., 2012) and confirmed that p24-1 protein was absent 
upon expression of p24-1GD12196 (Figure 17) and p24-1KK100594. Another method to confirm 
RNAi specificity is RESC and inter-species RNAi rescue (Kondo et al., 2009; Schulz et al., 2009). 
Upon expression of the RESC construct in glial cells, the protein could not be detected in the 
expected pattern, which might be due to the instability of the transcript. The inter-species 
rescue construct was localized in the expected pattern but could not rescue from p24-1 
induced lethality (Figure 18). Either p24-1 from D. virilis was still targeted by the RNAi, the 
protein was not fully functional across the species or the HA tag inhibited its functionality. 
Interestingly, it has been shown, that ubiquitous p24-1GD12196 and p24-1KK10094 knockdown was 
lethal, while the KK10094 line produced in a milder developmental phenotype than the 
GD12196 line (Saleem et al., 2012). Hence, the stronger glial phenotype observed in this 
study might be due to a stronger knockdown. 
Because it has been described that the family of p24 proteins possibly function as 
heterodimers or trimers (Buechling et al., 2011; Port et al., 2011), we tested all p24 family 
members for their involvement in nervous system integrity. Nine p24 family members are 
expressed in Drosophila melanogaster and for eight RNAi lines were available. Inhibition in 
the whole animal was described to be lethal for éclair, Chop24, p24-1, opossum and baiser, 
whereas p24-2 and CG9308 showed weak defects and CG31787 only reduced male fertility 
(Saleem et al., 2012). Knockdown in glia cells, in contrast, was only lethal for Chop24, p24-
1GD12196 and opossum. Chop24 RNAi expression in the glia led to lethality during early adult or 
pupal stages (Figure 19). Pan-glial opossum inhibition with both lines (opmGD10168 and 
opmKK101312) caused lethality in third instar larvae and analyses of the peripheral nerves 
revealed the axonal out-folding phenotype (Figure 19 B). There was no difference in 
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phenotype penetrance between p24-1 and opossum. Thus, we reasoned that p24-1 and 
opossum might function as heterodimers or in the same pathway. 
A microarray analysis of the adult Drosophila neural transcriptome confirmed that p24-1 is 
highly expressed in the brain. The comparison revealed that it is 1.65 times more expressed in 
repo positive cells than in elav positive cells. Opossum is weaker expressed in the adult brain 
and shows a slight increase (1.1 fold) in glia cells compared to neurons (DeSalvo et al., 2014). 
We concluded that the described glial p24-1 phenotype is specific and not due to an off-
target effect. Nevertheless, the phenotype should be confirmed by a cell type specific full 
knockout of p24-1 and opossum. p24-1 function is presumably critical for glia function 
although it is expressed in other tissues. 
4.2.2 p24 proteins in selective secretion 
The secretion process has a pivotal role in cell interaction and communication. It depends on 
multiple sorting and transporting steps. p24 proteins have an important function in the early 
secretory pathway where they shuttle between the ER to the Golgi compartment, but also 
show post-Golgi localization (Strating and Martens, 2009). The p24 protein family consists of 
~24 kDa type I transmembrane proteins, which are highly conserved across many phyla (e.g. 
yeast, plants and humans). p24 proteins are equipped with distinct domains. In proximate 
distance to the hydrophobic transmembrane domain, a short C-terminal domain faces 
towards the cytosol. Here, several highly conserved motifs allow the interaction with vesicle 
coat proteins like COP I and COP II (Belden and Barlowe, 2001; Dominguez et al., 1998; 
Strating and Martens, 2009). At the luminal site near the transmembrane region, p24 proteins 
have a helical domain which probably mediates interaction between family members (Ciufo 
and Boyd, 2000). The biggest part is covered by the GOLD domain (Golgi dynamics). This 
globular domain has been predicted to be necessary for the interactions with cargo molecules 
(Anantharaman and Aravind, 2002). The molecular structure indicates possible functions as 
cargo receptor, in vesicle formation and in quality control of secreted proteins (Carney and 
Bowen, 2004), which was confirmed by studies in yeast. Deletions of all eight p24 proteins did 
not cause lethality but the transport of secretory and membrane proteins was blocked and ER 
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resident proteins were secreted instead (Springer et al., 2000). In higher species, p24 proteins 
have vital functions. Mutations of p23δ1 are embryonically lethal in mice (Denzel et al., 2000). 
Down-regulation of most p24 proteins in Drosophila results in lethality during development 
(Saleem et al., 2012). Studies indicated that p24 proteins are expressed in a variety of 
different tissues but they might have cell type specific or temporal expression patterns during 
developmental stages (Boltz et al., 2007; Saleem et al., 2012). Evidence that p24 proteins 
might act in concert came from two studies proposing different combinations of p24 proteins 
are responsible for wingless secretion in the Drosophila wing disc (Buechling et al., 2011; Port 
et al., 2011). Thus, we tested if wingless is possibly involved in generating the p24 nervous 
system phenotype, but no link between wingless signaling and p24-1 in glial cells could be 
found. Another example of p24 function can be found in the adult Drosophila CNS, where 
logjam probably in combination with éclair and baiser is involved in the oviposition behavior 
(Boltz et al., 2007). Hence, as we found in our study that the inhibition generated the same 
phenotype, it might well be that p24-1 and opossum act together in glial cells. However, a 
biochemical confirmation is still needed. 
4.2.3 Non-cell autonomous effects of p24-1 inhibition 
Upon pan-glial p24-1 inhibition, we observed non-cell autonomous effects on axons indicating 
neuronal dysfunction. They included axonal instabilities with axonal swellings (Figure 11), 
axonal traffic jam (Figure 12 ), mitochondria defects (Figure 14), axonal loss (Figure 9) and 
photoreceptor migration defects (Figure 14). All these ultimate effects together with the 
knowledge about p24-1’s and opossum’s critical role in the secretory pathway, revealed that 
glial cells must secrete proteins, which are necessary for neurons. 
One example for a glia-derived neurotrophic factor is dMANF. This factor is secreted from 
embryonic glia cells. dMANF mutants die during early larval stages and show a reduced 
number of dopaminergic neurites (Palgi et al., 2009). Interestingly, an example of p24 family 
members involved in cell interaction can be found in vertebrates. It has been publicized that 
p24 proteins regulate the transport of GPI-anchored proteins to the plasma membrane, 
where they eventually function in cell to cell signaling (Takida et al., 2008). This data could be 
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confirmed in yeast suggesting that GPI-anchored proteins exit the ER upon concentration at 
the ER exit site (ERES) with support of p24 proteins (Castillon et al., 2009). An example for a 
GPI-anchored protein with nervous system function is Glial Lazarillo (GLaz). Absence of GLaz 
in adulthood leads to more lipid peroxidation products, reduces oxidative stress resistance in 
neural cells and causes neurodegeneration (Sanchez et al., 2006), whereas ubiquitous 
overexpression improves iron induced oxidative stress resistance (Ruiz et al., 2012). If GLaz 
secretion is affected by p24 inhibition could be further analyzed. Another study showed that 
the TNFα-like molecule Gurken, which is required for cell polarity in oogenesis of flies, is 
secreted with help of Cornichon (cni), a cargo receptor in the early secretory pathway. 
Surprisingly, the luminal part of cni can be replaced by the GOLD domain of the p24 family 
member Chop24 without affecting Gurken secretion (Bökel et al., 2006). Most likely cni is 
responsible for the transport of transmembrane proteins, whereas for example the Chop24 
yeast homolog Emp24p is required for the transport of GPI-anchored proteins (Castillon et al., 
2009). Evidence of p24 proteins’ involvement in neurodegeneration comes from studies of 
human diseases. Human p24β1 (which corresponds to D.m. Chop24) has been found to 
interact with atlastin and is linked to hereditary spastic paraplegias (Namekawa et al., 2007). 
Human p23/p24δ1 (which corresponds to D.m. baiser) is involved in the secretion of soluble 
APP and links p24 function to Alzheimer’s disease (Vetrivel et al., 2007). 
We were interested to identify the molecules, which are secreted by p24 proteins from glial 
cells during the end of the larval stages. Thus, we conducted a genetic screen (Figure 20). The 
secondary RNAi screen of secreted and Immunoglobulin superfamily members revealed three 
candidates, which reproduced the axonal out-folding phenotype upon glial inhibition 
(Ferritin1HCH, Yolk protein 2 and Dpr-2). This was partially supported by a study in Drosophila 
S2 cells, which identified Ferritin1HCH as one binding partners of p24-1 (Guruharsha et al., 
2011). p24 proteins are likely to be involved in the transport of difficult cargo like large 
oligomeric assemblies (D’Arcangelo et al., 2015). Thus, we propose that Ferritin1HCH is 
secreted from glia cells with help of p24-1 and opossum. 
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4.3 Ferritin functions as iron trap and transporter in the glia 
The function of Ferritin1HCH in glia cells was analyzed by using RNAi. Strikingly, pan-glial 
inhibition for all available Fer1HCH lines (Fer1HCHGD12925, Fer1HCHGD49536 and Fer1HCHKK102406) 
was lethal and generated the axonal out-folding phenotype (Figure 21 A). Very similar to p241 
knockdown, we could observe disassembly of glial cells and strong morphological and 
functional defects in neurons. The phenotype kinetics also showed a progressive 
development from the third instar larval stage on (Figure 21 B, C). Fer1HCH inhibition even 
revealed a slightly stronger defects since the average protrusion number per axon was 
around 1 upon p24-1 knockdown and 2 upon Fer1HCH knockdown at 118 hours AEL. 
There are three ferritin genes encoded in Drosophila named fer1hch, fer2lch and fer3hch. 
Fer1HCH and Fer2LCH are described to assemble in a complex storing iron (Missirlis et al., 
2007). Fer3HCH localizes to mitochondria and is homologous to the vertebrate mitochondrial 
ferritin, but is only present in the testis (Missirlis et al., 2006) and also did not lead to 
impairments upon glial inhibition. Ubiquitous knockdown of Ferritin has been shown to be 
lethal for Fer1HCH during first and second instar stages and for Fer2LCH at late pupal stage 
(Tang and Zhou, 2013b). Pan-glial inhibition of Fer1HCH, as already mentioned, is lethal after 
a prolonged larval stage. Fer2LCH was lethal in young adults short after eclosion when 
inhibited in glial cells. This discrepancy in the lethality time points might be either explained 
by the possibility that the RNAi line did not sufficiently inhibit the gene dosage of Fer2LCH or 
that Fer1HCH has another independent function. Interestingly, it has been proposed that 
Fer1HCH alone is also able to bind iron (Pozzi et al., 2015). In our hands, inhibition of Fer1HCH 
and Fer2LCH gene function in neurons (with n-sybGal4) did not cause any obvious defects 
during larval stages (Figure 22 B). However during aging, Fer1HCH inhibition in neurons 
triggered degeneration in the eye and brain vacuolization (Tang and Zhou, 2013b). This study 
also revealed that down-regulation of either Fer1HCH or Fer2LCH led to the inhibition of the 
other ferritin subunit on protein levels indicating a mechanism ensuring a constant ratio of 
Fer1HCH and Fer2LCH protein. 
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The RNA interference data were confirmed by a study, which analyzed ferritin-null mutants. 
Homozygous animals for the fer1hch451 or the fer2lch35 mutant allele died during 
development (González-Morales et al., 2015). These Animals, which showed lethality during 
embryonic stages (36 % for fer2lch35 and 43 % for fer1hch451) displayed cuticular phenotypes 
like germband retraction or dorsal closure defects. Also defects in the CNS were described, 
which included holes and twisted VNC, misguided axons or loss of parts of the PNS (González-
Morales et al., 2015). As around 50% of homozygous mutant animals survive the embryonic 
stages, we analyzed the appearance of the peripheral nerves of fer1hch451 in first instar stage 
(Figure 29). Some rare cases showed axonal defects (Figure 29 A), but more apparent were 
defects in glial cells. The uneven distribution of CD8GFP localized membrane indicated that 
eventually the cell differentiation or the lipid synthesis might be affected. Hence, those 
defects are most likely not due to toxic effects but rather a consequence of iron deficiency in 
all tissues. Ubiquitous expression of a tagged Ferritin1HCH construct partially rescued the 
mutant’s survival until the second instar stage and PNS defects were absent (Figure 29 B). 
However, these results also showed that the Fer1HCH construct was not fully functional. 
Although Fer1HCH-HA was at least partially integrated into the ferritin complex (Figure 26), 
the protein tag itself might hinder proper Fer1HCH function in either iron binding, complex 
formation or secretion. In contrast, expression of an untagged Fer1HCH including an IRE could 
rescue the survival to early adulthood (Tang and Zhou, 2013b). 
4.3.1 Functions of iron in the nervous system 
Ferritin is highly expressed in the nervous system of vertebrates and invertebrates. In adult 
Drosophila for instance, Fer1HCH is among the 50 highest expressed genes of surface glia 
cells (DeSalvo et al., 2014). In vertebrates, Fer1HCH is also highly expressed and 3 fold more 
enriched in oligodendrocytes compared to neurons. The highest expression can be observed 
in microglia (6.5 times more enriched than in oligodendrocytes) (Sharma et al., 2015). 
However the quantity of Ferritin transcripts is not directly linked to the protein amount, as 
they can be stored and their translation is regulated over the iron-response system 
(Pantopoulos, 2004). In Drosophila, the inhibition of Ferritin in neurons did not have an effect 
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during larval stages. Thus, we conclude that glia is the main iron mediator within the nervous 
system. In that regard it might be interesting to investigate, if a feedback loop exists that 
would allow the neuron to send signals when it requires iron. 
In both systems, iron is an indispensable factor for the function of respiratory chain and citric 
acid cycle (TCA, tricarboxylic acid cycle) proteins. Complex I (NADH dehydrogenase) contains 
eight ISCs, Complex II (succinate dehydrogenase) has three, Complex III (cytochrome bc1 
complex) and aconitase each contain one ISC (Lill et al., 2012; Rouault, 2016). Thus, restricting 
iron will also inhibit performance of the TCA cycle and the mitochondrial respiratory chain. 
Interestingly, blockage of Complex I function in Drosophila glia causes neuronal loss as well as 
mitochondrial enlargement and motor dysfunction (Hegde et al., 2014). 
The autosomal recessive inherited disease Friedreich’s ataxia (FRDA) demonstrates that iron 
is indispensable for the neuronal survival. The disease is caused by a mutation in the frataxin 
locus, which affects PNS and CNS neurons and is characterized by accumulation of iron in 
mitochondria, dysfunction of respiratory chain proteins as well as depleted aconitase function 
(Bulteau et al., 2004; Delatycki et al., 1999, 2000). Frataxin acts as an iron chaperone and is 
described to be involved in Fe/S cluster assembly and delivery to apo-proteins (Anderson et 
al., 2005; Shan and Cortopassi, 2012). 
Another evidence of how iron could be utilized in the Drosophila nervous system comes from 
a study showing iron involvement in the stability or formation of septate junction in the 
epithelium. Transferrin 2 (Tsf2, also described as Melanotransferrin) is a component of 
septate junctions and its function relies on iron binding, since versions of Tsf2 with a mutated 
iron binding site are not able to form apicolateral septate junctions (Tiklová et al., 2010). As 
septate junctions are a major component of subperineurial glia cells, it would be interesting 
to investigate the iron dependence of glial septate junctions. In accordance, Tsf2 has been 
shown to be expressed in the adult Drosophila brain (DeSalvo et al., 2014) and we observed 
rupture of the BBB upon blockage of iron secretion. 
Another possible function of iron in the nervous system might be linked to the synthesis of 
extracellular collagen. This matrix protein is produced by perineurial glia cells and represents 
a main component of the neural lamella surrounding CNS and PNS (Edwards et al., 1993). 
99  Discussion 
 
Maintenance of the BBB integrity might be linked to the composition of the ECM (Gould et al., 
2005; Vahedi et al., 2007). The two enzymes lysyl hydroxylase and collagen prolyl 4-
hydroxylase are critical for the synthesis of collagen. They are localized in the ER lumen using 
ferric iron as cofactor. Close observation of the TEM micrographs of p24-1 inhibited nerves 
revealed a thin and in other parts even missing neural lamella (Figure 9). This might give 
evidence on how the BBB integrity could be disrupted upon p24-1 or Fer1HCH inhibition in 
glial cells. 
How iron is utilized and distributed in vertebrates is also not entirely clear, although it is 
known that iron deficiency leads to hypo-myelination in humans and animal models (Beard 
and Connor, 2003; Lozoff and Georgieff, 2006; Ortiz et al., 2004; Yu et al., 1986). 
Oligodendrocytes are the cells in the brain, which stain the strongest for ferric iron (Connor 
and Menzies, 1996). Myelination in developing oligodendrocytes is an energy consuming 
process, which requires import of the metabolites lactate, glucose and ketone bodies 
(Vannucci and Simpson, 2003). Lactate is utilized to fuel mitochondria which produce ATP 
over oxidative phosphorylation (Bittar et al., 1996). Glucose also can be used for energy 
production over glycolysis and the pentose phosphate pathway. Glycolysis and breakdown of 
ketone bodies serve as a source of acetyl-CoA, which is required for fatty acid synthesis. 
Myelin membranes consist by 75% of lipids such as cholesterol, phospholipids, plasmalogen 
and galactolipids (Jahn et al., 2009). Iron-dependent enzymes needed for lipid synthesis (fatty 
acid synthesis) and degradation (lipid dehydrogenases) are highly expressed in 
oligodendrocytes (Cammer, 1984; Tansey et al., 1988). Also the synthesis of the abundant 
lipid cholesterol is described to be dependent on iron (Graham et al., 2010; Ong and Halliwell, 
2004). Interestingly, cholesterol is required and even rate-limiting for myelination (Saher et 
al., 2005). We also observed defects in wrapping glia maturation upon inhibition of p24-1 and 
Fer1HCH with repoGal4 and nrv2Gal4 (Figure 7, Figure 8). Wrapping glia produce large 
amounts of membrane during larval stages to enwrap and separate axons (Stork et al., 2008). 
It has been shown that synthesis of sphingolipids is critical for the maturation of wrapping glia 
(Ghosh et al., 2013). Hence, the reduced iron availability might explain the observed wrapping 
defects. 
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4.4 Iron homeostasis in the nervous system of Drosophila is regulated by glia 
4.4.1 Iron transport over the blood-brain barrier 
The BBB in Drosophila shields axons from the potassium-rich hemolymph to allow efficient 
nerve signal propagation (Auld et al., 1995), but at the same time also inhibits diffusion of 
nutrients from the hemolymph to the axon. Upon expression of Ferritin1HCH-HA in the glia, 
we were able to detect the protein in axons (Figure 23 A). Thus, we concluded that iron might 
be transferred via Fer1HCH from glial cells to neurons. This transfer can be inhibited by a 
blockage of Fer1HCH secretion through glial p24-1 knockdown (Figure 23 B). The protein 
transfer could also be confirmed in primary Drosophila cells in vitro (Figure 25). The same 
phenomenon has also been described in a recent study. Expression of tagged Fer1HCH or 
Fer1LCH constructs in hemocytes resulted in Ferritin accumulation in different tissues 
(González-Morales et al., 2015). Interestingly, transfer of iron loaded Fer1HCH was also 
observed in vertebrates. It has been publicized that murine oligodendrocytes (which have the 
highest demand on iron) take up Ferritin 1HCH with help of the receptor Tim-2 (Todorich et 
al., 2008). Although Transferrin is present in the ISF, oligodendrocytes have low amounts of 
Transferrin receptor (Roskams and Connor, 1994). Ferritin might be produced by microglia, 
which are likely to secrete Ferritin (Zhang et al., 2006) and thereby serve as an alternative 
iron source in the brain (Todorich et al., 2011). The Ferritin complex in vertebrates can be 
composed of different ratios between light and heavy chains, which differ between tissues. 
Heavy chain rich Ferritin complex is found in tissues with a high iron turnover like muscle and 
brain (Arosio et al., 2009; Harrison and Arosio, 1996). Even though vertebrate Ferritin does 
not harbor a secretion signal, numerous reports exist of cells releasing Ferritin. Eventually, it 
is actively secreted through the lysosomal secretory pathway (Cohen et al., 2010), but the 
exact mechanism remains elusive. Still, human plasma Ferritin is taken as a measure for body 
iron stores. Low serum Ferritin levels correlate with iron depletion and elevated levels with 
inflammation or high iron stores (Cook et al., 1974; Punnonen et al., 1997; Wang et al., 2010). 
That oligodendrocytes require Ferritin heavy chain has also been demonstrated using the 
Fer1HCH mouse mutant. Homozygous animals were embryonically lethal (Ferreira et al., 
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2000). Heterozygous animals, which have 20% of normal levels of Fer1HCH, showed altered 
myelinogenesis (less cholesterol and myelin proteins) and resembled models of dietary iron 
deficiency (Ortiz et al., 2004). In conclusion, Ferritin heavy chain has an important function in 
transporting and distributing iron in the nervous system of vertebrates and invertebrates. 
4.4.2 Iron accumulation causes ferroptosis in glia 
We found that glial inhibition of p24-1 led to ferrous iron accumulations (Figure 27). These 
accumulations are in general considered toxic, whereas Ferritin-bound iron is harmless. Free 
ferrous iron generates reactive oxygen species (ROS) via the Fenton reaction (Halliwell, 1992; 
Prousek, 2007). This is followed by impairment of ROS sensitive proteins such as kinases, 
transcription factors and glucose transporters and causes lipid peroxidation and 
mitochondrial dysfunction, which finally results in cell death (Keller et al., 1997; Salvador, 
2010). In accordance with our findings, iron accumulation can also be observed in a human 
disease called Neuroferritinopathy. This dominant inherited disease is caused by a missense 
mutation in the C-terminus of Ferritin light chain making the Ferritin complex less capable to 
sequester iron (Friedman et al., 2011). Consequently, iron is accumulating in deep brain 
regions, which leads to clinical symptoms in adulthood such as dystonia, dementia, ataxia and 
parkinsonism (Lehn et al., 2012). We observed glial degeneration upon inhibition of p24-1 and 
Fer1HCH (Figure 6 and Figure 21). Degeneration and axonal out-foldings could be significantly 
reduced when we applied iron chelators and Ferrostatin-1 (Figure 28). This implies that iron 
accumulation in glial cells causes ferroptosis. Ferroptosis, a form of iron-dependent and non-
apoptotic cell death, is characterized by iron accumulation and ROS production leading to the 
blebbing of plasma membrane, rounding of the cell and smaller mitochondria (Dixon et al., 
2012). We failed to detect markers of apoptosis like Tunnel positive cells (Figure 10), cleaved 
caspase 3 or phospho-histone 3 stain (not shown), which is in accordance to the 
morphological features observed during ferroptosis. This shows that disturbing the iron 
transport and storage in glial cells leads to toxic iron accumulations causing ferroptosis, which 
can be prevented by chelators and ferrostatins. 
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4.4.3 Glia regulates metabolic support of neurons 
Metabolic support of axons is conserved between vertebrates and invertebrates: both supply 
lactate or pyruvate to axons (Saab et al., 2013; Volkenhoff et al., 2015). Surprisingly, 
post-myelinating oligodendrocytes can solely survive on glycolysis, whereas neurons rely 
mainly on mitochondrial energy production by oxidative phosphorylation (Fünfschilling et al., 
2012; Hall et al., 2012). This discrepancy might be due to the different energy needs during 
the developmental stages of the cells. Although the brain represents a minor part of the total 
body mass, it uses about 20% of the oxygen and 25% of the glucose available. This energy is 
used to maintain ion gradients and allow action potentials, recycling of neurotransmitters and 
transport cargo in an anterograde and retrograde fashion (Alle et al., 2009; Attwell and 
Laughlin, 2001; Hirokawa and Takemura, 2005). For example, the maintenance of the resting 
potential through the ATP dependent Na+/K+ pump can consume up to 54% of the total 
energy of the neuron (Howarth et al., 2012). This energy demand is thought to be met by ATP 
production of mitochondria and by glycolytic enzymes directly associated with ion pumps 
(Mercer and Dunham, 1981; Paul et al., 1979). Although oxidative phosphorylation in 
mitochondria is 15 times more efficient than glycolysis, it depends on the availability of 
adenosine diphosphate (ADP) (Erecinska and Wilson, 1978). 
In Drosophila, fast axonal transport in long axons might partially rely on a newly described 
mechanism. Transport vesicles in neurons carry the glycolytic enzyme GAPDH, which is used 
for on-board ATP production (Zala et al., 2013). Upon glial Fer1HCH inhibition, we observed 
an axonal transport defect, which could be measured even before any signs of glial or axonal 
failure appeared (Figure 21 C). Bruchpilot-loaded vesicles have to move over very long 
distances from the VNC to the NMJ. We reasoned, that impaired neuronal mitochondria 
function decreased the transportation rate because less ATP is available. Our hypothesis is 
strengthened by the observation that reduction of the out-folding phenotype through iron 
chelators did not restore the vesicle transport defect (Figure 28). Furthermore, via ribosome 
profiling, we detected a significant down-regulation of mitochondrial iron-responsive 
transcripts and other transcripts, which rely on iron as cofactor (Table 15). This indicates that 
blockage of iron secretion from glia cells mimics iron deficiency in the neuron.  
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Positioning of mitochondria within the cell seems important. The vertebrate node of Ranvier 
is an area with high ATP demand (Waxman and Ritchie, 1993) and indeed, mitochondria stop 
at these sites when the axon is electrically active. In silent phases they reside at mitochondria 
stationary sites distributed throughout the axon (Ohno et al., 2011). During growth of 
neurons, the biogenesis of new mitochondria is increased. As the functions of major 
components of the respiratory chain rely on iron, also iron import is required during growth. 
Interestingly, a study in vertebrate nerves showed that mitochondrial biosynthesis does occur 
in the axon, which is relevant especially for long peripheral axons (Amiri and Hollenbeck, 
2008) and might explain why we observed transfer of iron to the axon. 99% of the neuronal 
cytoplasm is contained in the axon (Pilling et al., 2006). As some cytosolic proteins are 
translated locally, the cytosolic ISC protein assembly machinery requires import of iron, too. 
Surprisingly, in vivo it is not clear how iron enters the neuron since most studies are 
conducted in vitro (without oligodendrocytes), where TfR was observed in dendritic areas 
(Parton et al., 1992). Oligodendrocytes express Transferrin, which can even be found in 
compacted myelin areas (Lin and Connor, 1989). If they release iron loaded Transferrin to 
axonal myelinated sites has to be clarified in future studies. Briefly, the possible iron delivery 
path in Drosophila is depicted in Figure 31. 
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Figure 31: Possible iron delivery pathway in the Drosophila nervous system. Food iron is taken 
up over the gut and loaded on Ferritin secreted to the hemolymph. Ferritin-iron can be taken 
up by glial cells over a not yet identified mechanism and can be transported via the lysosome 
to the ER. Here, Ferritin is loaded with iron, transported with the help of p24-1 and opossum 
to the Golgi and further released to the neuron. Neurons can take up Ferritin and use iron for 
storage, mitochondria function or ISC assembly. 
 
 
4.4.4 Iron homeostasis in neurodegenerative disease 
Any kind of dysregulation in the iron homeostasis of the nervous system will cause 
pathological conditions: iron deficiency leads to myelin alterations, whereas overload is 
related to neurodegenerative disease (Lee et al., 2006; Todorich et al., 2009). Compared to 
other organs, the brain iron content is high and some structures in the brain show higher iron 
amounts than others (Hasan et al., 2012). Iron contents are age-related, meaning that iron 
accumulates during aging (Hardy et al., 2005). In diseases such as Alzheimer’s (AD), 
Parkinson’s (PD) and multiple sclerosis iron patterns are changed and iron accumulates 
(Wong and Duce, 2014). 
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PD patients are characterized by a loss of dopaminergic neurons and formation of 
filamentous inclusions of α synuclein between neurons (Parkinson, 2002). In the course of the 
disease, iron accumulates in the substantia nigra (SN) as well as in dopaminergic neurons 
within the SN and oxidative damage is observed (Halliwell, 1992; Lin and Beal, 2006; Zecca et 
al., 2004). There is evidence that ISC biosynthesis might be affected in the pathophysiology of 
PD. Inhibition of respiratory chain Complex I shows similar features as PD (Betarbet et al., 
2000; Horowitz and Greenamyre, 2010), which could lead to further downstream effects. 
Recently it has been proposed that there might be another link between iron and PD. In a 
Drosophila model of the disease it was demonstrated that mutant α synuclein (A53T and 
A30P) but not wild-type versions form toxic aggregates (Zhu et al., 2016) when exposed to 
free iron. In accordance with that finding, it is known that application of iron chelators can 
protect SN neurons in a mouse PD model (Kaur et al., 2003). AD is a common, age-related 
neurodegenerative disease, which is characterized by extracellular amyloid β plaques and 
neurofibrillary tangles (Selkoe, 1996). Magnetic resonance imaging also reveals elevated iron 
levels in AD patients (Bartzokis et al., 2000). Toxic Aβ plaques are derived from cleavage of 
the transmembrane protein precursor (APP). Interestingly, APP mRNA contains an IRE in the 
5’UTR (Rogers et al., 2002) and the protein possesses ferroxidase activity (Duce et al., 2010). 
Insoluble iron is localized in Aβ plaques of patients where it probably induces self-aggregation 
and oligomerization of Aβ peptide (Huang et al., 2004; Lovell et al., 1998). 
Once iron enters the brain it has to be stored inside and accumulates over life-time (Salvador, 
2010). Because the brain has a high metabolic activity and consumes a major fraction of the 
body’s oxygen, it also produces elevated amounts of ROS. These factors make the brain highly 
susceptible to iron-catalyzed oxidative damages (Napoli et al., 2006; Yan et al., 1997; Zecca et 
al., 2004). Therefore, iron even has the potential as a biomarker for diseases such as AD and 
PD, which are problematic to diagnose and treat (Schenck and Zimmerman, 2004). 
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5 Conclusion and Outlook 
In summary, we could identify in two screening approaches that the p24-1 protein seems to 
be required for the secretion of the iron binding protein Ferritin 1 heavy chain from glial cells. 
It is likely that Fer1HCH is secreted from glial cells and taken up by the neurons. As iron is 
indispensable for the function of the nervous system, we suggest that glia regulate the import 
of iron into the nervous system. In this study, we could also show that upon blockage of iron 
release from glial cells, iron accumulates and causes ferroptosis-dependent cell death. 
Ferroptosis inhibitors and iron chelators can prevent this cell death. The deficiency of 
neuronal iron upon glial iron blockage could be detected in a transcriptome analysis, which 
revealed a down-regulation of iron responsive transcripts. 
In summary, we identified a new mechanism of iron transport into the nervous system and 
found another example of metabolic support of the axon by glial cells. 
In further experiments, it will be interesting to identify the iron transport route within the 
vertebrate nervous system. Transferrin, which is described to be the main iron shuttle in 
vertebrates, is highly expressed in oligodendrocytes. Thus, closer investigation on how iron is 
transported to a myelinated axon will be intriguing. 
 
107 
 
Bibliography 
Abbott, N.J., Rönnbäck, L., and Hansson, E. (2006). (Review) Astrocyte–endothelial 
interactions at the blood–brain barrier. Nat. Rev. Neurosci. 7, 41–53. 
Aguzzi, A., Barres, B.A., and Bennett, M.L. (2013). Microglia: scapegoat, saboteur, or 
something else? Science 339, 156–161. 
Alle, H., Roth, A., and Geiger, J.R.P. (2009). Energy-efficient action potentials in hippocampal 
mossy fibers. Neuroforum 15, 130–131. 
Allen, N.J. (2014). Astrocyte regulation of synaptic behavior. Annu. Rev. Cell Dev. Biol. 30, 
439–463. 
Allen, N.J., and Barres, B. a (2005). Signaling between glia and neurons: focus on synaptic 
plasticity. Curr. Opin. Neurobiol. 15, 542–548. 
Altenhein, B., Cattenoz, P.B., and Giangrande, A. (2015). The early life of a fly glial cell. Wiley 
Interdiscip. Rev. Dev. Biol. 5. 
Amiri, M., and Hollenbeck, P.J. (2008). Mitochondrial biogenesis in the axons of vertebrate 
peripheral neurons. Dev. Neurobiol. 68, 1348–1361. 
Anantharaman, V., and Aravind, L. (2002). The GOLD domain, a novel protein module involved 
in Golgi function and secretion. Genome Biol. 3, research0023. 
Anderson, P.R., Kirby, K., Hilliker, A.J., and Phillips, J.P. (2005). RNAi-mediated suppression of 
the mitochondrial iron chaperone, frataxin, in Drosophila. Hum. Mol. Genet. 14, 3397–
3405. 
Arosio, P., Ingrassia, R., and Cavadini, P. (2009). Ferritins: a family of molecules for iron 
storage, antioxidation and more. Biochim. Biophys. Acta 1790, 589–599. 
Attwell, D., and Laughlin, S.B. (2001). An energy budget for signaling in the grey matter of the 
brain. J. Cereb. Blood Flow Metab. 21, 1133–1145. 
Auld, V.J., Fetter, R.D., Broadie, K., and Goodman, C.S. (1995). Gliotactin, a novel 
transmembrane protein on peripheral glia, is required to form the blood-nerve barrier in 
drosophila. Cell 81, 757–767. 
Awasaki, T., Lai, S.-L., Ito, K., and Lee, T. (2008). Organization and postembryonic 
development of glial cells in the adult central brain of Drosophila. J. Neurosci. 28, 13742–
13753. 
Awasaki, T., Huang, Y., O’Connor, M.B., and Lee, T. (2011). Glia instruct developmental 
neuronal remodeling through TGF-beta signaling. Nat Neurosci 14, 821–823. 
Bibliography  108 
Ball, R.W., Warren-Paquin, M., Tsurudome, K., Liao, E.H., Elazzouzi, F., Cavanagh, C., An, B.S., 
Wang, T.T., White, J.H., and Haghighi, A.P. (2010). Retrograde BMP signaling controls 
synaptic growth at the nmj by regulating trio expression in motor neurons. Neuron 66, 
536–549. 
Bartzokis, G., Sultzer, D., Cummings, J., Holt, L.E., Hance, D.B., Henderson, V.W., and Mintz, J. 
(2000). In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance 
imaging. Arch. Gen. Psychiatry 57, 47–53. 
Bate, M., and Arias, A.M. (1993). The development of Drosophila melanogaster (Cold Spring 
Harbor Laboratory Press). 
Baumgartner, S., Littleton, J.T., Broadie, K., Bhat, M.A., Harbecke, R., Lengyel, J.A., Chiquet-
Ehrismann, R., Prokop, A., and Bellen, H.J. (1996). A Drosophila neurexin is required for 
septate junction and blood-nerve barrier formation and function. Cell 87, 1059–1068. 
Beard, J.L., and Connor, J.R. (2003). Iron Status and Neural Functioning. Annu. Rev. Nutr. 23, 
41–58. 
Bélanger, M., Allaman, I., and Magistretti, P.J. (2011). Brain energy metabolism: focus on 
astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724–738. 
Belden, W.J., and Barlowe, C. (2001). Distinct Roles for the Cytoplasmic Tail Sequences of 
Emp24p and Erv25p in Transport between the Endoplasmic Reticulum and Golgi Complex. 
J. Biol. Chem. 276, 43040–43048. 
Bergmann, A., Tugentman, M., Shilo, B.Z., and Steller, H. (2002). Regulation of cell number by 
MAPK-dependent control of apoptosis: A mechanism for trophic survival signaling. Dev. 
Cell 2, 159–170. 
Betarbet, R., Sherer, T.B., Mackenzie, G., Garcia-osuna, M., Panov, A. V, and Greenamyre, J.T. 
(2000). Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. 
Nat. Neurosci. 3, 1301–1306. 
Bettedi, L., Aslam, M.F., Szular, J., Mandilaras, K., and Missirlis, F. (2011). Iron depletion in the 
intestines of Malvolio mutant flies does not occur in the absence of a multicopper oxidase. 
J. Exp. Biol. 214, 971–978. 
Bhat, M.A., Rios, J.C., Lu, Y., Garcia-Fresco, G.P., Ching, W., Martin, M.S., Li, J., Einheber, S., 
Chesler, M., Rosenbluth, J., et al. (2001). Axon-glia interactions and the domain 
organization of myelinated axons requires Neurexin IV/Caspr/Paranodin. Neuron 30, 369–
383. 
Bischof, J., Maeda, R.K., Hediger, M., Karch, F., and Basler, K. (2007). An optimized 
transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc. Natl. 
Acad. Sci. U. S. A. 104, 3312–3317. 
109  Bibliography   
Bischof, J., Björklund, M., Furger, E., Schertel, C., Taipale, J., and Basler, K. (2013). A versatile 
platform for creating a comprehensive UAS-ORFeome library in Drosophila. Development 
140, 2434–2442. 
Bittar, P.G., Charnay, Y., Pellerin, L., Bouras, C., and Magistretti, P.J. (1996). Selective 
distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human 
brain. J. Cereb. Blood Flow Metab. 16, 1079–1089. 
Bloch, B., Popovici, T., Levin, M.J., Tuil, D., and Kahn, A. (1985). Transferrin gene expression 
visualized in oligodendrocytes of the rat brain by using in situ hybridization and 
immunohistochemistry. Proc. Natl. Acad. Sci. U. S. A. 82, 6706–6710. 
Bökel, C., Dass, S., Wilsch-Bräuninger, M., and Roth, S. (2006). Drosophila Cornichon acts as 
cargo receptor for ER export of the TGFalpha-like growth factor Gurken. Development 133, 
459–470. 
Boltz, K. a, Ellis, L.L., and Carney, G.E. (2007). Drosophila melanogaster p24 genes have 
developmental, tissue-specific, and sex-specific expression patterns and functions. Dev. 
Dyn. 236, 544–555. 
Brand, A.H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell 
fates and generating dominant phenotypes. Development 118, 401–415. 
Brankatschk, M., and Eaton, S. (2010). Lipoprotein particles cross the blood-brain barrier in 
Drosophila. J. Neurosci. 30, 10441–10447. 
BrosiusLutz, A., and Barres, B.A. (2014). Contrasting the Glial Response to Axon Injury in the 
Central and Peripheral Nervous Systems. Dev. Cell 28, 7–17. 
Buechling, T., Chaudhary, V., Spirohn, K., Weiss, M., and Boutros, M. (2011). p24 proteins are 
required for secretion of Wnt ligands. EMBO Rep. 12, 1265–1272. 
Bulteau, A.-L., O’Neill, H. a, Kennedy, M.C., Ikeda-Saito, M., Isaya, G., and Szweda, L.I. (2004). 
Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. 
Science 305, 242–245. 
Burnette, W.N. (1981). “Western Blotting”: Electrophoretic transfer of proteins from sodium 
dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic 
detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195–203. 
Cammer, W. (1984). Oligodendroglia (Boston, MA: Springer US). 
Campbell, G., Göring, H., Lin, T., Spana, E., Andersson, S., Doe, C.Q., and Tomlinson,  a (1994). 
RK2, a glial-specific homeodomain protein required for embryonic nerve cord 
condensation and viability in Drosophila. Development 120, 2957–2966. 
Bibliography  110 
Carlson, S.D., Juang, J., Hilgers, S.L., and Garment, M.B. (2000). Blood Barriers of the Insect. 
Annu. Rev. Entomol. 45, 151–174. 
Carney, G.E., and Bowen, N.J. (2004). p24 proteins, intracellular trafficking, and behavior: 
Drosophila melanogaster provides insights and opportunities. Biol. Cell 96, 271–278. 
Casano, A.M., and Peri, F. (2015). Microglia: Multitasking specialists of the brain. Dev. Cell 32, 
469–477. 
Castillon, G. a, Watanabe, R., Taylor, M., Schwabe, T.M.E., and Riezman, H. (2009). 
Concentration of GPI-anchored proteins upon ER exit in yeast. Traffic 10, 186–200. 
Chell, J.M., and Brand, A.H. (2010). Nutrition-responsive glia control exit of neural stem cells 
from quiescence. Cell 143, 1161–1173. 
Chen, T.T., Li, L., Chung, D.-H., Allen, C.D.C., Torti, S. V, Torti, F.M., Cyster, J.G., Chen, C.-Y., 
Brodsky, F.M., Niemi, E.C., et al. (2005). TIM-2 is expressed on B cells and in liver and 
kidney and is a receptor for H-ferritin endocytosis. J. Exp. Med. 202, 955–965. 
Chotard, C., and Salecker, I. (2004). Neurons and glia: team players in axon guidance. Trends 
Neurosci. 27, 655–661. 
Ciufo, L.F., and Boyd, A. (2000). Identification of a lumenal sequence specifying the assembly 
of Emp24p into p24 complexes in the yeast secretory pathway. J. Biol. Chem. 275, 8382–
8388. 
Clarke, L.E., and Barres, B.A. (2013). Emerging roles of astrocytes in neural circuit 
development. Nat. Rev. Neurosci. 14, 311–321. 
Cohen, L.A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.L., Crooks, D.R., 
Sougrat, R., Morgenstern, A., Galy, B., Hentze, M.W., et al. (2010). Serum ferritin is derived 
primarily from macrophages through a nonclassical secretory pathway. Blood 116, 1574–
1584. 
Connor, J.R., and Menzies, S.L. (1996). Relationship of iron to oligodendrocytes and 
myelination. Glia 17, 83–93. 
Connor, J.R., Menzies, S.L., St Martin, S.M., and Mufson, E.J. (1990). Cellular distribution of 
transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27, 595–
611. 
Cook, J.D., Lipschitz, D.A., Miles, L.E.M., and Finch, C.A. (1974). Serum ferritin as a measure of 
iron stores in normal subjects. Am. J. Clin. Nutr. 27, 681–687. 
D’Arcangelo, J.G., Crissman, J., Pagant, S., ??opi??, A., Latham, C.F., Snapp, E.L., and Miller, 
E.A. (2015). Traffic of p24 proteins and COPII coat composition mutually influence 
membrane scaffolding. Curr. Biol. 25, 1296–1305. 
111  Bibliography   
Dautry-Varsat, A., Ciechanover, A., and Lodish, H.F. (1983). pH and the recycling of transferrin 
during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. 80, 2258–2262. 
Delatycki, M.B., Camakaris, J., Brooks, H., Evans-Whipp, T., Thorburn, D.R., Williamson, R., and 
Forrest, S.M. (1999). Direct evidence that mitochondrial iron accumulation occurs in 
Friedreich ataxia. Ann. Neurol. 45, 673–675. 
Delatycki, M.B., Williamson, R., and Forrest, S.M. (2000). Friedreich ataxia: an overview. J. 
Med. Genet. 37, 1–8. 
Denzel,  a, Otto, F., Girod,  a, Pepperkok, R., Watson, R., Rosewell, I., Bergeron, J.J., Solari, 
R.C., and Owen, M.J. (2000). The p24 family member p23 is required for early embryonic 
development. Curr. Biol. 10, 55–58. 
DeSalvo, M.K., Hindle, S.J., Rusan, Z.M., Orng, S., Eddison, M., Halliwill, K., and Bainton, R.J. 
(2014). The Drosophila surface glia transcriptome: Evolutionary conserved blood-brain 
barrier processes. Front. Neurosci. 8, 1–22. 
Dietzl, G., Chen, D., Schnorrer, F., Su, K.-C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K., 
Oppel, S., Scheiblauer, S., et al. (2007). A genome-wide transgenic RNAi library for 
conditional gene inactivation in Drosophila. Nature 448, 151–156. 
Dixon, S.J., and Stockwell, B.R. (2014). The role of iron and reactive oxygen species in cell 
death. Nat. Chem. Biol. 10, 9–17. 
Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, 
D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., et al. (2012). Ferroptosis: an iron-dependent 
form of nonapoptotic cell death. Cell 149, 1060–1072. 
Doherty, J., Logan, M.A., Taşdemir, O.E., and Freeman, M.R. (2009). Ensheathing glia function 
as phagocytes in the adult Drosophila brain. J. Neurosci. 29, 4768–4781. 
Dominguez, M., Dejgaard, K., Füllekrug, J., Dahan, S., Fazel, A., Paccaud, J.P., Thomas, D.Y., 
Bergeron, J.J.M., and Nilsson, T. (1998). gp25L/emp24/p24 protein family members of the 
cis-Golgi network bind both COP I and II coatomer. J. Cell Biol. 140, 751–765. 
Duce, J.A., Tsatsanis, A., Cater, M.A., James, S.A., Robb, E., Wikhe, K., Leong, S.L., Perez, K., 
Johanssen, T., Greenough, M.A., et al. (2010). Iron-Export Ferroxidase Activity of β-Amyloid 
Precursor Protein is Inhibited by Zinc in Alzheimer’s Disease. Cell 142, 857–867. 
Edenfeld, G., Stork, T., and Klämbt, C. (2005). Neuron-glia interaction in the insect nervous 
system. Curr. Opin. Neurobiol. 15, 34–39. 
Edenfeld, G., Volohonsky, G., Krukkert, K., Naffin, E., Lammel, U., Grimm, A., Engelen, D., 
Reuveny, A., Volk, T., and Kl??mbt, C. (2006). The Splicing Factor Crooked Neck Associates 
with the RNA-Binding Protein HOW to Control Glial Cell Maturation in Drosophila. Neuron 
52, 969–980. 
Bibliography  112 
Edwards, J.S., Swales, L.S., and Bate, M. (1993). The differentiation between neuroglia and 
connective tissue sheath in insect ganglia revisited: the neural lamella and perineurial 
sheath cells are absent in a mesodermless mutant of Drosophila. J. Comp. Neurol. 333, 
301–308. 
Enneking, E.-M., Kudumala, S.R., Moreno, E., Stephan, R., Boerner, J., Godenschwege, T. a, 
and Pielage, J. (2013). Transsynaptic coordination of synaptic growth, function, and 
stability by the L1-type CAM Neuroglian. PLoS Biol. 11, e1001537. 
Erecinska, M., and Wilson, D.F. (1978). Oxygen Transport to Tissue — III (Boston, MA: Springer 
US). 
Ferreira, C., Bucchini, D., Martin, M.E., Levi, S., Arosio, P., Grandchamp, B., and Beaumont, C. 
(2000). Early embryonic lethality of H ferritin gene deletion in mice. J. Biol. Chem. 275, 
3021–3024. 
Fields, R.D. (2002). New Insights into Neuron-Glia Communication. Science (80-. ). 298, 556–
562. 
Franzdóttir, S.R., Engelen, D., Yuva-Aydemir, Y., Schmidt, I., Aho, A., and Klämbt, C. (2009). 
Switch in FGF signalling initiates glial differentiation in the Drosophila eye. Nature 460, 
758–761. 
Freeman, M.R. (2015). Drosophila central nervous system glia. Cold Spring Harb. Perspect. 
Biol. 7. 
Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., and Galazka-Friedman, J. (2011). Ferritin 
as an important player in neurodegeneration. Park. Relat. Disord. 17, 423–430. 
Fuentes-Medel, Y., Ashley, J., Barria, R., Maloney, R., Freeman, M., and Budnik, V. (2012). 
Integration of a retrograde signal during synapse formation by glia-secreted TGF-β ligand. 
Curr. Biol. 22, 1831–1838. 
Fünfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., Brinkmann, B.G., 
Kassmann, C.M., Tzvetanova, I.D., Möbius, W., et al. (2012). Glycolytic oligodendrocytes 
maintain myelin and long-term axonal integrity. Nature 485, 517–521. 
Genova, J.L., and Fehon, R.G. (2003). Neuroglian, Gliotactin, and the Na+/k+ ATPase are 
essential for septate junction function in Drosophila. J. Cell Biol. 161, 979–989. 
Gerber, B., and Stocker, R.F. (2007). The drosophila larva as a model for studying 
chemosensation and chemosensory learning: A review. Chem. Senses 32, 65–89. 
Ghosh, A., Manrique-Hoyos, N., Voigt, A., Schulz, J.B., Kreutzfeldt, M., Merkler, D., and 
Simons, M. (2011). Targeted ablation of oligodendrocytes triggers axonal damage. PLoS 
One 6, e22735. 
113  Bibliography   
Ghosh, A., Kling, T., Snaidero, N., Sampaio, J.L., Shevchenko, A., Gras, H., Geurten, B., Göpfert, 
M.C., Schulz, J.B., Voigt, A., et al. (2013). A Global In Vivo Drosophila RNAi Screen Identifies 
a Key Role of Ceramide Phosphoethanolamine for Glial Ensheathment of Axons. PLoS 
Genet. 9, e1003980. 
Ghosh, M.C., Zhang, D.-L., and Rouault, T. a (2015). Iron misregulation and neurodegenerative 
disease in mouse models that lack iron regulatory proteins. Neurobiol. Dis. 
Gibson, E.M., Purger, D., Mount, C.W., Goldstein, A.K., Lin, G.L., Wood, L.S., Inema, I., Miller, 
S.E., Bieri, G., Zuchero, J.B., et al. (2014). Neuronal activity promotes oligodendrogenesis 
and adaptive myelination in the mammalian brain. Science 344, 1252304. 
Gillespie, M.J., and Stein, R.B. (1983). The relationship between axon diameter, myelin 
thickness and conduction velocity during atrophy of mammalian peripheral nerves. Brain 
Res. 259, 41–56. 
Gilmour, D.T., Maischein, H.M., and Nüsslein-Volhard, C. (2002). Migration and function of a 
glial subtype in the vertebrate peripheral nervous system. Neuron 34, 577–588. 
Ginhoux, F., Lim, S., Hoeffel, G., Low, D., and Huber, T. (2013). Origin and differentiation of 
microglia. Front. Cell. Neurosci. 7, 45. 
Gomez-Marin, A., and Louis, M. (2012). Active sensation during orientation behavior in the 
Drosophila larva: More sense than luck. Curr. Opin. Neurobiol. 22, 208–215. 
González-Morales, N., Mendoza-Ortíz, M.Á., Blowes, L.M., Missirlis, F., and Riesgo-Escovar, 
J.R. (2015). Ferritin Is Required in Multiple Tissues during Drosophila melanogaster 
Development. PLoS One 10, e0133499. 
Gould, D.B., Phalan, F.C., Breedveld, G.J., van Mil, S.E., Smith, R.S., Schimenti, J.C., Aguglia, U., 
van der Knaap, M.S., Heutink, P., and John, S.W.M. (2005). Mutations in Col4a1 cause 
perinatal cerebral hemorrhage and porencephaly. Science 308, 1167–1171. 
Gozzelino, R., and Arosio, P. (2016). Iron homeostasis in health and disease. Int. J. Mol. Sci. 17, 
2–14. 
Graham, R.M., Chua, A.C.G., Carter, K.W., Delima, R.D., Johnstone, D., Herbison, C.E., Firth, 
M.J., O’Leary, R., Milward, E.A., Olynyk, J.K., et al. (2010). Hepatic iron loading in mice 
increases cholesterol biosynthesis. Hepatology 52, 462–471. 
Granderath, S., Bunse, I., and Klämbt, C. (2000). gcm and pointed synergistically control glial 
transcription of the Drosophila gene loco. Mech. Dev. 91, 197–208. 
Granick, S. (1942). FERRITIN: I. PHYSICAL AND CHEMICAL PROPERTIES OF HORSE SPLEEN 
FERRITIN. J. Biol. Chem. 146, 451–461. 
Bibliography  114 
Green, C.H., Burnet, B., and Connolly, K.J. (1983). Organization and patterns of inter- and 
intraspecific variation in the behaviour of Drosophila larvae. Anim. Behav. 31, 282–291. 
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, 
S., Gollan, J.L., and Hediger, M.A. (1997). Cloning and characterization of a mammalian 
proton-coupled metal-ion transporter. Nature 388, 482–488. 
Guruharsha, K.G., Rual, J.-F., Zhai, B., Mintseris, J., Vaidya, P., Vaidya, N., Beekman, C., Wong, 
C., Rhee, D.Y., Cenaj, O., et al. (2011). A protein complex network of Drosophila 
melanogaster. Cell 147, 690–703. 
Hall, C.N., Klein-Flugge, M.C., Howarth, C., and Attwell, D. (2012). Oxidative Phosphorylation, 
Not Glycolysis, Powers Presynaptic and Postsynaptic Mechanisms Underlying Brain 
Information Processing. J. Neurosci. 32, 8940–8951. 
Halliwell, B. (1992). Reactive oxygen species and the central nervous system. J. Neurochem. 
59, 1609–1623. 
Han, J., Seaman, W.E., Di, X., Wang, W., Willingham, M., Torti, F.M., and Torti, S. V. (2011). 
Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS 
One 6. 
Harding, C., Heuser, J., and Stahl, P. (1983). Receptor-mediated endocytosis of transferrin and 
recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 97, 329–339. 
Hardy, P.A., Gash, D., Yokel, R., Andersen, A., Ai, Y., and Zhang, Z. (2005). Correlation of R2 
with total iron concentration in the brains of rhesus monkeys. J. Magn. Reson. Imaging 21, 
118–127. 
Harrison, P.M., and Arosio, P. (1996). The ferritins: molecular properties, iron storage function 
and cellular regulation. Biochim. Biophys. Acta 1275, 161–203. 
Hartenstein, V. (1993). Atlas of  Drosophila  Development. Atlas  Drosoph.  Dev. 1–57. 
Hartenstein, V. (2011). Morphological diversity and development of glia in Drosophila. Glia 59, 
1237–1252. 
Hasan, K.M., Walimuni, I.S., Kramer, L. a, and Narayana, P. a (2012). Human brain iron 
mapping using atlas-based T2 relaxometry. Magn. Reson. Med. 67, 731–739. 
Hegde, V.R., Vogel, R., and Feany, M.B. (2014). Glia are critical for the neuropathology of 
complex I deficiency in Drosophila. Hum. Mol. Genet. 1–24. 
Hentze, M.W., Muckenthaler, M.U., Galy, B., and Camaschella, C. (2010). Two to tango: 
regulation of Mammalian iron metabolism. Cell 142, 24–38. 
115  Bibliography   
Herculano-Houzel, S. (2014). The glia/neuron ratio: How it varies uniformly across brain 
structures and species and what that means for brain physiology and evolution. Glia 62, 
1377–1391. 
Hidalgo, A., Kinrade, E.F. V, and Georgiou, M. (2001). The Drosophila Neuregulin Vein 
Maintains Glial Survival during Axon Guidance in the CNS. Dev. Cell 1, 679–690. 
Hidalgo, A., Learte, A.R., McQuilton, P., Pennack, J., and Zhu, B. (2006). Neurotrophic and 
gliatrophic contexts in Drosophila. Brain. Behav. Evol. 68, 173–180. 
Hidalgo, A., Kato, K., Sutcliffe, B., McIlroy, G., Bishop, S., and Alahmed, S. (2011). Trophic 
neuron-glia interactions and cell number adjustments in the fruit fly. Glia 59, 1296–1303. 
von Hilchen, C.M., Hein, I., Technau, G.M., and Altenhein, B. (2010). Netrins guide migration 
of distinct glial cells in the Drosophila embryo. Development 137, 1251–1262. 
von Hilchen, C.M., Bustos, A.E., Giangrande, A., Technau, G.M., and Altenhein, B. (2013). 
Predetermined embryonic glial cells form the distinct glial sheaths of the Drosophila 
peripheral nervous system. Development 140, 3657–3668. 
Hirokawa, N., and Takemura, R. (2005). Molecular motors and mechanisms of directional 
transport in neurons. Nat. Rev. Neurosci. 6, 201–214. 
Holtmaat, A., and Svoboda, K. (2009). Experience-dependent structural synaptic plasticity in 
the mammalian brain. Nat. Rev. Neurosci. 10, 647–658. 
Horowitz, M.P., and Greenamyre, J.T. (2010). Mitochondrial iron metabolism and its role in 
neurodegeneration. J. Alzheimer’s Dis. 20. 
Hortsch, M., Bieber, A.J., Patel, N.H., and Goodman, C.S. (1990). Differential splicing generates 
a nervous system-Specific form of drosophila neuroglian. Neuron 4, 697–709. 
Hortsch, M., Nagaraj, K., and Godenschwege, T.A. (2009). The interaction between L1-type 
proteins and ankyrins--a master switch for L1-type CAM function. Cell. Mol. Biol. Lett. 14, 
57–69. 
Howarth, C., Gleeson, P., and Attwell, D. (2012). Updated energy budgets for neural 
computation in the neocortex and cerebellum. J. Cereb. Blood Flow Metab. 32, 1222–
1232. 
Huang, L.Y.M., Gu, Y., and Chen, Y. (2013). Communication between neuronal somata and 
satellite glial cells in sensory ganglia. Glia 61, 1571–1581. 
Huang, X., Atwood, C.S., Moir, R.D., Hartshorn, M.A., Tanzi, R.E., and Bush, A.I. (2004). Trace 
metal contamination initiates the apparent auto-aggregation, amyloidosis, and 
oligomerization of Alzheimer’s A?? peptides. J. Biol. Inorg. Chem. 9, 954–960. 
Bibliography  116 
Hummel, T., Krukkert, K., Roos, J., Davis, G., and Klämbt, C. (2000). Drosophila Futsch/22C10 is 
a MAP1B-like protein required for dendritic and axonal development. Neuron 26, 357–370. 
Hummel, T., Attix, S., Gunning, D., and Zipursky, S.L. (2002). Temporal control of glial cell 
migration in the Drosophila eye requires gilgamesh, hedgehog, and eye specification 
genes. Neuron 33, 193–203. 
Jacob, C. (2015). Transcriptional control of neural crest specification into peripheral glia. Glia 
63, 1883–1896. 
Jacobs, J.R. (2000). The Midline Glia of Drosophila: A molecular genetic model for the 
developmental functions of Glia. Prog. Neurobiol. 62, 475–508. 
Jahn, O., Tenzer, S., and Werner, H.B. (2009). Myelin proteomics: Molecular anatomy of an 
insulating sheath. Mol. Neurobiol. 40, 55–72. 
Jan, Y.-N., and Jan, L.Y. (2010). Branching out: mechanisms of dendritic arborization. Nat. Rev. 
Neurosci. 11, 316–328. 
Jessen, K.R., and Mirsky, R. (2016). The repair Schwann cell and its function in regenerating 
nerves. J. Physiol. 0, 1–11. 
Jones, B.W. (2005). Transcriptional control of glial cell development in Drosophila. Dev. Biol. 
278, 265–273. 
Jones, B.W., Fetter, R.D., Tear, G., and Goodman, C.S. (1995). glial cells missing: a genetic 
switch that controls glial versus neuronal fate. Cell 82, 1013–1023. 
Kasischke, K. a, Vishwasrao, H.D., Fisher, P.J., Zipfel, W.R., and Webb, W.W. (2004). Neural 
activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 
305, 99–103. 
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J.Q., Boonplueang, R., Viswanath, V., 
Jacobs, R., Yang, L., Beal, M.F., et al. (2003). Genetic or pharmacological iron chelation 
prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson’s disease. 
Neuron 37, 899–909. 
Keller, J.N., Mark, R.J., Bruce, A.J., Blanc, E., Rothstein, J.D., Uchida, K., Waeg, G., and Mattson, 
M.P. (1997). 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, 
impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 
80, 685–696. 
Keller, L.C., Cheng, L., Locke, C.J., Müller, M., Fetter, R.D., and Davis, G.W. (2011). Glial-
derived prodegenerative signaling in the Drosophila neuromuscular system. Neuron 72, 
760–775. 
117  Bibliography   
Kerr, K.S., Fuentes-Medel, Y., Brewer, C., Barria, R., Ashley, J., Abruzzi, K.C., Sheehan, A., 
Tasdemir-Yilmaz, O.E., Freeman, M.R., and Budnik, V. (2014). Glial Wingless/Wnt Regulates 
Glutamate Receptor Clustering and Synaptic Physiology at the Drosophila Neuromuscular 
Junction. J. Neurosci. 34, 2910–2920. 
Keshishian, H., Broadie, K., Chiba, A., and Bate, M. (1996). The drosophila neuromuscular 
junction: a model system for studying synaptic development and function. Annu. Rev. 
Neurosci. 19, 545–575. 
Kidd, T., Bland, K.S., and Goodman, C.S. (1999). Slit is the midline repellent for the robo 
receptor in Drosophila. Cell 96, 785–794. 
Kim, S.N., Jeibmann, A., Halama, K., Witte, H.T., Wälte, M., Matzat, T., Schillers, H., Faber, C., 
Senner, V., Paulus, W., et al. (2014). ECM stiffness regulates glial migration in Drosophila 
and mammalian glioma models. Development 3233–3242. 
Klaes, A., Menne, T., Stollewerk, A., Scholz, H., and Kl??mbt, C. (1994). The Ets transcription 
factors encoded by the Drosophila gene pointed direct glial cell differentiation in the 
embryonic CNS. Cell 78, 149–160. 
Klämbt, C., and Goodman, C.S. (1991). The diversity and pattern of glia during axon pathway 
formation in the Drosophila embryo. Glia 4, 205–213. 
Kohsaka, H., Okusawa, S., Itakura, Y., Fushiki, A., and Nose, A. (2012). Development of larval 
motor circuits in Drosophila. Dev. Growth Differ. 54, 408–419. 
Kolodziej, P.A., Timpe, L.C., Mitchell, K.J., Fried, S.R., Goodman, C.S., Jan, L.Y., and Jan, Y.N. 
(1996). frazzled Encodes a Drosophila member of the DCC immunoglobulin subfamily and 
is required for CNS and motor axon guidance. Cell 87, 197–204. 
Kondo, S., Booker, M., and Perrimon, N. (2009). Cross-species RNAi rescue platform in 
Drosophila melanogaster. Genetics 183, 1165–1173. 
Kosmidis, S., Botella, J. a, Mandilaras, K., Schneuwly, S., Skoulakis, E.M.C., Rouault, T. a, and 
Missirlis, F. (2011). Ferritin overexpression in Drosophila glia leads to iron deposition in the 
optic lobes and late-onset behavioral defects. Neurobiol. Dis. 43, 213–219. 
Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680–685. 
Landgraf, M., Sánchez-Soriano, N., Technau, G.M., Urban, J., and Prokop, A. (2003). Charting 
the Drosophila neuropile: A strategy for the standardised characterisation of genetically 
amenable neurites. Dev. Biol. 260, 207–225. 
Lang, M., Braun, C.L., Kanost, M.R., and Gorman, M.J. (2012). Multicopper oxidase-1 is a 
ferroxidase essential for iron homeostasis in Drosophila melanogaster. Proc. Natl. Acad. 
Sci. U. S. A. 109, 13337–13342. 
Bibliography  118 
Learte, A.R., Forero, M.G., and Hidalgo, A. (2008). Gliatrophic and gliatropic roles of PVF/PVR 
signaling during axon guidance. Glia 56, 164–176. 
Lee, B.P., and Jones, B.W. (2005). Transcriptional regulation of the Drosophila glial gene repo. 
Mech. Dev. 122, 849–862. 
Lee, T., and Luo, L. (1999). Mosaic analysis with a repressible cell marker for studies of gene 
function in neuronal morphogenesis. Neuron 22, 451–461. 
Lee, D.W., Andersen, J.K., and Kaur, D. (2006). Iron dysregulation and neurodegeneration: the 
molecular connection. Mol Interv 6, 89–97. 
Lee, T., Lee,  a, and Luo, L. (1999). Development of the Drosophila mushroom bodies: 
sequential generation of three distinct types of neurons from a neuroblast. Development 
126, 4065–4076. 
Lee, T., Marticke, S., Sung, C., Robinow, S., and Luo, L. (2000). Cell-autonomous requirement 
of the USP/EcR-B ecdysone receptor for mushroom body neuronal remodeling in 
Drosophila. Neuron 28, 807–818. 
Lehn, A., Boyle, R., Brown, H., Airey, C., and Mellick, G. (2012). Neuroferritinopathy. 
Parkinsonism Relat. Disord. 18, 909–915. 
Leiserson, W.M., and Keshishian, H. (2011). Maintenance and regulation of extracellular 
volume and the ion environment in Drosophila larval nerves. Glia 59, 1312–1321. 
Leiserson, W.M., Harkins, E.W., and Keshishian, H. (2000). Fray, a Drosophila serine/threonine 
kinase homologous to mammalian PASK, is required for axonal ensheathment. Neuron 28, 
793–806. 
Levy, F., Bulet, P., and Ehret-Sabatier, L. (2004). Proteomic analysis of the systemic immune 
response of Drosophila. Mol. Cell. Proteomics 3, 156–166. 
Lill, R., and Mühlenhoff, U. (2006). Iron-sulfur protein biogenesis in eukaryotes: components 
and mechanisms. Annu. Rev. Cell Dev. Biol. 22, 457–486. 
Lill, R., Hoffmann, B., Molik, S., Pierik, A.J., Rietzschel, N., Stehling, O., Uzarska, M.A., Webert, 
H., Wilbrecht, C., and Mühlenhoff, U. (2012). The role of mitochondria in cellular iron-
sulfur protein biogenesis and iron metabolism. Biochim. Biophys. Acta - Mol. Cell Res. 
1823, 1491–1508. 
Limmer, S., Weiler, A., Volkenhoff, A., Babatz, F., and Klämbt, C. (2014). The drosophila blood-
brain barrier: Development and function of a glial endothelium. Front. Neurosci. 8, 1–19. 
Lin, H.H., and Connor, J.R. (1989). The development of the transferrin-transferrin receptor 
system in relation to astrocytes, MBP and galactocerebroside in normal and myelin-
deficient rat optic nerves. Dev. Brain Res. 49, 281–293. 
119  Bibliography   
Lin, M.T., and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in 
neurodegenerative diseases. Nature 443, 787–795. 
Liu, H., and Naismith, J.H. (2008). An efficient one-step site-directed deletion, insertion, single 
and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8, 91. 
Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., and Markesbery, W.R. (1998). 
Copper, iron and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 158, 47–52. 
Lozoff, B., and Georgieff, M.K. (2006). Iron Deficiency and Brain Development. Semin. Pediatr. 
Neurol. 13, 158–165. 
Mahr, A., and Aberle, H. (2006). The expression pattern of the Drosophila vesicular glutamate 
transporter: A marker protein for motoneurons and glutamatergic centers in the brain. 
Gene Expr. Patterns 6, 299–309. 
Mandilaras, K., Pathmanathan, T., and Missirlis, F. (2013). Iron absorption in Drosophila 
melanogaster. Nutrients 5, 1622–1647. 
Manrique-Hoyos, N. (2012). Neurodegenration in toxin-mediated demyelinating animal 
models of Multiple Sclerosis. Georg-August University of Goettingen. 
Margeta, M.A., and Shen, K. (2010). Molecular mechanisms of synaptic specificity. Mol. Cell. 
Neurosci. 43, 261–267. 
Matzat, T., Sieglitz, F., Kottmeier, R., Babatz, F., Engelen, D., and Klämbt, C. (2015). Axonal 
wrapping in the Drosophila PNS is controlled by glia-derived neuregulin homolog Vein. 
Development 142, 1336–1345. 
McCarthy, R.C., and Kosman, D.J. (2013). Ferroportin and exocytoplasmic ferroxidase activity 
are required for brain microvascular endothelial cell iron efflux. J. Biol. Chem. 288, 17932–
17940. 
Mckenzie, I.A., Ohayon, D., Li, H., Faria, J.P. De, Emery, B., Tohyama, K., and Richardson, W.D. 
(2014). Motor skill learning requires active central myelination. Science (80-. ). 346, 318–
322. 
Mercer, R.W., and Dunham, P.B. (1981). Membrane-bound ATP fuels the Na/K pump. Studies 
on membrane-bound glycolytic enzymes on inside-out vesicles from human red cell 
membranes. J. Gen. Physiol. 78, 547–568. 
Meyron-Holtz, E.G., Moshe-Belizowski, S., and Cohen, L. a (2011). A possible role for secreted 
ferritin in tissue iron distribution. J. Neural Transm. 118, 337–347. 
Mi, H., Muruganujan, A., Casagrande, J.T., and Thomas, P.D. (2013). Large-scale gene function 
analysis with the PANTHER classification system. Nat. Protoc. 8, 1551–1566. 
Bibliography  120 
Michailov, G. V, Sereda, M.W., Brinkmann, B.G., Fischer, T.M., Haug, B., Birchmeier, C., Role, 
L., Lai, C., Schwab, M.H., and Nave, K.-A. (2004). Axonal neuregulin-1 regulates myelin 
sheath thickness. Science 304, 700–703. 
Miller, D., Hannon, C., and Ganetzky, B. (2012). A mutation in Drosophila Aldolase causes 
temperature-sensitive paralysis, shortened lifespan, and neurodegeneration. J. 
Neurogenet. 26, 317–327. 
Missirlis, F., Holmberg, S., Georgieva, T., Dunkov, B.C., Rouault, T. a, and Law, J.H. (2006). 
Characterization of mitochondrial ferritin in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 103, 
5893–5898. 
Missirlis, F., Kosmidis, S., Brody, T., Mavrakis, M., Holmberg, S., Odenwald, W.F., Skoulakis, 
E.M.C., and Rouault, T. a (2007). Homeostatic mechanisms for iron storage revealed by 
genetic manipulations and live imaging of Drosophila ferritin. Genetics 177, 89–100. 
Moos, T. (2002). Brain iron homeostasis. Dan. Med. Bull. 49, 279–301. 
Morrison, B.M., Lee, Y., and Rothstein, J.D. (2013). Oligodendroglia: Metabolic supporters of 
axons. Trends Cell Biol. 23, 644–651. 
Namekawa, M., Muriel, M.P., Janer, A., Latouche, M., Dauphin, A., Debeir, T., Martin, E., 
Duyckaerts, C., Prigent, A., Depienne, C., et al. (2007). Mutations in the SPG3A gene 
encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and 
Golgi morphogenesis. Mol. Cell. Neurosci. 35, 1–13. 
Napoli, E., Taroni, F., and Cortopassi, G.A. (2006). Frataxin, iron-sulfur clusters, heme, ROS, 
and aging. Antioxid. Redox Signal. 8, 506–516. 
Nave, K.A. (2010). Myelination and the trophic support of long axons. Nat Rev Neurosci 11, 
275–283. 
Nave, K.-A., and Trapp, B.D. (2008). Axon-glial signaling and the glial support of axon function. 
Annu. Rev. Neurosci. 31, 535–561. 
Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., and 
Kaplan, J. (2004). Hepcidin regulates cellular iron efflux by binding to ferroportin and 
inducing its internalization. Science 306, 2090–2093. 
Nichol, H., Law, J.H., and Winzerling, J.J. (2002). Iron metabolism in insects. Annu. Rev. 
Entomol. 47, 535–559. 
Noordermeer, J.N., Kopczynski, C.C., Fetter, R.D., Bland, K.S., Chen, W.Y., and Goodman, C.S. 
(1998). Wrapper, a novel member of the Ig superfamily, is expressed by midline glia and is 
required for them to ensheath commissural axons in Drosophila. Neuron 21, 991–1001. 
121  Bibliography   
Ohgami, R.S., Campagna, D.R., McDonald, A., and Fleming, M.D. (2006). The Steap proteins 
are metalloreductases. Blood 108, 1388–1394. 
Ohno, N., Kidd, G.J., Mahad, D., Kiryu-Seo, S., Avishai, A., Komuro, H., and Trapp, B.D. (2011). 
Myelination and axonal electrical activity modulate the distribution and motility of 
mitochondria at CNS nodes of Ranvier. J. Neurosci. 31, 7249–7258. 
Ong, W.Y., and Halliwell, B. (2004). Iron, atherosclerosis, and neurodegeneration: A key role 
for cholesterol in promoting iron-dependent oxidative damage? Ann. N. Y. Acad. Sci. 1012, 
51–64. 
Ortiz, E., Pasquini, J.M., Thompson, K., Felt, B., Butkus, G., Beard, J., and Connor, J.R. (2004). 
Effect of manipulation of iron storage, transport, or availability on myelin composition and 
brain iron content in three different animal models. J. Neurosci. Res. 77, 681–689. 
Ou, J., He, Y., Xiao, X., Yu, T.M., Chen, C., Gao, Z., and Ho, M.S. (2014). Glial cells in neuronal 
development: Recent advances and insights from Drosophila melanogaster. Neurosci. Bull. 
30, 584–594. 
Palgi, M., Lindström, R., Peränen, J., Piepponen, T.P., Saarma, M., and Heino, T.I. (2009). 
Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic 
neurons. Proc. Natl. Acad. Sci. U. S. A. 106, 2429–2434. 
Pantopoulos, K. (2004). Iron metabolism and the IRE/IRP regulatory system: an update. Ann. 
N. Y. Acad. Sci. 1012, 1–13. 
Paradkar, P.N., Zumbrennen, K.B., Paw, B.H., Ward, D.M., and Kaplan, J. (2009). Regulation of 
mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. 
Mol. Cell. Biol. 29, 1007–1016. 
Parkinson, J. (2002). An essay on the shaking palsy. 1817. J. Neuropsychiatry Clin. Neurosci. 
14, 223–236; discussion 222. 
Parton, R.G., Simons, K., and Dotti, C.G. (1992). Axonal and dendritic endocytic pathways in 
cultured neurons. J. Cell Biol. 119, 123–137. 
Patel, B.N., Dunn, R.J., Jeong, S.Y., Zhu, Q., Julien, J.-P., and David, S. (2002). Ceruloplasmin 
regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578–
6586. 
Paul, R.J., Bauer, M., and Pease, W. (1979). Vascular smooth muscle: aerobic glycolysis linked 
to sodium and potassium transport processes. Science (80-. ). 206, 1414–1416. 
Pellerin, L., Bouzier-Sore, A.K., Aubert, A., Serres, S., Merle, M., Costalat, R., and Magistretti, 
P.J. (2007). Activity-dependent regulation of energy metabolism by astrocytes: An update. 
Glia 55, 1251–1262. 
Bibliography  122 
Pereanu, W., Shy, D., and Hartenstein, V. (2005). Morphogenesis and proliferation of the 
larval brain glia in Drosophila. Dev. Biol. 283, 191–203. 
Pham, D.Q.D., and Winzerling, J.J. (2010). Insect ferritins: Typical or atypical? Biochim. 
Biophys. Acta 1800, 824–833. 
Pilling, A.D., Horiuchi, D., Lively, C.M., and Saxton, W.M. (2006). Kinesin-1 and Dynein are the 
primary motors for fast transport of mitochondria in Drosophila motor axons. Mol. Biol. 
Cell 17, 2057–2068. 
Port, F., Hausmann, G., and Basler, K. (2011). A genome-wide RNA interference screen 
uncovers two p24 proteins as regulators of Wingless secretion. EMBO Rep. 12, 1144–1152. 
Potter, C.J., Tasic, B., Russler, E. V., Liang, L., and Luo, L. (2010). The Q system: A repressible 
binary system for transgene expression, lineage tracing, and mosaic analysis. Cell 141, 
536–548. 
Pozzi, C., Di Pisa, F., Bernacchioni, C., Ciambellotti, S., Turano, P., and Mangani, S. (2015). Iron 
binding to human heavy-chain ferritin. Acta Crystallogr. D. Biol. Crystallogr. 71, 1909–1920. 
Prousek, J. (2007). Fenton chemistry in biology and medicine. Pure Appl. Chem. 79, 2325–
2338. 
Punnonen, K., Irjala, K., and Rajamäki,  a (1997). Serum transferrin receptor and its ratio to 
serum ferritin in the diagnosis of iron deficiency. Blood 89, 1052–1057. 
Reese, T., and Karnovsky, M. (2005). From the Archive: Endothelial tigh junctions form the 
blood-brain barrier. J. Cell Biol. 169, 378–379. 
Rodrigues, F., Schmidt, I., and Klämbt, C. (2011). Comparing peripheral glial cell differentiation 
in Drosophila and vertebrates. Cell. Mol. Life Sci. 68, 55–69. 
Rodrigues, V., Cheah, P.Y., Ray, K., and Chia, W. (1995). malvolio, the Drosophila homologue 
of mouse NRAMP-1 (Bcg), is expressed in macrophages and in the nervous system and is 
required for normal taste behaviour. EMBO J. 14, 3007–3020. 
Rogers, J.T., Randall, J.D., Cahill, C.M., Eder, P.S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., 
Sarang, S.S., Utsuki, T., et al. (2002). An iron-responsive element type II in the 5′-
untranslated region of the Alzheimer’s amyloid precursor protein transcript. J. Biol. Chem. 
277, 45518–45528. 
Roskams,  a J., and Connor, J.R. (1994). Iron, transferrin, and ferritin in the rat brain during 
development and aging. J. Neurochem. 63, 709–716. 
Rouault, T. a (2006). The role of iron regulatory proteins in mammalian iron homeostasis and 
disease. Nat. Chem. Biol. 2, 406–414. 
123  Bibliography   
Rouault, T. a (2013). Iron metabolism in the CNS: implications for neurodegenerative 
diseases. Nat. Rev. Neurosci. 14, 551–564. 
Rouault, T.A. (2015). Mammalian iron-sulphur proteins: novel insights into biogenesis and 
function. Nat. Rev. Mol. Cell Biol. 16, 45–55. 
Rouault, T.A. (2016). Mitochondrial iron overload: Causes and consequences. Curr. Opin. 
Genet. Dev. 38, 31–37. 
Rowitch, D.H., and Kriegstein, A.R. (2010). Developmental genetics of vertebrate glial-cell 
specification. Nature 468, 214–222. 
Ruiz, M., Wicker-Thomas, C., Sanchez, D., and Ganfornina, M.D. (2012). Grasshopper Lazarillo, 
a GPI-anchored Lipocalin, increases Drosophila longevity and stress resistance, and 
functionally replaces its secreted homolog NLaz. Insect Biochem. Mol. Biol. 42, 776–789. 
Saab, A.S., Tzvetanova, I.D., and Nave, K.A. (2013). The role of myelin and oligodendrocytes in 
axonal energy metabolism. Curr. Opin. Neurobiol. 23, 1065–1072. 
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R., Wehr, M.C., Wieland, F., 
Ishibashi, S., and Nave, K.-A. (2005). High cholesterol level is essential for myelin 
membrane growth. Nat. Neurosci. 8, 468–475. 
Saleem, S., Schwedes, C.C., Ellis, L.L., Grady, S.T., Adams, R.L., Johnson, N., Whittington, J.R., 
and Carney, G.E. (2012). Drosophila melanogaster p24 trafficking proteins have vital roles 
in development and reproduction. Mech. Dev. 129, 177–191. 
Salvador, G. a (2010). Iron in neuronal function and dysfunction. Biofactors 36, 103–110. 
Salzer, J.L. (2015). Schwann cell myelination. Cold Spring Harb. Perspect. Biol. 7. 
Salzer, J.L., Brophy, P.J., and Peles, E. (2008). Molecular domains of myelinated axons in the 
peripheral nervous system. Glia 56, 1532–1540. 
Sanchez, D., López-Arias, B., Torroja, L., Canal, I., Wang, X., Bastiani, M.J., and Ganfornina, 
M.D. (2006). Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and 
stress resistance in Drosophila. Curr. Biol. 16, 680–686. 
Schenck, J.F., and Zimmerman, E. a (2004). High-field magnetic resonance imaging of brain 
iron: birth of a biomarker? NMR Biomed. 17, 433–445. 
Schmidt, I., Thomas, S., Kain, P., Risse, B., Naffin, E., and Klämbt, C. (2012). Kinesin heavy chain 
function in Drosophila glial cells controls neuronal activity. J. Neurosci. 32, 7466–7476. 
Schulz, J.G., David, G., and Hassan, B. a (2009). A novel method for tissue-specific RNAi rescue 
in Drosophila. Nucleic Acids Res. 37, e93. 
Bibliography  124 
Schummers, J., Yu, H., and Sur, M. (2008). Tuned responses of astrocytes and their influence 
on hemodynamic signals in the visual cortex. Science 320, 1638–1643. 
Seeger, M., Tear, G., Ferres-Marco, D., and Goodman, C.S. (1993). Mutations affecting growth 
cone guidance in Drosophila: genes necessary for guidance toward or away from the 
midline. Neuron 10, 409–426. 
Seidl, A.H. (2014). Regulation of conduction time along axons. Neuroscience 276, 126–134. 
Selkoe, D.J. (1996). Amyloid beta-protein and the genetics of Alzheimer’s Disease. J. Biol. 
Chem. 271, 18295–18298. 
Sepp, K.J., and Auld, V.J. (1999). Conversion of lacZ enhancer trap lines to GAL4 lines using 
targeted transposition in Drosophila melanogaster. Genetics 151, 1093–1101. 
Sepp, K.J., Schulte, J., and Auld, V.J. (2000). Developmental dynamics of peripheral glia in 
Drosophila melanogaster. Glia 30, 122–133. 
Sepp, K.J., Schulte, J., and Auld, V.J. (2001). Peripheral glia direct axon guidance across the 
CNS/PNS transition zone. Dev. Biol. 238, 47–63. 
Shan, Y., and Cortopassi, G. (2012). HSC20 interacts with frataxin and is involved in iron-sulfur 
cluster biogenesis and iron homeostasis. 
Shandala, T., Takizawa, K., and Saint, R. (2003). The dead ringer/retained transcriptional 
regulatory gene is required for positioning of the longitudinal glia in the Drosophila 
embryonic CNS. Development 130, 1505–1513. 
Sharma, K., Schmitt, S., Bergner, C.G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., Kongi, 
K., Cantuti, L., Hanisch, U.-K., Philips, M.-A., et al. (2015). Cell type&ndash; and brain 
region&ndash;resolved mouse brain proteome. Nat. Neurosci. 18, 1–16. 
Shigemoto-Mogami, Y., Hoshikawa, K., Goldman, J.E., Sekino, Y., and Sato, K. (2014). Microglia 
enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. 
J. Neurosci. 34, 2231–2243. 
Silies, M., and Klämbt, C. (2010). APC/C(Fzr/Cdh1)-dependent regulation of cell adhesion 
controls glial migration in the Drosophila PNS. Nat. Neurosci. 13, 1357–1364. 
Silies, M., and Klämbt, C. (2011). Adhesion and signaling between neurons and glial cells in 
Drosophila. Curr. Opin. Neurobiol. 21, 11–16. 
Silies, M., Yuva-Aydemir, Y., Rut Franzdottir, S., and Klämbt, C. (2014). The eye imaginal disc as 
a model to study the coordination of neuronal and glial development. Fly (Austin). 4, 71–
79. 
Simons, M., and Nave, K. (2015). Oligodendrocytes: Myelination and Axonal Support. Cold 
Spring Harb. Perspect. Biol. 8, 1–16. 
125  Bibliography   
Snaidero, N., Möbius, W., Czopka, T., Hekking, L.H.P., Mathisen, C., Verkleij, D., Goebbels, S., 
Edgar, J., Merkler, D., Lyons, D.A., et al. (2014). Myelin membrane wrapping of CNS axons 
by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156, 277–290. 
Spéder, P., and Brand, A.H. (2014). Gap junction proteins in the blood-brain barrier control 
nutrient-dependent reactivation of Drosophila neural stem cells. Dev. Cell 30, 309–321. 
Springer, S., Chen, E., Duden, R., Marzioch, M., Rowley, A., Hamamoto, S., Merchant, S., and 
Schekman, R. (2000). The p24 proteins are not essential for vesicular transport in 
Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 97, 4034–4039. 
Squarzoni, P., Oller, G., Hoeffel, G., Pont-Lezica, L., Rostaing, P., Low, D., Bessis, A., Ginhoux, 
F., and Garel, S. (2014). Microglia Modulate Wiring of the Embryonic Forebrain. Cell Rep. 8, 
1271–1279. 
Stebbings, L.A., Todman, M.G., Phillips, R., Greer, C.E., Tam, J., Phelan, P., Jacobs, K., Bacon, 
J.P., and Davies, J.A. (2002). Gap junctions in Drosophila: Developmental expression of the 
entire innexin gene family. Mech. Dev. 113, 197–205. 
Stephan, R. (2008). Functional studies of the abelson interactor gene during the development 
of Drosophila melanogaster. Westfälische Wilhelms-Universität Münster. 
Stork, T., Engelen, D., Krudewig, A., Silies, M., Bainton, R.J., and Klämbt, C. (2008). 
Organization and function of the blood-brain barrier in Drosophila. J. Neurosci. 28, 587–
597. 
Stork, T., Thomas, S., Rodrigues, F., Silies, M., Naffin, E., Wenderdel, S., and Klämbt, C. (2009). 
Drosophila Neurexin IV stabilizes neuron-glia interactions at the CNS midline by binding to 
Wrapper. Development 136, 1251–1261. 
Stork, T., Bernardos, R., and Freeman, M.R. (2012). Analysis of glial cell development and 
function in Drosophila. Cold Spring Harb. Protoc. 7, 1–17. 
Strating, J.R.P.M., and Martens, G.J.M. (2009). The p24 family and selective transport 
processes at the ER-Golgi interface. Biol. Cell 101, 495–509. 
Stratoulias, V., and Heino, T.I. (2015). Analysis of the conserved neurotrophic factor MANF in 
the Drosophila adult brain. Gene Expr. Patterns 18, 8–15. 
Subbarao, K., Forrest, S., Ackley, D.H., Perelson, A.S., Bush, R.M., Bender, C.A., Cox, N.J., 
Galvani, A.P., Bush, R.M., Murphy, A.M., et al. (2006). Structure of Dual Function Iron 
Regulatory Protein 1 Complexed with Ferritin IRE-RNA. Science 314, 1903–1909. 
Suzuki, A., Stern, S.A., Bozdagi, O., Huntley, G.W., Walker, R.H., Magistretti, P.J., and Alberini, 
C.M. (2011). Astrocyte-neuron lactate transport is required for long-term memory 
formation. Cell 144, 810–823. 
Bibliography  126 
Takida, S., Maeda, Y., and Kinoshita, T. (2008). Mammalian GPI-anchored proteins require p24 
proteins for their efficient transport from the ER to the plasma membrane. Biochem. J. 
409, 555–562. 
Tandara, L., and Salamunic, I. (2012). Iron metabolism: current facts and future directions. 
Biochem Med 22, 311–328. 
Tang, X., and Zhou, B. (2013a). Iron homeostasis in insects: Insights from Drosophila studies. 
IUBMB Life 65, 863–872. 
Tang, X., and Zhou, B. (2013b). Ferritin is the key to dietary iron absorption and tissue iron 
detoxification in Drosophila melanogaster. FASEB J. 27, 288–298. 
Tansey, F.A., Thampy, K.G., and Cammer, W. (1988). Acetyl-CoA carboxylase in rat brain . II . 
43, 131–138. 
Taveggia, C. (2016). Schwann cells–axon interaction in myelination. Curr. Opin. Neurobiol. 39, 
24–29. 
Tessier-Lavigne, M., and Goodman, C.S. (1996). The molecular biology of axon guidance. 
Science 274, 1123–1133. 
Thomas, A., Lee, P.-J., Dalton, J.E., Nomie, K.J., Stoica, L., Costa-Mattioli, M., Chang, P., 
Nuzhdin, S., Arbeitman, M.N., and Dierick, H. a (2012). A versatile method for cell-specific 
profiling of translated mRNAs in Drosophila. PLoS One 7, e40276. 
Tiklová, K., Senti, K.-A., Wang, S., Gräslund, A., and Samakovlis, C. (2010). Epithelial septate 
junction assembly relies on melanotransferrin iron binding and endocytosis in Drosophila. 
Nat. Cell Biol. 12, 1071–1077. 
Todorich, B., Zhang, X., Slagle-Webb, B., Seaman, W.E., and Connor, J.R. (2008). Tim-2 is the 
receptor for H-ferritin on oligodendrocytes. J. Neurochem. 107, 1495–1505. 
Todorich, B., Pasquini, J.M., Garcia, C.I., Paez, P.M., and Connor, J.R. (2009). Oligodendrocytes 
and myelination: the role of iron. Glia 57, 467–478. 
Todorich, B., Zhang, X., and Connor, J.R. (2011). H-ferritin is the major source of iron for 
oligodendrocytes. Glia 59, 927–935. 
Tsacopoulos, M., and Magistretti, P.J. (1996). Metabolic coupling between glia and neurons. J. 
Neurosci. 16, 877–885. 
Urbán, N., and Guillemot, F. (2014). Neurogenesis in the embryonic and adult brain: same 
regulators, different roles. Front. Cell. Neurosci. 8, 396. 
Vahedi, K., Kubis, N., Boukobza, M., Arnoult, M., Massin, P., Tournier-Lasserve, E., and 
Bousser, M.G. (2007). COL4A1 mutation in a patient with sporadic, recurrent intracerebral 
hemorrhage. Stroke 38, 1461–1464. 
127  Bibliography   
Vannucci, S.J., and Simpson, I. a (2003). Developmental switch in brain nutrient transporter 
expression in the rat. Am. J. Physiol. Endocrinol. Metab. 285, E1127–E1134. 
Vetrivel, K.S., Gong, P., Bowen, J.W., Cheng, H., Chen, Y., Carter, M., Nguyen, P.D., Placanica, 
L., Wieland, F.T., Li, Y.-M., et al. (2007). Dual roles of the transmembrane protein 
p23/TMP21 in the modulation of amyloid precursor protein metabolism. Mol. 
Neurodegener. 2, 4. 
Virchow, R.L.K. (1871). Die Cellularpathologie in ihrer Begründung auf physiologische und 
pathologische Gewebelehre (Berlin, Unter den Linden: Verlag von August Hirschfeld). 
Volkenhoff, A., Weiler, A., Letzel, M., Stehling, M., Klämbt, C., and Schirmeier, S. (2015). Glial 
glycolysis is essential for neuronal survival in drosophila. Cell Metab. 22, 437–447. 
Volterra, A., and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: 
the revolution continues. Nat. Rev. Neurosci. 6, 626–640. 
Wang, W., Knovich, M.A., Coffman, L.G., Torti, F.M., and Torti, S. V (2010). Serum ferritin: 
Past, present and future. Biochim. Biophys. Acta 1800, 760–769. 
Waxman, S.G., and Ritchie, J.M. (1993). Molecular dissection of the myelinated axon. Ann. 
Neurol. 33, 121–136. 
Wong, B.X., and Duce, J.A. (2014). The iron regulatory capability of the major protein 
participants in prevalent neurodegenerative disorders. Front. Pharmacol. 5 APR. 
Xiao, G., Wan, Z., Fan, Q., Tang, X., and Zhou, B. (2014). The metal transporter ZIP13 supplies 
iron into the secretory pathway in Drosophila melanogaster. Elife 3, e03191. 
Xiong, W.C., Okano, H., Patel, N.H., Blendy, J.A., and Montell, C. (1994). repo encodes a glial-
specific homeo domain protein required in the Drosophila nervous system. Genes Dev. 8, 
981–994. 
Yan, L.J., Levine, R.L., and Sohal, R.S. (1997). Oxidative damage during aging targets 
mitochondrial aconitase. Proc. Natl. Acad. Sci. U. S. A. 94, 11168–11172. 
Yoshiga, T., Georgieva, T., Dunkov, B.C., Harizanova, N., Ralchev, K., and Law, J.H. (1999). 
Drosophila melanogaster transferrin: Cloning, deduced protein sequence, expression 
during the life cycle, gene localization and up-regulation on bacterial infection. Eur. J. 
Biochem. 260, 414–420. 
Yu, G.S., Steinkirchner, T.M., Rao, G.A., and Larkin, E.C. (1986). Effect of prenatal iron 
deficiency on myelination in rat pups. Am. J. Pathol. 125, 620–624. 
Yuasa, Y. (2003). Drosophila homeodomain protein REPO controls glial differentiation by 
cooperating with ETS and BTB transcription factors. Development 130, 2419–2428. 
Bibliography  128 
Zala, D., Hinckelmann, M.-V., Yu, H., Lyra da Cunha, M.M., Liot, G., Cordelières, F.P., Marco, S., 
and Saudou, F. (2013). Vesicular glycolysis provides on-board energy for fast axonal 
transport. Cell 152, 479–491. 
Zecca, L., Youdim, M.B.H., Riederer, P., Connor, J.R., and Crichton, R.R. (2004). Iron, brain 
ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863–873. 
Zhang, X., Surguladze, N., Slagle-Webb, B., Cozzi, A., and Connor, J.R. (2006). Cellular iron 
status influences the functional relationship between microglia and oligodendrocytes. Glia 
54, 795–804. 
Zhu, Z.J., Wu, K.C., Yung, W.H., Qian, Z.M., and Ke, Y. (2016). Differential interaction between 
iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila. 
Biochim. Biophys. Acta - Mol. Basis Dis. 1862, 518–525. 
Zuchero, J.B., and Barres, B.A. (2013). Intrinsic and extrinsic control of oligodendrocyte 
development. Curr. Opin. Neurobiol. 23, 914–920. 
 
 
I 
 
Appendix 
Table 16: Primer designed and used in this study. Note that primers used for generation of pENTR plasmids for Gateway 
based cloning contain a CACC sequence for site directed insertion. Primers were synthesized by AGCT Lab (Core facility, 
MPI experimental medicine). 
Cloning Primer Sequence 5' - 3' Description 
pENTR_p24-1 for CACCATGAACACACAAATCGTTGTATT cloning Primer #1 forward, pENTR_p24-1 
pENTR_p24-1 S rev CTACAGCCGCCCGTAGTGTGC 
cloning Primer #1 reverse, pENTR_p24-
1_Stop 
pENTR_p24-1 OS rev CAGCCGCCCGTAGTGTGCCTG 
cloning Primer #1 reverse, pENTR_p24-
1_ohneStop 
pENTR_p24-1 D_OUT rev CAGCACCATAATCTGGACGAGAC 
cloning Primer #1 reverse, pENTR_p24-1 
delta outside 
pENTR_p24-1 sb_Gold rev CCGCTGATTGAGATCTTCGGC 
cloning Primer #1 reverse, pENTR_p24-1 
GOLD soluble 
pENTR_Fer1HC O.S. rev CAGGGTCTTGTCGAACAGGAAC 
cloning Primer #1 reverse, 
pENTR_Ferritin1HC ohne Stop 
pENTR_Fer1HC for CACCATGGTGAAACTAATTGCTAGCC 
cloning Primer #1 forward, 
pENTR_Ferritin1HC Iso A-D 
pENTR_Fer1HC rev TTACAGGGTCTTGTCGAACAGGA 
cloning Primer #1 reverse, 
pENTR_Ferritin1HC 
MUTA Fer1HC FLAG for 
GATGACTACAAAGACGATGACGACAAGTTCA
AGTGCTCCCTGGCTGTTCCTGAGATTACCAA
G 
mutagenesis Primer #1 forward, 
pENTR_Ferritin1HC FLAG 
MUTA Fer1HC FLAG rev 
GAACTTGTCGTCATCGTCTTTGTAGTCATCTC
CATAGGCCTGGGCCACCACGGCC 
mutagenesis Primer #1 reverse, 
pENTR_Ferritin1HC FLAG 
attB land site for GTCGACGATGTAGGTCACGGTC cloning primer forward attB landing site 
attB land site rev GTCGACATGCCCGCCGTG cloning primer reverse attB landing site 
attB land site rev 
CATCAAGTCTAGACTAGTAAAGACGCTGGG
GC 
cloning primer reverse Rpl10a with XbaI and 
linker 
MUTA FLAG-HA for 
CACGACTACAAAGACGATGACGACAAGCGC
GGTGGAGGCCGCATCTTTTACCCATACGATG
TTCC 
mutagenesis Primer  FLAG HA pUAST attB 
MUTA FLAG-HA rev 
GCGCTTGTCGTCATCGTCTTTGTAGTCGTGG
AGATCCATTCTAGCAGATATCACCACTTTGTA
CAAGAAAGCTGAACG 
mutagenesis Primer FLAG HA pUAST attB rev 
Rpl10ab-XbaI rev 
CATCAAGTCTAGACTAGTAAAGACGCTGGG
GC 
cloning primer reverse Rpl10a with XbaI and 
linker 
GFP for with Eco for 
GTTACAGAATTCCACCATGGTGAGCAAGGG
CGA 
cloning primer forward GFP with EcoRI , 
Kozak and linker, GFP-Rpl10ab 
HA for with Eco for 
GTTACAGAATTCCACCATGTACCCATACGAC
GTCCC 
cloning primer forward HA with EcoRI , Kozak 
and linker, HA-Rpl10ab 
pENTR_p24-1Viri for CACCATGCGCGACGAGCAGCTGAATAA 
cloning Primer #1 forward, pENTR_p24-1 
D.viri 
pENTR_p24-1Viri S rev TTACAGGCGACCATAGCGCGC 
cloning Primer #1 reverse, pENTR_p24-1Viri 
mit Stop 
Appendix  II 
pENTR_p24-1Viri o.S. rev CAGGCGACCATAGCGCGC 
cloning Primer #1 reverse, pENTR_p24-1Viri 
mit ohneStop 
   
PCR Primer Sequence 5' - 3' Description 
QF2 for ATGCCGACGGACACGCCGACG PCR primer forward QF2 and QF2w 
QF2 rev GAGGCCGTAGCCGTGGCGGTAGG PCR primer reverse QF2 and QF2w 
LandSite 51D rev CAGGTAGTTGAGGAGCTAACGTC 
PCR Primer for genomic localization of 
landing site 51D reverse 
LandSite 22A rev GCCGTGCAAAGACAGCTCTCG 
PCR Primer for genomic localization of 
landing site 22A reverse 
LandSite 51C rev GAGCCACAATGAGCTGGAGTAGC 
PCR Primer for genomic localization of 
landing site 51C reverse 
PCR p24-1 for GAACCCCAGACCTATCGTGCGGCG PCR Primer #1 forward, p24-1 
PCR p24-1 rev TGACGCCCTTCTATTGAAACGCTTTGTG PCR Primer #1 reverse, p24-1 
UAS for CGGAGTACTGTCCTCCGAG PCR primer forward UAS 
repo for ATGAAGCTACTGTCTTCTATCG PCR primer Gal4 for 
repo rev AAGAGCATCCCTGGGCATAAA PCR primer Gal4 rev 
UAS for CGGAGTACTGTCCTCCGAG PCR primer forward UAS 
PCR p24-1 for GAACCCCAGACCTATCGTGCGGCG PCR Primer #1 forward, p24-1 
PCR p24-1 rev TGACGCCCTTCTATTGAAACGCTTTGTG PCR Primer #1 reverse, p24-1 
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Table 17: Fly transformation plasmids generated in this work.  Note that different strategies (Gateway system, 
conventional cloning and PCR site directed insertion) were used to generate plasmids. pUAST and pQUAST 
harbor an ampicillin resistance gene for selection. The attB landing can be used for site directed insertion into 
the fly genome. 
Plasmid Cloning strategy 
pUASTattB-p24-1 Gateway with pENTR-p24-1 
pUASTattB-p24-1-GFP Gateway with pENTR-p24-1 w/o stop 
pUASTattB-p24-1-ΔOUT-HA Gateway with pENTR-p24-1 Δout w/o stop 
pUASTattB-p24-1-ΔOUT-GFP Gateway with pENTR-p24-1 Δout w/o stop 
pUASTattB-p24-1-HA Gateway with pENTR-p24-1 w/o stop 
pUASTattB-Myc-p24-1 Gateway with pENTR-p24-1 
pUASTattB-p24-1 stringDNA-GFP Gateway with pENTR-p24-1 stringDNA w/o stop 
pUASTattB-p24-1 [D.Viri]-HA Gateway with pENTR-p24-1 [D.virilis] w/o stop 
pUASTattB-RfA-FLAG-HA PCR site directed insertion of FLAG-HA 
pUASTattB-p24-1 FLAG-HA Gateway with pENTR-p24-1 w/o stop 
pUASTattB-p24-1-ΔOUT-FLAG-HA Gateway with pENTR-p24-1 Δout w/o stop 
pUASTattB-Fer1HCH-GFP Gateway with pENTR-Fer1HCH w/o stop 
pUASTattB-Fer1HCH-HA Gateway with pENTR-Fer1HCH w/o stop 
pUASTattB-SP-FLAG-Fer1HCH 
PCR site directed insertion of FLAG between signal 
peptide and ORF 
pQUASTattB Conventional cloning of attB in StuI restriction site 
pQUASTattb-GFP-Rpl10ab 
Conventional cloning of GFP-RPL10ab with EcoI and 
XbaI in MCS 
pQUAST-attb-HA-Rpl10ab 
Conventional cloning of HA-RPL10ab with EcoI and 
XbaI in MCS 
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Table 18: Screened RNAi lines. PNS defects observed upon confocal analysis are indicated (X). 
Gene ID  
Gene 
name 
VDRC ID 
PNS 
defect 
 
Gene ID  
Gene 
name 
VDRC ID 
PNS 
defect 
FBgn0037092  M6  101757   
 
FBgn0035587  Gdap1  106485   
FBgn0261822  Bsg  2789   
 
FBgn0261862  whd  4047 x 
FBgn0011708  Syx5  108928 x 
 
FBgn0032949  Lamp1  7309   
FBgn0036211  CG5946  110688 x 
 
FBgn0034753  CG2852  15069 x 
FBgn0002543  robo2  11823   
 
FBgn0010473  tutl  3064   
FBgn0004456  mew  109608   
 
FBgn0025678  CaBP1  43148   
FBgn0250874  ttm50  5587 x 
 
FBgn0038038  CG5167  6092   
FBgn0000108  Appl  42673 x 
 
FBgn0032833  COX4  3923 x 
FBgn0039734  Tace  2733   
 
FBgn0028692  Rpn2  44135 x 
FBgn0037710  CG9393  44400   
 
FBgn0015623  Cpr  44232   
FBgn0026438  Eaat2  104371   
 
FBgn0013343  Syx1A  33112 x 
FBgn0051547  CG31547  105911   
 
FBgn0005666  bt  46253 x 
FBgn0004868  Gdi  26537 x 
 
FBgn0030887  CG6867  37416 x 
FBgn0036843  CG6812  8534   
 
FBgn0031981  CG7466  42462 x 
FBgn0037240  Cont  40613 x 
 
FBgn0023537  CG17896  107006   
FBgn0029870  Marf  40478   
 
FBgn0030035  CG11190  14821   
FBgn0051229  CG31229  9660   
 
FBgn0023549  Mct1  106773   
FBgn0031500  CG17221  25229 x 
 
FBgn0027865  Tsp96F  3422   
FBgn0033020  COX4L  106700   
 
FBgn0265296  Dscam2  1100   
FBgn0002921  Atpalpha  12330   
 
FBgn0036509  CG7739  51521 x 
FBgn0015399  kek1  36252 x 
 
FBgn0024947  NTPase  7265 x 
FBgn0035032  ATPsynF  13324   
 
FBgn0050491  CG30491  12817   
FBgn0029687  Vap-33A  30404 x 
 
FBgn0004619  GluRIA  44439   
FBgn0033451  CG1665  9958   
 
FBgn0033906  CG8331  105290   
FBgn0039213  atl  6719 x 
 
FBgn0263219  Dscam4  25365   
FBgn0000071  Ama  22944 x 
 
FBgn0036821  CG3961  37305   
FBgn0013997  Nrx-IV  9039 x 
 
FBgn0250876  Sema-5c  9428 x 
FBgn0051619  nolo  33102   
 
FBgn0034368  CG5482  4991   
FBgn0035523  CG1311  39695   
 
FBgn0265140  Meltrin  3704 x 
FBgn0031392  AIF  2544   
 
FBgn0027786  Mtch  106996   
FBgn0030341  p24-1  12196 x 
 
FBgn0032679  bsf  22837   
FBgn0083950  CG34114  103456 x 
 
FBgn0034645  ND-B12  8837 x 
FBgn0261260  mgl  103661   
 
FBgn0029131  Debcl  47517 x 
FBgn0000497  ds  36219   
 
FBgn0262870  axo  107491 x 
V  Appendix   
Gene ID  
Gene 
name 
VDRC ID 
PNS 
defect  
Gene ID  
Gene 
name 
VDRC ID 
PNS 
defect 
FBgn0259214  PMCA  101743 x 
 
FBgn0035798  frac  104254   
FBgn0026439  Eaat1  109401   
 
FBgn0028671  Vha100-1  22925   
FBgn0039688  Kul  28347 x 
 
FBgn0267828  Fatp  9406   
FBgn0259110  mmd  103449 x 
 
FBgn0032850  Kua  101360 x 
FBgn0014868  Ost48  105881   
 
FBgn0028331  l(1)G0289  1054   
FBgn0005631  robo1  42241   
 
FBgn0035600  Cyt-c1  9180   
FBgn0039709  Cad99C  27211   
 
FBgn0261985  Ptpmeg  38652 x 
FBgn0039140  Miro  106683 x 
 
FBgn0260743  GC1  106319   
FBgn0021764  sdk  9437   
 
FBgn0033095  CG3409  37141 x 
FBgn0053113  Rtnl1  7866   
 
FBgn0003360  sesB  48582 x 
FBgn0011259  Sema-1a  36147 x 
 
FBgn0038837  CG3822  4085 x 
FBgn0051072  Lerp  1251   
 
FBgn0032536  Ance-3  43198   
FBgn0042135  CG18812  39224   
 
FBgn0035519  CG1309  37227   
FBgn0037239  CG11739  44562 x  FBgn0001250  if  5600 x 
FBgn0025608  Faf2  107414 x  FBgn0265187  CG44252  3528   
FBgn0004919  gol  37435 x  FBgn0039528  dsd  1106   
FBgn0025741  PlexA  4740    FBgn0011455  ND-SGDH  11381 x 
FBgn0030883  CG7772  30431    FBgn0050404  Tango11  29385   
FBgn0263006  SERCA  4474    FBgn0038975  Nrx-1  36328   
FBgn0019886  Letm1  6662    FBgn0035473  mge  109502 x 
FBgn0037756  CG8507  42640    FBgn0034497  CG9090  44297 x 
FBgn0000447  Dhod  51061    FBgn0267849  Syx7  107264 x 
FBgn0053303  CG33303  107778    FBgn0036702  CG6512  8515 x 
FBgn0039689  CIA30  14861    FBgn0030703  MSBP  45185 x 
FBgn0010051  Itp-r83A  106982 x  FBgn0015031  cype  13403   
FBgn0259714 
 DIP-
epsilon  
23490 x  FBgn0039830 
 ATPsynC  106834   
FBgn0033324  CG14744  40829    FBgn0039651  Cyt-c1L  106229   
FBgn0265042  Irk1  28431    FBgn0035588  CG10672  18661   
FBgn0266758  Esyt2  28418    FBgn0004242  Syt1  8875 x 
FBgn0264975  Nrg  27202    FBgn0028369  kirre  3111   
FBgn0000635  Fas2  36351    FBgn0019957  ND-42  110787   
FBgn0034997  CG3376  12226 x  FBgn0031401  papi  2554   
FBgn0026409  Mpcp  8366 x  FBgn0024189  sns  109442   
FBgn0036279  Ncc69  106499 x  FBgn0023529  CG2918  18440   
FBgn0283499  InR  992    FBgn0011592  fra  16923   
FBgn0000464  Lar  36270 x  FBgn0013675  mt:CoII  109401   
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Table 19: Screen list of secreted and IgSF candidates. Lethality observed upon neuronal + glial (NG), glial (G) and 
neuronal (N) is indicated (X). 
Gene ID Gene name VDRC ID NG G N 
 
Gene ID Gene name VDRC ID NG G N 
FBgn0034920 CG5597 12875       
 
FBgn0014007 Ptp69D 104761 x   x 
FBgn0261822 Bsg 105293       
 
FBgn0033159 Dscam1 108835       
FBgn0010238 Lac 107450 x x   
 
FBgn0039584 beat-VI 105798 x   x 
FBgn0013433 beat-Ia 4543       
 
FBgn0038494 beat-IIb 104935       
FBgn0034730 ppk12 105131       
 
FBgn0010473 tutl 108746       
FBgn0002543 robo2 11823       
 
FBgn0052791 DIP-alpha 104044       
FBgn0259716 CG42370 110244       
 
FBgn0261046 Dscam3 6685       
FBgn0001257 ImpL2 106543 x   x 
 
FBgn0029082 hbs 105913 x   x 
FBgn0039431 plum 101135       
 
FBgn0038084 beat-Vc 102793 x   x 
FBgn0025878 wrapper 105314 x   x 
 
FBgn0005592 btl 110277       
FBgn0031016 kek5 47768       
 
FBgn0052311 zormin 101304 x   x 
FBgn0024189 sns 877       
 
FBgn0032479 CG16974 100366 x   x 
FBgn0083950 CG34114 103456       
 
FBgn0265296 Dscam2 1100       
FBgn0037240 Cont 40613 x x   
 
FBgn0005666 bt 46253 x     
FBgn0015399 kek1 101166       
 
FBgn0267911 trol 110494       
FBgn0036146 CG14141 43017       
 
FBgn0259245 DIP-beta 49553       
FBgn0000071 Ama 22944       
 
FBgn0030887 CG6867 37416       
FBgn0052311 zormin 104689       
 
FBgn0051708 DIP-zeta 107866       
FBgn0051619 nolo 104736 x     
 
FBgn0030174 CG15312 101286       
FBgn0267728 otk2 106266       
 
FBgn0034724 babos 36304       
FBgn0032006 Pvr 105353 x x   
 
FBgn0037107 CG7166 107945       
FBgn0000636 Fas3 100642 x   x 
 
FBgn0040388 boi 108265       
FBgn0041097 robo3 44702       
 
FBgn0031627 CG15630 107797       
FBgn0030723 dpr18 983       
 
FBgn0085382 CG34353 102326       
FBgn0028482 bdl 109857       
 
FBgn0265002 CG44153 102832       
FBgn0032629 beat-IIIc 109015       
 
FBgn0037908 dpr5 102228       
FBgn0052057 dpr10 103511       
 
FBgn0035170 dpr20 101673 x     
FBgn0038092 beat-Vb 106502       
 
FBgn0034788 CG13532 105696       
FBgn0259245 DIP-beta 106021       
 
FBgn0085400 CG34371 22710       
FBgn0038282 dpr9 38690       
 
FBgn0000547 ed 104279       
FBgn0005631 robo1 100624       
 
FBgn0086604 CG12484 104814       
FBgn0265607 beat-IIIa 45866       
 
FBgn0034013 unc-5 110155       
FBgn0261871 dpr2 29742 x x   
 
FBgn0051431 CG31431 104697 x   x 
FBgn0085420 DIP-delta 42353       
 
FBgn0029974 dpr14 102040       
FBgn0036145 CG7607 9208       
 
FBgn0053202 dpr11 23243       
FBgn0000633 fas 102073 x   x 
 
FBgn0030466 CG15744 1096       
FBgn0265002 CG44153 44494       
 
FBgn0038087 beat-Va 102698 x   x 
FBgn0021764 sdk 106217       
 
FBgn0051774 fred 101138 x   x 
FBgn0053543 CG33543 17859       
 
FBgn0028645 beat-Ib 101662       
FBgn0028644 beat-Ic 105066 x   x 
 
FBgn0004839 otk 104688 x   x 
FBgn0003137 Ppn 108005       
 
FBgn0083949 CG34113 101967       
FBgn0053512 dpr4 102905       
 
FBgn0037993 dpr15 46245       
FBgn0003495 spz 105017       
 
FBgn0017590 klg 108818       
FBgn0051361 dpr17 100978 x   x 
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Gene ID Gene name VDRC ID NG G N  Gene ID Gene name VDRC ID NG G N 
FBgn0034286 dpr13 107676 x   x 
 
FBgn0003034 SP 109175 x   x 
FBgn0034723 CG13506 104632       
 
FBgn0264810 Pburs 102690 x     
FBgn0053481 dpr7 106546 x   x 
 
FBgn0004360 Wnt2 104338       
FBgn0039089 beat-IV 52413       
 
FBgn0025583 IM2 46291       
FBgn0259245 DIP-beta 107402 x   x 
 
FBgn0027109 NPF 108772       
FBgn0250908 beat-VII 102329       
 
FBgn0002563 Lsp1beta 35584       
FBgn0011828 Pxn 107180 x x   
 
FBgn0032144 CG17633 13283 x     
FBgn0037736 CG12950 106353       
 
FBgn0015584 Acp53Ea 52435       
FBgn0003285 rst 27223       
 
FBgn0034329 IM1 8812       
FBgn0028370 kek3 6354       
 
FBgn0043577 PGRP-SB2 106538       
FBgn0263219 Dscam4 23488       
 
FBgn0014411 Vps26 110384 x x x 
FBgn0264975 Nrg 107991 x x   
 
FBgn0025456 CREG 108999       
FBgn0051646 DIP-theta 100781       
 
FBgn0039298 to 100079       
FBgn0000635 Fas2 103807 x   x 
 
FBgn0011581 Ms 108760 x   x 
FBgn0053519 Unc-89 106267       
 
FBgn0011746 ana 9287       
FBgn0038156 CG14372 16636       
 
FBgn0031701 TotM 106727       
FBgn0000464 Lar 107996       
 
FBgn0002863 Acp95EF 6853       
FBgn0037295 dpr16 102628 x     
 
FBgn0014076 Vm32E 102810       
FBgn0011592 fra 16923       
 
FBgn0005391 Yp2 50156 x x   
FBgn0053516 dpr3 6692 x     
 
FBgn0004240 DptA 104287 x x   
FBgn0031756 CG13992 2642       
 
FBgn0043575 PGRP-SC2 104578 x   x 
FBgn0051814 CG31814 102224 x     
 
FBgn0040813 Nplp2 15305       
FBgn0051806 CG31806 107474       
 
FBgn0003865 tsg 108750       
FBgn0262509 nrm 104295       
 
FBgn0036713 Mip 106076       
FBgn0039862 kek6 109681 x   x 
 
FBgn0020277 lush 102307 x   x 
FBgn0040823 dpr6 103521       
 
FBgn0010388 Dro 105251       
FBgn0031872 ihog 102602       
 
FBgn0040717 Nplp4 104662       
FBgn0035410 CG14964 43603       
 
FBgn0030099 CG12056 108336       
FBgn0086906 sls 47298 x x   
 
FBgn0000594 Est-P 30870       
FBgn0053202 dpr11 107548 x   x 
 
FBgn0000278 CecB 103148       
FBgn0052600 dpr8 106791       
 
FBgn0000592 Est-6 35607       
FBgn0263219 Dscam4 25365       
 
FBgn0034328 IM23 15385       
FBgn0015400 kek2 4745       
 
FBgn0262728 Pal2 102238       
FBgn0011260 Sema-2a 15810       
 
FBgn0001112 Gld 108361 x   x 
FBgn0016061 side 1283       
 
FBgn0011279 Obp69a 39523       
FBgn0034083 lbk 106679       
 
FBgn0011694 EbpII 103004       
FBgn0031837 DIP-iota 18054       
 
FBgn0010225 Gel 37865       
FBgn0085414 dpr12 44740       
 
FBgn0004009 wg 13352       
FBgn0053516 dpr3 106517 x   x 
 
FBgn0038134 wntD 107727       
FBgn0036454 CG17839 100149       
 
FBgn0264089 sli 108853 x x   
FBgn0028369 kirre 109585       
 
FBgn0036565 CG5235 108305       
FBgn0259213 CG42313 103687       
 
FBgn0015585 Acp63F 106565       
FBgn0032484 kek4 105647       
 
FBgn0023178 Pdf 50750       
FBgn0040726 dpr1 33816       
 
FBgn0039678 Obp99a 100475 x x x 
FBgn0266801 CG45263 102322       
 
FBgn0011293 a10 11478       
Fbgn0032233 dpr19 110059       
 
FBgn0010359 gammaTry 31016       
FBgn0039617 DIP-gamma 104056 x   x 
 
FBgn0003751 trk 51240       
FBgn0003984 vn 109437 x     
 
FBgn0044050 Ilp3 106512       
FBgn0001114 Glt 15428       
 
FBgn0010295 ng3 102175 x x x 
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Gene ID Gene name VDRC ID NG G N  Gene ID Gene name VDRC ID NG G N 
Fbgn0039722 Capa 101705 x   x 
 
FBgn0003979 Vm26Aa 101812       
FBgn0002121 l(2)gl 109604       
 
FBgn0004569 aos 47180 x     
FBgn0261534 l(2)34Fc 12405       
 
FBgn0261987 Pxt 104446 x x   
FBgn0004045 Yp1 13343       
 
FBgn0004644 hh 1402       
FBgn0087002 apolpp 100944       
 
FBgn0283462 IMPPP 12843       
FBgn0015001 iotaTry 43206       
 
FBgn0067905 IM14 110032       
FBgn0041579 AttC 101213       
 
FBgn0011669 Mst57Db 29219       
FBgn0015773 NetA 108577       
 
FBgn0010294 ng2 109556 x x x 
FBgn0011259 Sema-1a 104505       
 
FBgn0020509 Acp62F 107475 x   x 
FBgn0043578 PGRP-SB1 101298       
 
FBgn0044048 Ilp5 105004 x     
FBgn0004034 y 106068       
 
FBgn0002562 Lsp1alpha 101101       
FBgn0000808 gd 14892       
 
FBgn0011591 fng 51977       
FBgn0267327 Acp33A 109126       
 
FBgn0001254 ImpE2 100148 x   x 
FBgn0030310 PGRP-SA 5594       
 
FBgn0041581 AttB 52342       
FBgn0064237 Idgf5 100977       
 
FBgn0000500 Dsk 106592       
FBgn0000658 fj 6774       
 
FBgn0003313 sala 100432 x   x 
FBgn0034468 Obp56a 100850       
 
FBgn0044028 Notum 103775       
FBgn0035092 Nplp1 107116       
 
FBgn0004552 Akh 105063       
FBgn0030695 PGRP-LE 23664       
 
FBgn0002564 Lsp1gamma 38129       
FBgn0000533 ea 102357       
 
FBgn0045866 bai 100612 x   x 
FBgn0000427 dec-1 22940       
 
FBgn0044046 Ilp7 105024       
FBgn0028396 TotA 106548       
 
FBgn0002926 ndl 102818       
FBgn0000277 CecA2 9715       
 
FBgn0011559 Acp36DE 105453       
FBgn0015583 Acp29AB 100995       
 
FBgn0030251 CG2145 110580       
FBgn0010357 betaTry 102898       
 
FBgn0050031 CG30031 38031       
FBgn0034470 Obp56d 100671       
 
FBgn0014865 Mtk 109740       
FBgn0000299 Col4a1 104536 x   x 
 
FBgn0035806 PGRP-SD 107879       
FBgn0034803 CG9849 12852       
 
FBgn0004956 upd1 3282       
FBgn0010296 ng4 104038 x   x 
 
FBgn0030926 psh 18543       
FBgn0016122 Acer 3324       
 
FBgn0011283 Obp28a 103254       
FBgn0003450 snk 107337       
 
FBgn0020414 Idgf3 12423       
FBgn0013767 Crz 106876       
 
FBgn0023496 Lip1 105572 x     
FBgn0000715 FMRFa 37965       
 
FBgn0002565 Lsp2 109979       
FBgn0010385 Def 102437       
 
FBgn0036141 wls 103812       
FBgn0003390 shf 14803       
 
FBgn0025615 Torsin 110073       
FBgn0069242 eca 101388       
 
FBgn0003866 tsh 16892       
FBgn0010453 Wnt4 104671 x   x 
 
FBgn0011653 mas 103955 x     
FBgn0267327 Acp33A 50979       
 
FBgn0039685 Obp99b 109839       
FBgn0029838 CG4666 109818       
 
FBgn0040323 GNBP1 107100 x   x 
FBgn0010114 hig 109863 x     
 
FBgn0004047 Yp3 46785       
FBgn0011281 Obp83a 102733       
 
FBgn0011282 Obp84a 1849       
FBgn0002856 Acp26Ab 107536       
 
FBgn0034475 Obp56h 102562       
FBgn0028374 Hug 107771       
 
FBgn0031381 Npc2a 106771       
FBgn0011554 etaTry 33233       
 
FBgn0036545 GXIVsPLA2 100558       
FBgn0000359 Cp36 14824       
 
FBgn0011695 EbpIII 100157       
FBgn0033367 PPO2 107772       
 
FBgn0086782 amn 5606       
FBgn0020416 Idgf1 12414       
 
FBgn0044811 TotF 101199       
IX  Appendix   
 
Gene ID Gene name VDRC ID NG G N  Gene ID Gene name VDRC ID NG G N 
FBgn0011670 Mst57Dc 106728        FBgn0261363 PPO3 50737    
FBgn0038901 Burs 102204 x   x 
 
FBgn0263597 Acp98AB 102677 x   x 
FBgn0044810 TotX 100514 x   x 
 
FBgn0025879 Timp 109427       
FBgn0042201 Nplp3 105584       
 
FBgn0000221 brn 45457       
FBgn0000564 Eh 44967 x     
 
FBgn0024913 Actbeta 108663       
FBgn0011668 Mst57Da 40694       
 
FBgn0261800 LanB1 23119       
FBgn0016031 lama 107629 x   x 
 
FBgn0011556 zetaTry 108756       
FBgn0000358 Cp19 110305       
 
FBgn0004181 Ebp 100183 x x   
FBgn0003980 Vm26Ab 103228 x   x 
 
FBgn0015586 Acp76A 108698       
FBgn0000719 fog 101125 x x   
 
FBgn0031109 Obp19a 9387       
FBgn0030501 BthD 45975 x x   
 
FBgn0011280 Obp19d 46707       
FBgn0044047 Ilp6 102465 x   x 
 
FBgn0000357 Cp18 102367       
FBgn0002855 Acp26Aa 41193       
 
FBgn0015774 NetB 100840 x x x 
FBgn0010194 Wnt5 101621       
 
FBgn0044049 Ilp4 105516 x   x 
FBgn0005590 scw 21400       
 
FBgn0000094 Anp 109202       
FBgn0040736 IM3 104908       
 
FBgn0044812 TotC 106379       
FBgn0011294 a5 100657       
 
FBgn0000355 Cp15 13860       
FBgn0028418 Lk 14091       
 
FBgn0010403 Obp83b 102252 x   x 
FBgn0031902 Wnt6 104020 x   x 
 
FBgn0010425 epsilonTry 30807       
FBgn0267348 LanB2 104013 x   x 
 
FBgn0026415 Idgf4 104968       
FBgn0000356 Cp16 104999 x x x 
 
FBgn0015222 Fer1HCH 12925 x x   
FBgn0038838 TotB 51123       
 
FBgn0002526 LanA 18873       
FBgn0283509 Phm 104028       
 
FBgn0004577 Pxd 48588       
FBgn0011555 thetaTry 102026       
 
FBgn0023415 Acp32CD 102687       
FBgn0037976 Tk 103662 x   x 
 
FBgn0039774 CDase 110671       
FBgn0040322 GNBP2 104094       
 
FBgn0029708 CG3556 30230       
FBgn0003863 alphaTry 103292       
 
FBgn0033327 PGRP-SC1b 51237       
FBgn0031414 eys 107636       
 
FBgn0013763 Idgf6 100906       
FBgn0012037 Ance 41219       
 
FBgn0027095 Manf 100814       
FBgn0031903 Wnt10 100867 x x   
 
FBgn0003867 tsl 14429       
FBgn0003983 Vm34Ca 102199 x x   
 
FBgn0044051 Ilp1 5198       
FBgn0032048 Dh31 50295       
 
FBgn0036046 Ilp2 102158 x   x 
FBgn0015591 AstA 103215 x   x 
 
FBgn0043576 PGRP-SC1a 43201       
FBgn0283461 Drs 2703       
 
FBgn0037906 PGRP-LB 104557 x   x 
FBgn0040321 GNBP3 37255       
 
FBgn0002933 ng1 109143 x x x 
 
 
